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ABSTRACT 
Phillip W. Clapp: Modification of Respiratory System Innate Defense Mechanisms by 
Flavoring Agents in Electronic Cigarettes  
(Under the direction of Ilona Jaspers) 
 
Electronic cigarettes (e-cigarettes) have emerged as a potentially safer alternative to 
traditional cigarettes. Because e-cigarettes deliver nicotine without burning tobacco, their use 
likely confers a lower overall health risk than inhaling combustible tobacco products. 
However, e-cigarette emissions contain solvents (propylene glycol and glycerol), flavorings, 
and other additives, which have not been evaluated for inhalation toxicities. The inhalation of 
flavoring agents, which are frequently aldehydes, poses a significant unknown in regards to 
the potential health risks of e-cigarette use as many of these chemicals are structurally similar 
to toxic aldehydes in cigarette smoke. Furthermore, aldehyde flavoring agents are often used 
at exceedingly high concentrations in e-cigarettes which may lead to high exposure doses. 
The work presented in this dissertation focuses on evaluating the effects of flavored e-
cigarettes, particularly those containing ⍺,β-unsaturated cinnamaldehyde, on respiratory 
innate defense mechanisms and assessing whether and how these flavorings may alter 
susceptibility to respiratory infections. In Chapter 2, we report that cinnamon-flavored e-
cigarette refill liquids and cinnamaldehyde modify human respiratory innate immune cell 
defense functions, including neutrophil and alveolar macrophage phagocytosis, neutrophil 
extracellular trap formation, and natural killer (NK) cell-mediated killing of leukemia cells. 
Based on these observations we established the cinnamaldehyde exposure concentrations that 
inhibit normal defense functions (IC50) and induce cytotoxicity (LC50). In Chapter 3, we 
iv 
 
report that cinnamon-flavored e-liquids, cinnamon e-cigarette aerosols, and cinnamaldehyde 
temporarily suppress motile cilia on human bronchial epithelial cells (hBE) and that this 
response is driven by transient inhibition of mitochondrial respiration and glycolysis. In 
Chapter 4, we report that cinnamaldehyde, guaiacol, and eugenol elicit a dose-dependent 
bimodal effect on Nrf2-pathway activation in bronchial epithelial cells (Beas-2B) and 
cinnamaldehyde exposure significantly depletes cellular glutathione (GSH) levels at low 
micromolar concentrations. Taken together, the work presented in this dissertation 
demonstrates that flavoring agents, in the context of e-cigarette use, are capable of 
dysregulating essential respiratory defense responses, which may increase susceptibility of 
respiratory infections and lung disease in e-cigarette users. It is our hope that the information 
provided here will be useful in the development of health-protective policies aimed at 
reducing or eliminating harmful and potentially harmful chemicals from e-cigarettes. 
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CHAPTER 1. 
INTRODUCTION 
1.1  Respiratory system host defense against pathogens and pollutants 
Gas exchange is the primary function of the respiratory system where the interface 
between environment and host is essential for life. Inspired oxygen is transported across 
alveolar epithelial cells and enters the pulmonary circulation, and carbon dioxide is released 
from the blood into the external environment. However, this environment/host interface also 
provides a potential site for injury and infection. An average adult who is moderately active 
breathes approximately 20,000 liters of air over a 24-hour period. Inevitably, this air contains 
potentially harmful pathogens, particulate matter, and gasses.  Particles and bioaerosols, such 
as soot, dust, mold, fungi, bacteria, and viruses can deposit on respiratory mucosal surfaces 
and cause damage to the airways and underlying tissues. Particle deposition in the lung is 
largely dependent upon size and aerodynamic diameter. Particles greater than 10µm 
generally deposit in the nasopharynx and oropharynx by impaction where inertial forces 
carry them out of the airstream and against the posterior pharyngeal wall (2). Particles 
between 5µm and 10µm enter the conducting airways but generally sediment onto the 
mucociliary surface. Particles less than 5µm (the size of viral particles and many bacteria) 
reach the respiratory airways and alveoli. As protection from environmental threats, 
respiratory tissues have evolved a tightly-regulated immune system which relies on innate 
and adaptive responses to neutralize and eliminate foreign or dangerous material. Innate 
immunity is the non-specific first response to inhaled material and is composed of physical
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barriers, such as airway mucus, mucociliary clearance, and epithelial tight junctions, soluble 
antimicrobial molecules, such as surfactant proteins and cytokines, and resident and 
circulating innate immune cells, such as macrophages and neutrophils (3). Cellular cross-talk 
during innate immune responses is necessary to establish the appropriate inflammatory 
response and to direct adaptive immune responses (4, 5). Adaptive immunity is an antigen-
specific, cell- and antibody-mediated immune response to eliminate specific invading 
pathogens (4). The adaptive immune response is mediated by antigen-presenting cells 
(predominately dendritic cells and macrophages) and T and B lymphocytes, and typically 
results in immunological memory of a specific pathogen (4, 6). Effective communication 
between the innate and adaptive immune systems is not only essential for eliminating 
potential threats, but also for discriminating between potential threats, host tissues, and 
innocuous substances, and maintaining a state of tolerance to prevent unnecessary 
inflammation. Disruption of normal respiratory immune function increases susceptibility to 
respiratory infection, stimulates tissue inflammation, and promotes tissue damage. This can 
exacerbate existing respiratory conditions, such as asthma (7) and cystic fibrosis (8), and 
contribute to the development and progression of lung disease, such as pulmonary fibrosis (9) 
and chronic obstructive pulmonary disease (COPD) (10, 11). The work in this dissertation 
focuses on the respiratory innate immune system, which will be discussed in more detail in 
the following sections. 
1.2 Innate immunity in the respiratory system  
The respiratory innate immune system is an evolutionarily conserved defense system 
that provides the first line of defense against inhaled pathogens and foreign material. The 
components of the innate immune system include 1) airway epithelial cells and physical and 
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mechanical barriers at the luminal epithelial surface, 2) circulating and airway resident 
leukocytes, and 3) soluble proteins which bind to microbial antigens and facilitate uptake by 
leukocytes. Each of these components will be described in more detail in the following 
paragraphs. 
1.2.1 Physical and mechanical barriers of respiratory innate immune system 
Airway epithelial cells. Airway epithelial cells line the entire respiratory tract and 
provide a continuous protective barrier against inhaled environmental insults. The type and 
relative abundance of epithelial cell populating the respiratory tract changes depending on the 
anatomical region of the airway. The proximal conducting airways which include the nasal 
passages, pharynx, larynx, trachea, bronchi, and bronchioles, are composed of 
pseudostratified columnar epithelial cells, goblet cells (mucus-producing secretory cells), 
serous cells (serous fluid-producing secretory cells in submucosal gland acini), and basal 
cells (multi-potent stem cells), which function to humidify, warm, and clean inspired air (12-
14). As bronchi branch into bronchioles and terminal bronchioles, the pseudostratified 
epithelium gradually transitions to a simple columnar epithelium and then a simple cuboidal 
epithelium which is predominately populated with ciliated epithelial cells, club cells (non-
ciliated, non-mucus producing secretory cells), and neuroendocrine cells (15). The most 
distal respiratory airways consist of respiratory bronchioles, alveolar ducts, and clusters of 
alveoli composed of simple squamous Type I and cuboidal Type II pneumocytes which 
facilitate gas exchange and secrete surfactant proteins, respectively (16). While epithelial 
cells of the lower respiratory airways do provide a barrier and generate immune responses to 
pathogens, the proximal conducting airways play the greatest role in defending the lungs 
from inhaled foreign material (17).  
 
 4 
Airway epithelial cell junctions. An essential feature of airway epithelium is the 
apical junctional complex that forms between neighboring epithelial cells to regulate 
paracellular permeability. These complexes are made of apical tight junctions (formed from 
claudin family proteins, tight junction–associated MAL and related proteins for vesicle 
trafficking and membrane link (MARVEL) proteins, and IgG-like proteins), which regulate 
the paracellular transport of ions and certain molecules, and underlying adherens junctions 
(formed from E-cadherin and nectin family proteins), which initiate and maintain cell-cell 
adhesion through interactions with the cellular cytoskeleton (18). In addition to creating a 
nearly impenetrable cell-cell barrier that prevents inhaled pathogens and other environmental 
insults from injuring the airways, apical junction complexes serve as signaling platforms that 
regulate gene expression and cell proliferation and are essential for establishing apical–basal 
epithelial cell polarity (19).    
Airway surface liquid. Mucociliary clearance is an important innate defense 
mechanism that protects the airways from inhaled infectious and toxic substances. Goblet 
cells in the proximal conducting airways and submucosal gland acini secrete high molecular 
weight gel-forming mucin glycoproteins (predominately MUC5AC and MUC5B) which 
confer upon the airway surface liquid the biochemical and biophysical properties necessary 
for entrapment and transport of foreign material from the lung (20). The airway surface 
liquid is composed of two layers; an upper layer of viscoelastic mucus which sits above a less 
viscous periciliary layer. The periciliary layer is composed of a hydrated macromolecular 
mesh of membrane-spanning mucins (predominately MUC1, MUC4, and MUC16) and large 
membrane-bound glycoproteins that are densely tethered to cilia, microvilli, and the 
epithelial surface (21). In the large conducting airways, the periciliary layer is approximately 
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7µm in height (the length of outstretched cilia) and provides a lubricating environment for 
cilia beating (17). Effective mucociliary clearance of airway surface liquid depends on the 
composition of the mucus layer (i.e. the relative abundance of gel-forming mucins) and 
hydration of the periciliary layer.  
Airway cilia. Motile airway cilia are hair-like structures that provide the mechanism 
by which airway surface liquid containing trapped material is transported from the lung. 
Ciliated cells account for over 50% of all epithelial cells in the proximal conducting airways 
and each ciliated cell has approximately 200 to 300 cilia projecting from its apical surface 
(22).  Cilia are microtubule-based organelles, which extend from basal bodies at the apical 
cell surface. An axoneme, which is the central strand of a cilium, contains a ring of nine 
microtubule doublets surrounding a central pair, known as a 9+2 configuration. Inner and 
outer arm dynein ATPases connect the nine microtubule doublets and generate the force 
needed for cilia motility in an ATP-dependent process. There are thousands of dynein 
ATPase motors in a single axoneme which require sufficient and sustained levels of ATP to 
maintain cilia function (23). Although ATP controls basal cilia function, regulation of cilia 
beat frequency depends on other intracellular and secreted second messengers including 
cyclic nucleotides (cAMP and cGMP), nitric oxide, intracellular calcium, progesterone, and 
pH (24-26).  
1.2.2  Leukocytes of the respiratory innate immune system 
Pulmonary macrophages. Pulmonary macrophages are the most abundant immune 
cell in the lung under normal homeostatic conditions and provide a variety of specialized 
functions, including maintenance of pulmonary homoeostasis, removal of cell debris, 
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immune surveillance, microbial clearance, responses to infection, and resolution of 
inflammation (27). The remarkable plasticity of these cells can be attributed to differences in 
their origin, lung microenvironment, and exposure to environmental stimuli. Resident 
alveolar macrophages (characterized as CD11blow/CD11chigh) have a high phagocytic 
capacity and secrete antimicrobial compounds, such as oxygen metabolites, lysozyme, and 
proteases to eliminate pathogens and debris that have infiltrated the respiratory airways (27, 
28). However, alveolar macrophages also actively suppress the induction of adaptive 
immunity to maintain lung homeostasis (29). When exposed to larger quantities of pathogens 
or particularly virulent microbes, alveolar macrophages can mount a robust immune response 
by synthesizing and secreting an array of cytokines (including IL-1, IL-6, and TNF-α), 
chemokines (including IL-8), and arachidonic acid metabolites (including prostaglandins and 
leukotrienes) to promote inflammation and recruit neutrophils to the alveoli (30, 31). Less is 
known about interstitial macrophages (characterized as CD11bhigh/CD11clow), which reside in 
the lung parenchyma. Recent studies suggest that interstitial macrophages play a significant 
role in modulating adaptive immune responses by TLR4/MyD88-mediated production of IL-
10 and subsequent negative regulation of Th2- and Th17-mediated inflammatory responses 
(32). 
Dendritic cells. Dendritic cells are a heterogeneous population of antigen-presenting 
cells that bridge the innate and adaptive immune systems. These cells form an elaborate 
network throughout the conducting airways, lung interstitium, lung vasculature, pleura, and 
bronchial lymph nodes (33, 34). Myeloid dendritic cells, the predominant respiratory 
dendritic cell type, are continuously recruited to the lungs to serve as sentinels for pathogens 
in the respiratory tract.  Myeloid dendritic cells localize at the epithelial basal lamina and 
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extend their cellular processes between airway epithelial cells into the lumen where pattern 
recognition receptors (PRRs) bind to microbial proteins on pathogens (35, 36). Upon 
recognition, pathogens are phagocytosed and destroyed in phagosomes; however, this 
process is much gentler than phagosomal degradation in macrophages and neutrophils, 
allowing for the preservation of antigen integrity (37).  Pathogen proteins are processed into 
peptide fragments and antigens are presented via major histocompatibility complex (MHC) 
molecules to T cells at regional lymph nodes (35). In addition to antigens presented on MHC 
molecules, T cells require co-stimulatory signals (such as CD80/CD86), polarizing signals 
(such as IL-12 and CCL2), and feedback stimulation (by CD40) to sufficiently mount an 
adaptive immune response (38). Lack of complementary signaling induces T cell anergy as a 
mechanism of inactivation and immune tolerance (38). 
Neutrophils. Neutrophils, also known as polymorphonuclear cells (PMNs), are the 
primary effector cell in acute inflammatory responses and actively eradicate pathogens with a 
variety of killing mechanisms (39). They are continuously produced in the bone marrow by 
myeloid precursor cells in a process regulated by granulocyte colony stimulating factor 
(G-CSF) (40). However, recent data suggest that mature neutrophils may proliferate outside 
of the bone marrow in response to specific signaling molecules, such as serum amyloid A 
(41). As neutrophils mature, they form primary, secondary, tertiary, and secretory granules, 
which are filled with proteins necessary for extravasation and the recognition and elimination 
of pathogens. Primary (azurophilic) granules store toxic antimicrobial mediators, including 
myeloperoxidase, lysozyme, elastase, defensins, and cathepsins (42). Secondary (specific) 
granules contain proteins necessary for extravasation and recognition of pathogen-associated 
and damage-associated molecular patterns, which include collagenase, lactoferrin, matrix 
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metalloprotease 9, and bacterial protein (fMLP) and complement (c3bi) receptors (43). 
Tertiary granules are similar to secondary granules and contain matrix metalloproteases and 
gelatinase (44). Secretory granules/vesicles contain membrane proteins, receptors, and pre-
formed cytokines that play an important role in adhesion to endothelial cell membranes and 
initiation of inflammatory responses, including CD10, CD11b, alkaline phosphatase, plasma 
proteins, IL-6, IL-12, and CXCL2 (44, 45). Under normal physiologic conditions, neutrophils 
remain in the systemic circulation while congregating in specific tissues, such as the bone 
marrow, spleen, liver, and lungs (46, 47). The pulmonary vasculature represents the largest 
pool of neutrophils in the human body; however there are limited numbers of neutrophils in 
the airways and alveoli of healthy individuals (48). Conversely, neutrophils are the 
predominant leukocyte in the nasal passages (49).  During acute inflammation, 
proinflammatory chemokines secreted by pulmonary macrophages, mast cells, and epithelial 
cells (predominately IL-8), and bacterial-derived chemotactic peptides (such as fMLP), 
stimulate neutrophils to adhere to capillary walls and extravasate across the thin barrier 
separating the capillary lumen from the alveolar space (50).  These proinflammatory signals 
result in a rapid and often massive influx of neutrophils into the airways to rapidly eliminate 
pathogens and suppress infection. Neutrophils eliminate microbes using both intra- and extra-
cellular methods. Phagocytosis is the most common method neutrophils use to eradicate 
pathogens, and neutrophils kill phagosome-encapsulated pathogens with antimicrobial 
proteins from granules and reactive oxygen species generated by NADPH oxygenase-
dependent mechanisms. In instances of more severe infection, primary granules will undergo 
exocytosis and the toxic contents will be released into the extracellular milieu, thereby 
eliminating more pathogens than could be cleared by phagocytosis (42). Neutrophils can also 
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eliminate extracellular organisms through the release of neutrophil extracellular traps 
(NETs), which are composed of sticky de-condensed chromatin containing antimicrobial 
histones, toxic granule proteins (including cathepsins, defensins, and lacteoferrin), and 
enzymes (including lysozyme, neutrophil elastase, and myeloperoxidase) (51). Through this 
active form of cell death, neutrophils ensnare pathogens in a microbicidal web and, thereby, 
prevent the spread of infection. While neutrophils are extremely efficient at eliminating 
pathogens, their antimicrobial actions can also damage host tissues, disrupt the resolution of 
acute inflammation, and promote chronic inflammation. Aberrant neutrophil activation and 
accumulation of neutrophils in the airways is associated with the pathogenesis and 
progression of multiple pulmonary diseases, including asthma, bronchitis, pneumonia, 
pulmonary fibrosis, and COPD (52). Conversely, aberrant suppression of neutrophil function 
increases susceptibility to respiratory infection and contributes to the frequent infections 
associated with chronic granulomatous disease and congenital myeloperoxidase deficiency 
(53-55). 
Natural killer (NK) cells. Natural killer (NK) cells are cytotoxic lymphocytes that 
play an essential role in innate immune response by identifying and killing tumorigenic and 
pathogen-infected host cells. Using a repertoire of activating and inhibitory receptors, NK 
cells circulate through the vasculature, lymphatic system, and peripheral tissues interrogating 
host cells for the presence or absence of specific surface markers indicative of transformation 
or infection (56). While NK cells account for approximately 10% of the resident leukocyte 
population in the lung, they represent nearly 25% of the leukocyte population in the nasal 
passages (57, 58). However, NK cell numbers rapidly increase in both the lung and nasal 
passages in response to infection and inflammation. Inhibitory receptors on NK cells, which 
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include major histocompatibility complex class I receptors, killer cell immunoglobulin-like 
receptors (KIRs), leukocyte immunoglobulin-like receptors (LILRs), Ly49, and CD94-
NKG2A, search for ligands on host cells which inhibit NK cell killing (59). The inhibitory 
receptors share a common cytoplasmic immunoreceptor tyrosine-based inhibitory motif 
(ITIM) that, when activated, recruit phosphatases to the interface between the NK cell and 
host cell. Phosphatases subsequently dephosphorylate protein substrates on tyrosine kinases 
linked to activating receptors which terminates killing mechanisms and NK cell proliferation 
signals (56). NK cells also contain a vast combinatorial array of activating receptors 
(including CD16, DAP12, Fcε-RI#, and CD3-") that work in conjunction with inhibiting 
receptors to regulate targeted cell killing (60). Activating receptors contain a cytoplasmic 
immunoreceptor tyrosine-based activating motif (ITAM) that, when stimulated by ligand 
binding, induces actin cytoskeleton reorganization, NK cell polarization, release of cytotoxic 
granules containing perforin and granzyme proteins, and transcription of various cytokines 
and chemokines, including IFNγ, Th2 cytokines (IL-5 and IL-13), and regulatory cytokines 
such as IL-10 (56, 61). The function of NK cells is intricately regulated through complex 
signaling pathways, and simultaneous activation of different pairs or combinations of 
receptors can enhance or suppress effector function (56). Normal NK cell function is critical 
for maintaining respiratory immune homeostasis as functional impairment is associated with 
increased cancer risk and enhanced susceptibility of respiratory virus infections (57, 60, 62). 
Other cell types. There are other cell types that contribute to innate immunity in the 
lung or function to bridge the innate and adaptive immune responses. However, they are 
generally not recognized specifically as cells of the innate immune system. These include 
mast cells, eosinophils, and basophils. Each of these are granulocytes with specific effector 
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functions. Mast cells are myeloid-derived cells that reside near epithelial tissue, airway 
smooth muscle, blood vessels, nerves, and submucosal secretory glands (63). Mast cell 
granules contain an abundance of proteases including chymase and β-tryptase, as well as 
cytokines, histamine, heparin, GM-CSF, proteoglycans, and leukotrienes. Activation of mast 
cells by antigen-specific IgE binding to FcεRI receptors results in degranulation and the rapid 
onset of allergy-type symptoms (64). In the context of acute respiratory bacterial infections, 
mast cells are capable of binding and phagocytosing bacteria. Furthermore, they can secrete 
inflammatory mediators, including TNF⍺, IL-4, IL-6, IL-10, leukotrienes, and mast cell-
specific proteases to modulate innate and adaptive inflammatory responses (63). Eosinophils 
and basophils represent 1-3% and less than 1% of the circulating leukocyte population, 
respectively (65). While the specific granule content between these cells varies, they both 
play a central role in antimicrobial responses to parasitic helminths and RNA viruses. Along 
with mast cells, eosinophils and basophils mediate allergic and asthmatic responses (65). In 
the context of innate immunity, eosinophils, but not basophils, are capable of phagocytosing 
bacteria (66, 67). However, both contain pre-formed cytokines, chemokines, and growth 
factors, which can be immediately released in response to acute inflammatory signals (65).   
1.2.3  Humoral components of respiratory innate immunity 
Humoral, or soluble, components in the alveolar and airway lining fluids play an 
important role in respiratory innate immune responses by directly neutralizing pathogens or 
facilitating interactions between pathogens and effector cells. Most of these components, 
including naturally occurring antibodies, defensins, collectins, lactoferrin, and lysozyme, are 
produced and secreted by resident cells of the respiratory system. However, others, such as 
C-reactive protein (CRP) and serum amyloid P (SAP), are synthesized in other tissues and 
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transported to the lungs via the systemic circulation (68). Both CRP and SAP are in the 
pentaxin family of proteins and function in the innate immune system as opsonins that bind 
bacteria, fungi, and yeast, to enhance their phagocytosis and killing by macrophages and 
neutrophils. The airway surface liquid lining the upper airways is rich in protective soluble 
components, including pentaxins, lysozyme (a glycoside hydrolase enzyme that disrupts 
glycosidic bonds in the cell walls of some bacteria), lactoferrin (an iron-binding glycoprotein 
that has bacteriostatic and bactericidal functions), IgA and IgG (naturally occurring 
antibodies which bind to pathogens, cell debris, and apoptotic cells, and promote pathogen 
recognition by phagocytes), and defensins (cationic antimicrobial peptides that activate 
bacterial cell wall lytic enzymes and disrupt virus function) (69-71). The alveolar fluid in the 
lower respiratory airways is also saturated with soluble immune mediators. These include 
IgG, complement proteins (opsonins that enhance pathogen recognition and phagocytosis by 
alveolar macrophages and neutrophils), hydrophilic surfactant proteins SP-A and SP-D 
(collectin proteins that opsonize bacteria and enhance phagocytosis by alveolar macrophages 
and neutrophils), sCD14 (a soluble co-receptor for bacterial lipopolysaccharide (LPS) which 
enhances macrophage recognition of bacteria), and LBP (a protein that binds to shed 
bacterial LPS to enhance LPS recognition by specific protein receptor complexes on 
leukocytes) (3, 72-74). These soluble mediators of innate immunity enhance the physical and 
cellular components of the respiratory innate immune system and provide another layer of 
protection against inhaled microbes. Compromised humoral immunity, particularly 
reductions in the levels or functionality of IgG and IgA, has been shown to increase 
susceptibility to bacterial and viral infections (75, 76).   
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1.3  Effects of cigarette smoke on respiratory innate immune system  
Cigarette smoke causes harm to nearly every organ in the body and smokers have a 
significantly higher risk for multiple cancers, heart disease, respiratory tract infections, 
chronic lung disease, Crohn’s disease, rheumatoid arthritis, and delayed recovery from injury 
(77). Some of the constituents of cigarette smoke that cause deleterious health effects include 
nicotine, ‘tar’ (resinous, partially combusted particulate matter containing polycyclic 
aromatic hydrocarbons, hydroquinones, catechol, phenol, benzene, and other substances), 
aldehydes (including formaldehyde, acetaldehyde, acrolein, and crotonaldehyde), metals 
(arsenic, cadmium, chromium, nickel, and lead), benzopyrenes, ammonia, carbon monoxide, 
cyanide, and nitrogen oxides (78). As cigarette smoke enters the respiratory tract, soluble 
gases are rapidly absorbed in the conducting airways and large particles deposit on airway 
walls. Small particles remain in the air stream traversing the branching airways until they 
ultimately settle in the alveoli or are exhaled. Once inhaled, cigarette smoke causes activation 
or suppression of various respiratory innate immune components.  
1.3.1  Effects of cigarette smoke on physical and mechanical innate defenses 
Chronic mucus hypersecretion, commonly referred to as excessive phlegm, is a 
hallmark of chronic bronchitis and is strongly associated with loss of pulmonary function, 
recurring respiratory infections, and the development of COPD (79). Furthermore, there is a 
significant association between chronic mucus hypersecretion, reductions in pulmonary 
function (FEV1), and death from obstructive lung disease (80). Cigarette smoking stimulates 
mucus hypersecretion and is the primary etiological factor for COPD. However, exactly how 
cigarette smoke stimulates mucus hypersecretion is still unclear (81). Healthy smokers with 
normal lung function as well as cigarette smokers with symptoms of chronic bronchitis and 
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chronic airflow limitation have been reported to have a greater number of goblet cells and 
inflammatory cells in the epithelium of peripheral airways as compared to non-smoker 
controls (82). Haswell and colleagues exposed well-differentiated human bronchial epithelial  
cells (hBE) to cigarette smoke total particulate matter and various aldehydes present in 
cigarette smoke, including formaldehyde, acetaldehyde, and acrolein. They found that 
cigarette smoke particulate matter and acrolein, but not formaldehyde or acetaldehyde, 
significantly increased the number of MUC5AC positive goblet cells in cultures (83). 
Borchers and colleagues observed that acrolein and the inflammatory mediators 
prostaglandin E2 and TNF⍺, increased MUC5AC transcription in H292 lung carcinoma cells, 
suggesting that reactive aldehydes, like acrolein, can directly and indirectly (via 
inflammatory mediators) increase mucin gene expression (84). Other laboratory data suggest 
that smoking reduces the hydration of airway surfaces and stimulates mucin production, 
which leads to increased mucin concentrations in the airway surface liquid (85-87). Button 
and colleagues recently proposed the “two-gel” model of mucociliary transport which 
predicts that high mucin content in the viscoelastic upper gel layer of airway surface liquid 
will out-compete the lower periciliary gel layer for hydration and result in failed mucociliary 
clearance and accumulation of airway mucus (21). Recent data published by Kesimer and 
colleagues which used the Subpopulations and Intermediate Outcome Measures in COPD 
Study (SPIROMICS) cohort were consistent with this model (88). The authors of this study 
found that high total mucin concentrations (both MUC5AC and MUC5B) in smokers were 
associated with both patient-reported phlegm production and increased mucoid properties of 
the expectorated material. Moreover, MUC5B was found to be the dominant secreted mucus 
in smokers and the ratio of total MUC5AC to total MUC5B concentration was higher among 
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current smokers as compared to never-smoker control subjects (88). Together, these findings 
indicate that cigarette smoke and its constituent acrolein modify the physical barriers of the 
respiratory innate defense system and, thereby, contribute to the progression of lung disease. 
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Figure 1.1   The effects of cigarette smoke on airway surface liquid composition and 
mucociliary transport. Reproduced with permission from Kesimer, M., Ford, A. A., Ceppe, 
A., Radicioni, G., Cao, R., Davis, C. W., Doerschuk, C. M., Alexis, N. E., Anderson, W. H., 
and Henderson, A. G. (2017) Airway mucin concentration as a marker of chronic bronchitis. 
New England Journal of Medicine 377, 911-922., Copyright Massachusetts Medical Society.  
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Among the earliest observations on the respiratory effects of smoking was that 
cigarette smoke elicited an acute reduction of airway epithelial cell cilia motility. In 1937, 
Mendenhall and Shreeve exposed calf tracheas to cigarette smoke and observed reduced cilia 
motility and impaired mucociliary transport of carmine particles (89). Rakieten and 
colleagues expanded on this observation in 1952 by exposing respiratory epithelium 
collected from humans, rabbits, and rats to solutions of nicotine and menthol, as well as 
smoke from mentholated and non-mentholated cigarettes. Mentholated and non-mentholated 
cigarettes, but not menthol or nicotine solutions, significantly reduced cilia motility (90). 
Recent studies have confirmed these early observations using animal and hBE cell culture 
models (91-93). Histopathology studies have shown that cigarette smoke also causes 
structural abnormalities of the ciliated airway epithelium. A post-mortem analysis of 1522 
Caucasian adults found that bronchial epithelial cells from male and female smokers 
displayed patches of atypical nuclei and significantly fewer cilia than non-smokers (94). 
Follow-up studies have determined that these types of abnormalities are proportional to the 
length of time an individual smokes and occur more frequent in smokers using high-
tar/nicotine cigarettes (95). Smokers also have reduced cilia length in the large and small 
airways as compared to non-smoker controls. Furthermore, this abnormality was more 
pronounced in smokers with COPD (96). Electron microscopy studies have also noted 
smoking-related ultrastructural abnormalities in axonemal organization. Lungarella and 
colleagues observed that airway cilia from patients with chronic bronchitis had structural 
changes in the axonemal 9 + 2 pattern of organization which are not apparent in non-smokers 
(97). Many of the direct effects of cigarette smoke on cilia structure and function may be due 
to the reactive aldehydes in cigarette smoke. Hastie and colleagues exposed rabbit and 
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porcine tracheal explants to formaldehyde and observed a rapid but reversible reduction in 
cilia motility. Further, they observed a dose-dependent reduction in ciliary axoneme ATPase 
activity that was also reversible (98). Sander and Steffens observed that exposure of chicken 
hatchlings to formaldehyde gas caused rapid ciliostasis and morphologic changes to 
axonemal organization (99). Acetaldehyde is reported to induce concentration- and time-
dependent reductions in CBF and cilia-derived dynein ATPase activity in primary cultures 
and isolated axonemes of bovine airway epithelial cells (100). Acrolein has been reported to 
induce ciliostasis at concentrations as low as 0.14ppm (0.14mg/L) (101-104). Data strongly 
suggest that aldehydes contribute to the increased occurrence of respiratory infections and 
pathogenesis of lung disease in smokers (105, 106).  
Cigarette smoke has been shown to increase mucosal permeability in both animals 
and humans (107-109). While the exact mechanisms by which cigarette smoke disrupts 
epithelial barrier integrity have not been elucidated, data indicate that the loss of tight 
junction integrity is involved (108-110). Oliver and colleagues exposed Calu-3 bronchial 
epithelial cells to a single exposure of mainstream cigarette smoke and observed a transient 
reduction in transepithelial electrical resistance (TEER), which persisted for 30 minutes. 
Inhibition of Rho kinase reduced smoke-induced epithelial permeability, while inhibition of 
myosin light chain kinase exacerbated the effect of cigarette smoke (111). These data suggest 
that the smoke-induced reduction in epithelial junction integrity is a regulated process rather 
than a cytotoxic response. A follow-up study from this group found that mainstream cigarette 
smoke increased phosphorylation of proteins involved in the regulation of actin 
polymerization and caused a redistribution of tight-junction proteins from the apical surface 
to a more basolateral arrangement, further suggesting a regulated response to smoke (112). 
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Acrolein has been shown to directly disrupt epithelial barrier function. Hales and colleagues 
exposed dogs to synthetic smoke (carbon particles with a mean particle diameter of 4.3µm) 
containing acrolein or hydrochloric acid for 10 minutes and monitored extravascular lung 
water accumulation for 5 hours thereafter. While both acid and acrolein caused epithelial 
injury, only acrolein caused a dose-dependent increase in peribronchiolar edema (113). The 
disruption of epithelial junctions provides access for pathogens and allows infection of 
respiratory tissues, a common ailment among smokers and a contributing factor to the 
progression of lung disease.      
1.3.2  Effects of cigarette smoke on leukocyte function 
Cigarette smoking increases the numbers of infiltrating peripheral blood monocytes 
and alveolar macrophages occupying the respiratory airways several fold (114). Infiltrating 
macrophages secrete elastase, which can damage host tissues and exacerbate 
proinflammatory responses (115). The resulting damage to connective tissues and the lung 
parenchyma may contribute to chronic bronchitis and the pathogenesis of COPD (114). 
Despite having higher levels of oxygen radicals and myeloperoxidase, the alveolar 
macrophages from smokers have reduced phagocytic function as demonstrated by studies 
reporting significantly impaired clearance of S. aureus and L. monocytogenes bacteria (116, 
117). Moreover, alveolar macrophages from smokers have an impaired ability to mount 
normal proinflammatory cytokine responses to LPS (118). The inability to clear bacterial 
pathogens and orchestrate immune responses increases susceptibility to lower respiratory 
infections, which further exacerbates cigarette smoke-induced inflammation.  
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Pulmonary accumulation of neutrophils is common among active smokers and 
massive pulmonary neutrophil influx is a typical feature of chronic inflammatory lung 
diseases, such as COPD (119). Cigarette smoke and nicotine have been reported to impair 
neutrophil phagocytosis, dysregulate production of a respiratory burst, and significantly 
reduce the elimination of bacterial pathogens (120). Compromised neutrophil anti-bacterial 
activity has been proposed as a major cause of increased susceptibility to respiratory 
infections in smokers (120). Additionally, cigarette smoke-induced neutrophil necrosis- and 
NETosis-mediated release of proteolytic enzymes, particularly elastase and matrix 
metalloproteinase, can cause significant damage to host tissue and is believed to be a key 
mediator of destructive lung diseases (121). Under normal conditions, neutrophils have a 
short lifespan and undergo caspase-3-dependent spontaneous, as well as phagocytosis-
induced, apoptosis (122). Some of the chemical constituents of cigarette smoke, including 
acrolein and nicotine, have been reported to delay neutrophil spontaneous death (123-126). 
This is believed to contribute to the accumulation of neutrophils and emphysema in 
individuals with COPD (127).   
NK cells are also impaired by toxicants in cigarette smoke. Ferson et al. investigated 
whether smoking status altered NK cell function in age- and sex-matched individuals with 
and without melanoma. Peripheral blood NK cells from all smoking subjects, regardless of 
melanoma status, were significantly less effective at recognizing and killing cultured 
melanoma and Chang cells as compared to cells from non-smoker subjects (128). Smokers 
have also been reported to have significantly fewer circulating NK cells as compared to non-
smokers. This is despite overall increases in circulating leukocytes and lymphocytes (129). 
More recently, Horvath and colleagues investigated whether smoking altered nasal NK cell 
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responses to live attenuated influenza virus, a cold-adapted surrogate for natural influenza. 
Their data indicate that nasal NK cells from smokers had significantly lower expression of 
the activating receptor CD16, as well as significantly lower expression of the cytotoxic serine 
protease granzyme B, as compared to matched non-smoker controls (130). Taken together, 
these findings suggest that smoking-induced suppression of NK cell function may result in 
inadequate surveillance of tumorigenic and virus-infected host cells.          
Based on these examples, it is clear that smoking produces various morphological, 
physiological, biochemical, and enzymatic changes in respiratory leukocytes. In many cases, 
these changes impair antimicrobial defenses, cellular regulatory activity, and inflammatory 
responses in the airways, and ultimately contribute to the pathogenesis of lung disease. 
1.3.3  Effects of cigarette smoke on humoral immunity 
As discussed in the previous sections, cigarette smoke alters the biological activity 
and function of many respiratory cell types. Furthermore, smoking can alter biological 
systems throughout the body. It is therefore not surprising that cigarette smoke can alter the 
composition and function of soluble immune mediators in the airway lining fluid milieu. 
Several studies have shown that tobacco smoke alters pulmonary surfactant, increases 
alveolar surface tension, and negatively impacts airway compliance (131-134). The lung 
lining fluid of smokers has also been reported to have reduced anti-protease activity, which 
may promote elastase-induced host damage and the progression of emphysema and COPD 
(135, 136). Cigarette smoke is reported to reduce levels of IgA and IgG in the saliva of 
smokers which suggests smoking may disrupt local antibody production in the upper airways 
(137). However, studies of IgA and IgG levels in the bronchial alveolar lavage (BAL) fluid 
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of smokers indicate no significant difference from non-smokers (138, 139). Gene expression 
of defensin proteins HBD-1 and HBD-2 are reported to be significantly suppressed in the oral 
mucosa of smokers (140). Other soluble mediators have been shown to be more abundant in 
the BAL of smokers, including lysozyme and fibronectin, which is indicative of enhanced 
inflammation (141, 142). Levels of complement proteins are also elevated in the BAL of 
smokers; however, complement-receptor-mediated phagocytosis in smokers is impaired 
(143-147). 
1.4  Electronic cigarettes: a safe cigarette or cause for concern? 
The smoking epidemic is one of the greatest public health catastrophes of the 
twentieth century. Between 1900 and 1999, approximately 100 million deaths were directly 
attributed to smoking (148, 149), and exposure to tobacco smoke (both first- and second-
hand) will likely kill 6 million people this year alone (150). The annual costs attributed to 
smoking in the United States are between $289 billion and $333 billion (151). These 
estimates include approximately $130 billion for direct medical care, $150 billion for lost 
productivity due to premature death, and more than $5 billion for lost productivity from 
premature death due to exposure to secondhand smoke. The Centers for Disease Control and 
Prevention reports that in 2016, 15.5% of adults identified as current smokers and 10.2% of 
middle and high school students reported smoking a cigarette in the past 30 days (152, 153). 
Over one third of U.S. smokers attempt cessation each year. However, the success rate per 
attempt is low (154). Few smokers seek assistance for cessation and for those that do, the 
effectiveness of pharmaceutical aids for cessation is limited (155). This has left many 
smokers enslaved to cigarettes in order to satisfy their nicotine addiction. 
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Over the last decade, electronic cigarettes (e-cigarettes) have emerged as an 
alternative to traditional cigarettes. Because e-cigarettes deliver nicotine without burning 
tobacco or producing smoke, their use likely confers a lower overall health risk than inhaling 
combustible tobacco products (156). Thus, for both individuals and the public health, e-
cigarettes may have the potential to promote smoking cessation among established cigarette 
smokers, or at least to reduce smokers’ exposure to toxicants in tobacco smoke. Two recent 
meta analyses of randomized control trials for the effectiveness of e-cigarettes as cessation 
aids reported that e-cigarettes with nicotine improved long-term smoking cessation compared 
to e-cigarettes without nicotine. However, there were insufficient data to determine if e-
cigarettes were more effective than traditional nicotine replacement therapies (157, 158). In 
addition to providing a new means for complete smoking cessation, replacing conventional 
cigarettes with e-cigarettes may provide an effective method for harm reduction by reducing 
tobacco-related health risks at the individual and population levels. If the use of e-cigarettes 
presents lower health risks compared to combustible tobacco cigarettes, then encouraging use 
of e-cigarettes as a reduced risk product rather than encouraging complete abstinence could 
have public health benefits (156). While e-cigarettes have not been theoretically or 
experimentally proven to be safe, the absence of many known toxicants present in tobacco 
smoke may make them significantly less harmful than cigarettes in at least some scenarios. 
Although there may be great potential for e-cigarettes as cessation aids or cigarette 
replacements in smoking adults, the surge in e-cigarette popularity among teens and young 
adults cannot be ignored. E-cigarette use among adolescents and young adults who have 
never smoked cigarettes is common (156). Past 30-day e-cigarette use in high school students 
increased from 1.5% in 2011 to a high of 16.0% in 2015 before declining to 11.3% in 2016 
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(153). Unlike adults who frequently use e-cigarettes to quit or reduce smoking, teens between 
the ages of 12 and 17 are more likely to cite enjoyment of flavors and social factors as 
reasons for using e-cigarettes (159, 160). One of the major concerns of adolescent e-cigarette 
use is that e-cigarettes will provide a gateway to cigarette smoking and increase the number 
of smoking adults in the years to come (161).  Part of this concern lies in the potential for 
nicotine addiction resulting from e-cigarette use (162). The recently devised catalyst 
hypothesis proposes several additional processes through which e-cigarette use could lead to 
smoking. Because vaping may produce positive sensations to the airways, pleasant tastes, 
and lack aversive effects like lung discomfort, the catalyst hypothesis proposes that vaping 
may cause adolescents to alter their perceptions about cigarettes and view smoking more 
favorably (163). Indeed, a recent evaluation of the existing e-cigarette literature by the 
National Academies of Sciences, Engineering, and Medicine concluded that “There is 
substantial evidence that e-cigarette use increases risk of ever using combustible tobacco 
cigarettes among youth and young adults.” (156). Furthermore, A recent study found that e-
cigarettes were perceived more positively, and usage was more prevalent among adolescents 
with asthma (12.4%) as compared to their non-asthmatic peers (10.2%) (164). Similarly, data 
from the 2012 Florida Youth Tobacco Survey indicate that e-cigarette use in Florida high 
school students was greater in asthmatics than in non-asthmatics (165). This same trend was 
reported in studies from Canada (166) and South Korea (167). Thus, while e-cigarettes may 
decrease the use of conventional cigarettes in adults with an existing smoking history, the 
prevalence of e-cig usage is greater in adolescents, and even greater in asthmatics relative to 
non-asthmatics, which is cause for concern (168). 
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Although use of e-cigarettes by adolescents may increase transition to smoking later 
in life, e-cigarettes might also increase adult smoking cessation and reduce exposures to 
cigarette smoke. The net public health effect, harm or benefit, of e-cigarettes depends on 
three factors: 1) their effect on youth transition to tobacco smoking, 2) their effect on adult 
smoking cessation, and 3) their intrinsic toxicity. If significant numbers of adult smokers 
abstain from cigarette smoking the benefit to public health could be considerable. If e-
cigarettes prove to be an ineffective tool for adult smoking cessation, they would prove 
detrimental to public health because of the inherent harms of adolescent e-cigarette users 
transitioning to cigarettes. However, understanding the unique toxicities and risks associated 
with vaping is an essential step in determining whether e-cigarettes can be considered safer 
cigarettes or whether they present new concerns for public health.  
1.4.1  The emergence of e-cigarettes 
While the emergence of e-cigarettes is a recent phenomenon, the concept dates back 
to 1965 when Herbert Gilbert patented "a smokeless non-tobacco cigarette". In his patent, 
Gilbert stated that his device was “a safe and harmless means for and method of smoking by 
replacing burning tobacco and paper with heated, moist, flavored air.” (169). Attempts were 
made to commercialize Gilbert’s e-cigarette; however, the device was not received well and 
the idea was abandoned.  The modern e-cigarette, which has striking similarities to Gilbert’s 
design, was developed by the Beijing pharmacist Hon Lik in 2003 (170). Lik’s invention was 
patented in China in 2003 and by 2004 the e-cigarettes were being marketed by the Chinese 
company Ruyan. By 2005 Ruyan began exporting out of China and by 2006 the Ruyan e-
cigarettes were being marketed in Europe. Ruyan e-cigarettes entered the US market in 2007, 
which marked the beginning of the e-cigarette boom in the US.  
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1.4.2  Components of e-cigarettes 
Since 2007, the e-cigarette industry has grown tremendously and current e-cigarette 
products have evolved from the original Ruyan device. Now, the term “electronic cigarette” 
or “e-cigarette” describes a diverse group of battery-powered devices that deliver nicotine, 
flavorings, and other constituents to the user by heating flavored e-cigarette liquid (e-liquid) 
solutions to temperatures sufficient to form aerosols (171). Inhalation of e-cigarette aerosols 
(commonly referred to as “vapor”) provides the sensation of smoking and the desired 
nicotine effect without combusting tobacco. Despite the different names for e-cigarettes, 
which include electronic nicotine delivery systems (ENDS), electronic vaporizers, cig-a-
likes, e-cigs, vape pens, mods (regulated and unregulated), pod-vapes, e-hookahs, e-cigars, 
and advanced personal vaporizers (APV), the basic physical components of the devices are 
the same: a battery, an atomizer, and a tank or cartridge containing e-liquid (162). Each of 
these components has the potential to affect health outcomes of e-cigarette users.  
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Table 1.1  Examples of common e-cigarette devices. Reproduced with permission from 
Clapp, P. W., and Jaspers, I. (2017) Electronic Cigarettes: Their Constituents and Potential 
Links to Asthma. Curr Allergy Asthma Rep 17, 79., Copyright Springer Nature.  
 
 
 
 
 
 
1st Generation
“Cig-a-like”
2nd Generation
“Vape-pen”
3rd Generation
“Box mod”
4th Generation
“Temperature Control (TC) 
Box mod”
• Low price
• Similar in size and shape 
to traditional cigarette
• Disposable or 
rechargeable
• Some new models have  
refillable cartridges
• Available at most 
convenience stores
• Power settings not 
adjustable
• Often used by novice 
vapers or former smokers 
transitioning from 
cigarettes
• Low to moderate price
• Refillable tank
• Rechargeable lithium-ion 
battery
• Some customizability 
with user-defined voltage 
(typically 3.0V to 6.0V) 
• Most have heating coils 
with >1.0Ω resistance
• Often used by novice or 
intermediate vapers 
• Moderate to high price
• One or two rechargeable lithium-ion 
batteries 
• Highly customizable: user-determines 
settings for voltage or wattage
• Can accommodate a wide variety of 
refillable tanks, rebuildable atomizers 
(RBAs), or tankless “dripping” atomizer
• Heating coils with <1.0Ω resistance are 
commonly used with these devices (sub-
ohm vaping)
• Heating coil temperatures may exceed 
300°C with high wattage and low resistance 
• Generate significantly more aerosol than 1st
or 2nd generation devices
• Most often used by experienced vapers
• Among most highly priced devices due 
to more advanced electronics
• User can program a maximal heating 
coil temperature to prevent overheating 
e-liquids and or burning the wicking 
material (i.e., a “dry hit”)
• Temperature control (TC) mode 
requires stainless steel, nickel, or 
titanium heating coils
• One or two rechargeable lithium-ion or 
lithium polymer (LiPo) high amperage 
batteries
• Other features and functions similar to 
3rg generation box mods
• Most often used by experienced vapers
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Batteries. Most e-cigarette devices are powered by a rechargeable battery (a 
manufacturer-supplied unit), a non-rechargeable battery, or a replaceable battery 
(rechargeable or non-rechargeable) (156). Nickelcadmium (NiCad), nickel metal-hydride 
(NiMh), lithium ion (Li-ion), alkaline and lithium polymer (Li-poly), and lithium manganese 
(LiMn) batteries are all commonly used in e-cigarettes (172). However, lithium batteries are 
often preferred because they provide a large amount of energy in a compact size. There have 
been numerous accounts of e-cigarette fires, explosions, and injuries resulting from “thermal 
runaway” of lithium batteries (173). 
Atomizers. An atomizer is the component of an e-cigarette that converts liquid into 
aerosol. There are several variants of e-cigarette atomizers, which include cartomizers 
(plastic cartridges), clearomizers (refillable plastic tanks), glassomizers (refillable glass 
tanks), and dripping atomizers (no tank). However, they all consist of wicking material which 
brings e-liquid solutions into contact with a heating coil. The materials used for heating coils 
and wicks vary significantly among devices. Common wicking materials include silica cord, 
organic cotton, rayon fibers, hemp, stainless steel mesh, ceramic, fiberglass, and bamboo 
yarn. Heating coils are typically resistance wires made from various metal alloys, including 
Kanthal (iron, chromium, and aluminum), stainless steel (iron, carbon, and chromium), and 
Nichrome (chromium and nickel). However, pure metal coils of nickel and titanium are also 
popular (168). E-cigarette power settings (battery output), heating coil resistance, the 
quantity and type of wicking material, and volume of e-liquid determine the temperature of 
the atomizer, which contributes to the chemical profile of e-cigarette aerosols.  
E-liquids. E-liquids (also referred to as e-juices) are typically solutions of propylene 
glycol (PG) and vegetable glycerin (VG), nicotine, and various flavoring agents. PG and VG 
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are the primary components of essentially all e-liquids and provide the base to which nicotine 
and flavoring agents are added.  PG and VG are viscous substances that keep nicotine and 
flavoring agents in suspension, enhance the absorption of wicking materials, and generate 
plumes of aerosolized particles when heated to sufficient temperatures (168). Additionally, 
PG and VG are hygroscopic humectants, which produce a dry-mouth or dry-throat sensation 
when inhaled. This property provides e-cigarette users with a “throat hit” similar to cigarette 
smoking (174, 175). The PG:VG ratio varies between products and many manufacturers 
allow customers to choose the PG and VG content of their preference (this is often dependent 
on the flavor as some flavoring agents are preferentially soluble in PG or VG). Ex-smokers 
or smokers attempting to quit frequently prefer e-liquids with a high PG content as the throat-
hit is reported to be stronger than that of VG (175). Other users prefer e-liquids with a high 
VG content, which is reported to be less irritating to the throat and capable of generating 
larger “clouds” of aerosol. 
Nicotine is a botanically-derived, parasympathomimetic alkaloid that is readily 
absorbed by the body through dermal, oral, and inhalational exposures, and easily crosses 
biological membranes including the blood brain barrier.  Inhalation of nicotine increases 
blood pressure, pulse rate, free fatty acids in the plasma, mobilizes blood sugar, and 
stimulates the release of norepinephrine and dopamine (176-178). Unlike traditional 
cigarettes, e-cigarettes allow the user to choose the concentration of nicotine that provides the 
desired effect. Most suppliers offer any flavored e-liquid in a variety of nicotine 
concentrations which typically include 6, 12, 18, 24, and 36mg/ml. Additionally, many e-
cigarette retailers offer solutions of concentrated nicotine for supplementation to e-liquids. 
Flavored e-liquids can also be purchased without nicotine. The most recent e-cigarette 
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devices are using nicotine salts instead of the “free-base” nicotine used in traditional 
cigarettes and most e-cigarette liquids. Pankow and colleagues recently analyzed the 
chemical composition of JUUL™ pod pre-filled e-cigarette cartridges and found benzoic acid 
and nicotine in a 0.97 to 1 molar concentration ratio. When heated during vaping, the 
nicotine salt, nicotine benzoate, forms and is delivered to the user in the aerosol (179). Users 
of these products claim that nicotine salt provides an enhanced nicotine effect without the 
harsh throat-hit typically experienced with free-base nicotine. Whether the inhalation of 
nicotine salts will have different health outcomes than free-base nicotine is currently 
unknown.   
E-liquids are available in almost any flavor imaginable. However, most e-liquids can 
be broadly grouped into one of five general categories based on their dominant flavor: 
tobacco flavors (cigarette, cigar, pipe tobacco, etc.), fruit flavors (blueberry, peach, etc.), 
minty flavors (menthol, peppermint, etc.), sweet flavors (candy, cookie, cake etc.) and other 
flavors (coffee, wine, foods, etc.) (180). Flavoring agents are typically food-grade flavoring 
additives which are mixed in various combinations to produce uniquely-flavored products. 
Pure flavoring agents (i.e. menthol, cinnamaldehyde, furaneol, limonene, etc.) are used to 
flavor e-liquids. However, many e-liquid manufacturers purchase pre-mixed flavoring oils, 
emersions, and blends from various food additive distributors, and blend those further to 
achieve the desired e-liquid flavor. Flavoring agents are represented by various chemical 
groups, including alcohols, aldehydes, esters, ketones, lactones, thiols, and terpenes. Many e-
liquid manufacturers also use flavor enhancers (i.e. maltol, ethyl maltol, glutamic acid etc.) 
and stabilizers (i.e. citric acids, ascorbic acid, acetic acid, etc.) to extend the shelf-life of e-
liquids.    
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1.4.3  Flavoring agents pose a significant unknown 
The inhalation of flavoring agents poses a significant unknown in regards to the 
potential risks of e-cigarette use. While the majority of e-cigarette flavoring agents carry the 
“generally recognized as safe” (GRAS) designation by the United States Food and Drug 
Administration (US FDA), GRAS substances are only evaluated for safety during oral 
consumption as a food additive. Other routes of exposure were not considered and, therefore, 
GRAS designation is not applicable for the inhalation of food additives. Furthermore, there is 
precedent for inhalation of a GRAS flavoring agent causing irreversible lung disease. 
Inhalational exposures to high concentrations of aerosolized diacetyl (2,3-butanedione), a 
diketone with butter-flavor characteristics, were reported to induce acute onset bronchiolitis 
obliterans, an irreversible obstructive lung disease, in workers at a microwave popcorn 
manufacturing facility (181). A recent study evaluated the chemical composition of 159 e-
liquids and found that diacetyl was present in 110 (69.2%) of the products tested (182). The 
authors determined that, under normal use, 52 of the e-liquids containing diacetyl would 
result in exposures greater than the 5ppb recommended 8-hour time-weighted occupational 
exposure limit established by the National Institute for Occupational Safety and Health 
(NIOSH) and the Centers for Disease Control (CDC). Twenty-six of the e-liquids tested 
would result in exposures greater than five times the 5ppb limit and the e-liquid with the 
highest diacetyl content would result in an exposure 490 times greater than the NIOSH limit 
(182). However, it is still unclear whether e-cigarette exposures to diacetyl will cause 
respiratory harm. The Flavor and Extract Manufacturers Association (FEMA) of the USA, a 
trade association of flavor ingredient manufacturers which evaluates the safety of food 
flavorings, has identified 1037 food-safe flavoring agents as potential respiratory hazards due 
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to possible volatility and respiratory irritant properties (183). Common e-cigarette flavoring 
agents on this list include, but are not limited to: diacetyl, acetoin, 2,3-pentanedione (buttery 
flavors), camphor and cyclohexanone (minty flavors), benzaldehyde (cherry or almond 
flavors), cinnamaldehyde (cinnamon flavor), cresol (leathery or medicinal flavor), 
butyraldehyde (chocolate flavor), and isoamyl acetate (banana flavor) (168, 183). While 
these flavoring agents are predicted to be respiratory hazards, there is a paucity of data on 
whether or how they affect the respiratory health of e-cigarette users. 
Flavoring agents, by definition, are biologically active compounds. Non-volatile, 
polar flavoring agents activate receptors on chorda tympani and trigeminal nerve endings in 
papillae on the tongue to produce taste, astringency, pungency, and cooling sensations. 
Volatilized aromatic flavoring agents travel from the mouth to the nasal passages where they 
activate receptors on cilia of olfactory receptor neurons and trigger odorous sensations (184). 
Indeed, our ability to taste and smell substances relies on the inherent reactivity of flavoring 
and odorant chemicals. Most flavorings and odorants have thresholds for detection and 
recognition by taste and odor neurons in the low parts per billion (ppb) range. For example, 
cinnamaldehyde, the ⍺,β-unsaturated aromatic aldehyde which gives cinnamon its 
characteristic flavor and odor, is reported to have an odor threshold of 4.45ppb (185). Studies 
evaluating the cinnamaldehyde content of e-liquids have reported concentrations greater than 
1.0M (123,162,000.0ppb) in some products (186, 187). Inhalation of such high 
concentrations raises concerns for individual dose exposures and the potential for toxicity or 
altered biological functions. Reactive carbonyls, such as cinnamaldehyde and other aldehyde 
flavoring agents, share structural similarity with toxic aldehydes in cigarette smoke.  
Cinnamaldehyde (3-phenylprop-2-enal) is structurally similar to acrolein (prop-2-enal). 
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Benzaldehyde (phenylmethanal) is structural similarity to formaldehyde (methanal). 
Acetaldehyde itself is a flavoring agent which has been used to impart the taste of green 
apples (188). As discussed in previous sections, aldehydes in cigarette smoke are known to 
have damaging effects on the lung and have varying disruptive effects on respiratory innate 
immune function. However, whether structurally similar aldehyde flavoring agents in e-
cigarettes will have similar effects is unknown.  
 
 
 
 
 34 
 
 
Figure 1.2   Biological effects of exposure to chemicals in e-cigarette aerosols. 
Reproduced with permission from Clapp, P. W., and Jaspers, I. (2017) Electronic Cigarettes: 
Their Constituents and Potential Links to Asthma. Curr Allergy Asthma Rep 17, 79., 
Copyright Springer Nature. 
 
 
 
 
 
Propylene glycol and 
vegetable glycerin Flavoring agents Nicotine
• Increased cough
• Dry throat
• Chest tightness
• Increased mucosal secretions
• Minimal reductions in lung 
function and fraction of exhaled 
nitric oxide (FeNO)
• Reactive carbonyls (acrolein, 
acetaldehyde, formaldehyde)  
generated by thermal 
degradation have known 
respiratory toxicities 
Acute Exposures
Chronic Exposures
Acute Exposures Acute Exposures
Chronic Exposures
Chronic Exposures
• Workplace exposures associated 
with reduced forced expiratory 
volume-one second (FEV1) and 
forced vital capacity (FVC)
• No data for chronic inhalational 
exposures from e-cig use 
• Increased release and 
metabolism of neurotransmitters
• Increased pulse rate and blood 
pressure
• Mobilization of blood sugar
• Increased mucus production and 
mucus viscosity
• Reduced cell proliferation and 
suppression of apoptosis
• Reduced allergen-induced 
inflammation in rodents
• Epigenetic reprogramming of rat 
germline cells resulting in 
impaired fetal lung development 
and transgenerational asthma
• Reduced inflammatory responses 
are associated with increased 
respiratory viral infections
• Workplace Inhalation of diacetyl, 
2, 3-pentanedione, and acetoin 
(buttery flavorings) caused 
bronchiolitis obliterans
• Few reported cases of mint 
allergy and mint-induced asthma  
• Occupational asthma reported in 
workers inhaling cinnamon dust
• No chronic inhalational exposure 
data on most flavoring agents 
used to flavor e-cigs
• Effects are often flavor-specific 
and dose-dependent
• TRPA1 and TRPV1 agonists, 
such as cinnamon, mint, and 
clove, induce strong pulmonary 
reflex responses
• Very little data on acute 
inhalational exposures
 
 35 
1.5  Scope of this dissertation     
Smoking continues to be the leading cause of preventable death accounting for 12% 
of all mortalities among adults worldwide. U.S. FDA regulations have limited the sale, 
marketing, and use of traditional tobacco products in the U.S.; however, regulations on new 
and emerging tobacco products, such as flavored e-cigarettes, are pending. “Vaping” has 
gained popularity in the U.S. as e-cigarette usage has increased steadily over the past several 
years, particularly among teens and young adults. While e-cigarettes are commonly 
represented as safer alternatives to cigarettes, little is known regarding the health effects of 
their short- or long-term use. We have previously demonstrated that cigarette smoking 
significantly affects innate and antiviral host defenses in the context of influenza infections 
by modifying type I-interferon responses and mucosal immune cell function, thereby 
enhancing viral entry into epithelial cells. However, whether and how chemicals in flavored 
e-cigarettes affect respiratory innate immune defenses and, thereby, modify susceptibility to 
respiratory infections is completely unknown. 
The overall objective of this work was to evaluate the effects of flavored e-liquids, 
particularly those containing ⍺,β-unsaturated cinnamaldehyde, on respiratory innate defense 
mechanisms, and to assess whether and how these products alter susceptibility to respiratory 
infections. To achieve this objective, I used tightly-linked human in vitro and ex vivo 
translational research approaches to elucidate how flavored e-liquids, and specifically, 
cinnamaldehyde, affect innate defense mechanisms of the respiratory tract. The hypothesis 
that flavored e-liquids containing cinnamaldehyde will alter respiratory innate immune 
mechanisms and impair host defense capabilities was tested by exposing human innate 
immune cells to e-liquids and cinnamaldehyde alone, and quantifying changes in innate 
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immune functions (Chapter 2). Additionally, human bronchial epithelial cells were exposed 
to e-liquids, vaped aerosols, and cinnamaldehyde, and changes in cilia motility and 
bioenergetic processes were assessed (Chapter 3). Finally, common e-cigarette flavoring 
agents were evaluated for their ability to activate the Nrf2-antioxidant response element 
signaling pathway, a major mechanism in the cellular defense against oxidative or 
electrophilic stress (Chapter 4).  
The findings in this dissertation provide compelling evidence that flavored e-liquids 
and cinnamaldehyde, a common food-safe flavoring agent, have the capacity to alter innate 
immune defense functions in respiratory tissues. These data indicate that, 1) cinnamaldehyde 
suppresses neutrophil, alveolar macrophage, and NK cell defense functions in dose-
dependent manner at concentrations well below cytotoxic levels, 2) cinnamon-flavored e-
liquids (both unheated and vaped) and cinnamaldehyde transiently suppress cilia motility on 
airway epithelial cells via inhibition of cell mitochondrial and glycolytic functions, and 3) 
cinnamaldehyde, eugenol, and guaiacol significantly induce Nrf2 pathway activation in 
bronchial epithelial cells suggesting increased cellular oxidative stress.  
The data presented herein provide evidence that flavoring agents in e-cigarettes, 
particularly electrophilic aldehydes such as cinnamaldehyde, have the capacity to impair 
respiratory innate defenses, and may place e-cigarette users at a greater risk of respiratory 
infections. I anticipate that the work in this dissertation will be useful for developing federal 
regulations aimed at reducing or eliminating harmful and potentially harmful constituents 
from e-cigarettes.  
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CHAPTER 2. 
FLAVORED E-CIGARETTE LIQUIDS AND CINNAMALDEHYDE IMPAIR 
RESPIRATORY INNATE IMMUNE CELL FUNCTION1 
2.1  Introduction 
Smoking continues to be the leading cause of preventable death accounting for 12% 
of all mortalities among adults worldwide (1). A link between cigarette smoke exposure, 
suppression of respiratory immune responses, and enhanced susceptibility to respiratory 
infection is well established (2-8). While tobacco use is steadily declining in the U.S., 
electronic cigarettes (e-cigarettes) are rapidly gaining popularity, particularly among teens 
and young adults (9) who often perceive these products as less harmful than traditional 
cigarettes (10). This perception is in part due to targeted marketing which identifies these 
products as a “safer alternative” to traditional cigarettes (11); however, little is known 
regarding the effects of “vaping” on respiratory innate immune cell function. A recent study 
by Sussan et al. reported that mice exposed to e-cigarette aerosols exhibited impaired 
bacterial clearance and increased susceptibility to respiratory virus infection (12). 
Furthermore, lung macrophages from these exposed mice exhibited reduced phagocytic 
capacity. More recently, Hwang et al. exposed human epithelial cell lines, murine alveolar 
_______________________ 
1 This chapter previously appeared as an article in the American Journal of Physiology Lung Cellular and 
Molecular Physiology. The original citation is as follows: 
Clapp, P. W., Pawlak, E. A., Lackey, J. T., Keating, J. E., Reeber, S. L., Glish, G. L., and Jaspers, I. (2017) 
Flavored e-cigarette liquids and cinnamaldehyde impair respiratory innate immune cell function. Am J Physiol 
Lung Cell Mol Physiol 313, L278-L292.
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macrophages, and human neutrophils to “e-cigarette vapor extract” and observed dose-
dependent cytotoxicity and reduced antimicrobial activity against Staphylococcus aureus 
(13). The findings in both publications were largely attributed to the immunosuppressive 
effects of nicotine; however, reactive carbonyls present in these flavored e-liquids and 
generated by e-cigarette devices may also play a role in the observed immunomodulatory 
effects (14-16). 
E-cigarette devices aerosolize flavored e-liquids, which are typically composed of 
humectants (propylene glycol and/or vegetable glycerin), chemical flavorings, and nicotine. 
There are currently more than 7,700 commercially available e-liquids which contain 
flavorings that have not been evaluated for inhalational toxicity (17). While many of these 
flavorings are classified as generally recognized as safe (GRAS) for oral consumption by the 
United States Food and Drug Administration (U.S. FDA), prolonged inhalation of some 
GRAS flavorings, such as diacetyl, 2,3-pentanedione, and acetoin, can cause irreversible lung 
disease (18-20). GRAS chemicals commonly used as e-liquid flavoring agents include 
aliphatic aldehydes (for fruity flavors) and aromatic aldehydes (for sweet and spicy flavors) 
(21, 22). The Flavor and Extract Manufacturers Association (FEMA) has identified over 
1000 GRAS flavorings that may pose a respiratory hazard due to possible volatility and 
irritant properties (23, 24); however, it is unclear whether these flavorings, in the context of 
e-cigarette exposures, directly impact respiratory innate immune cells. Previous studies have 
demonstrated that vanillin and cinnamaldehyde, aromatic aldehydes commonly used as e-
liquid flavoring and odorant agents, can suppress macrophage function (25-32). However, 
most of these studies were conducted in non-human cell lines without direct relevance to the 
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lung. Consequently, how exposure of innate immune cells patrolling the respiratory tract to 
these flavoring chemicals induces potential functional changes is unknown.  
The testing paradigm we chose to address this knowledge gap was to screen popular e 
liquids for their potential to alter innate immune cell function, identify common flavoring 
agents in the e-liquids eliciting a response, and investigate whether exposure to a shared 
flavoring agent alone could recapitulate the observed response. To this end, we collected 
alveolar macrophages, peripheral blood neutrophils, and NK cells from healthy, non-smoker 
volunteers and exposed the cells to varying dilutions of nicotine-free flavored e-liquids and 
evaluated changes in normal immune functions. The chemical composition of e-liquids 
which altered immune cell responses was determined, and a shared chemical flavoring, 
cinnamaldehyde, was investigated for its role in the e-liquid-induced effects on respiratory 
immune cell function. 
2.2  Materials and methods 
Subjects 
Healthy individuals between the ages of 18-49 were recruited to donate venous blood 
for the isolation of neutrophils or NK cells or to undergo bronchoscopy and bronchoalveolar 
lavage for the collection of alveolar macrophages. Subjects donating venous blood were 
healthy, nonsmoking, nonvaping adults who are not routinely exposed to secondhand smoke. 
Exclusion criteria included pregnant or nursing females or individuals with a history of egg 
allergy, allergic rhinitis, aspirin therapy, asthma, immunodeficiency (HIV or other), Guillain- 
Barre Syndrome, COPD, cardiac disease, any chronic cardiorespiratory condition, or 
fever/respiratory illness within three weeks prior to entry into study. Subjects undergoing 
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bronchoscopy received a physical examination, a routine blood panel with complete blood 
count (CBC) and differential, serum electrolyte, glucose, and liver enzyme testing. Female 
subjects had to have a negative urine pregnancy test prior to bronchoscopy and all volunteers 
were required to be free of chronic cardiovascular or respiratory illness and be free of acute 
respiratory illness within the proceeding three weeks. All subjects undergoing bronchoscopy 
had forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) ≥ 80% 
predicted and FEV1/FVC ≥ 80% predicted normal for height and age and were nonvapers and 
nonsmokers with no smoking history. Subjects were matched for sex, age, and BMI between 
experimental conditions. Participants in this study were not currently taking 
immunosuppressive drugs including corticosteroids. Informed consent was obtained from all 
subjects and all studies were approved by the University of North Carolina at Chapel Hill 
School of Medicine Institutional Review Board. 
Alveolar Macrophage Isolation 
Bronchoalveolar lavage (BAL) fluid was collected during bronchoscopy as 
previously described (33). Briefly, a flexible, fiber-optic bronchoscope was inserted 
transnasally and wedged into a subsegment of the medial segment of the right middle lobe 
(fifth or sixth generation). Saline was instilled and immediately aspirated to recover alveolar 
leukocytes. Recovered BAL fluid was centrifuged and cells (>95% alveolar macrophages) 
were resuspended in RPMI-1640 medium (Thermo Fisher Scientific, Waltham, MA, USA).  
Neutrophil Isolation 
Venous blood was collected into vacutainer tubes containing ethylenediamine 
tetraacetic acid (EDTA) and allowed to cool to room temperature with gentle rocking prior to 
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cell isolation. Neutrophils were isolated by density centrifugation of venous blood over 
Histopaque 1119 (Sigma-Aldrich, St. Louis, MO, USA) and subsequently over a 
discontinuous Percoll (GE Healthcare Life Sciences, Marlborough, MA, USA) gradient as 
previously described (34, 35). Isolated neutrophils were re-suspended in RPMI-1640 medium 
containing 10mM HEPES buffer and 0.5% fetal bovine serum (FBS). Cells were incubated at 
37˚C and 5% CO2 for 30 minutes prior to challenges. 
Natural Killer Cell Isolation 
Venous blood was collected into vacutainer tubes containing heparin and allowed to 
cool to room temperature with gentle rocking prior to cell isolation. Blood was diluted 1:4 
with PBS and centrifuged over Lymphoprep density gradient medium (STEMCELL 
Technologies Inc., Vancouver, Canada) to fractionate whole blood components. The plasma 
and peripheral blood mononuclear cell (PBMC) fractions were harvested and briefly washed 
with PBS. NK cells were isolated from the PBMC fraction using negative antibody selection 
with the Dynabeads® Untouched™ Human NK Cell negative selection kit (Thermo Fisher 
Scientific, Waltham, MA, USA). Purified NK cells were kept at 37˚C and 5% CO2 in RPMI-
1640 medium with 10% FBS prior to challenges. 
Flavored E-cigarette Liquids 
A panel of 7 flavored, nicotine-free e-liquids was purchased from a local vendor (The 
Vapor Girl, Chapel Hill, NC, USA). E-liquids were selected for this study based on either a 
“top-seller” designation (“Menthol Tobacco” and “Solid Menthol”) or their likelihood to 
contain chemical flavorings identified as potential respiratory hazards by FEMA, such as 
cinnamaldehyde (“Hot Cinnamon Candies”, “Kola”, and “Sini-cide”) and isoamyl acetate 
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(“Banana Pudding” and “Banana”). E-liquids were stored in opaque glass bottles at room 
temperature and were diluted for use at the time of each experiment. All e-liquids used in this 
study were reported by the manufacturer to contain the humectants propylene glycol and 
vegetable glycerin at relative proportions of 55% and 45%, respectively. A mixture of 55% 
propylene glycol (Thermo Fisher Scientific, Waltham, MA, USA) and 45% vegetable 
glycerin (Sigma-Aldrich, St. Louis, MO, USA) was used as a vehicle control for all e-liquid 
experiments. 
Stimulation and Quantification of Neutrophil Extracellular Traps (NETs)  
Neutrophils were seeded at a density of 1x105 in 100µl volume per well of a cell 
culture treated 96-well plate and allowed to incubate at 37˚C and 5% CO2 for 30 minutes. 
Cells were then challenged with a final concentration of 1.0% e-liquid diluted in cell culture 
medium with or without 25nM phorbol 12-myristate 13- acetate (PMA; Sigma-Aldrich, St. 
Louis, MO, USA), a protein kinase C activator and potent NET agonist. Wells were assayed 
for extracellular chromatin every hour during a 4-hour challenge. Chromatin extruded by 
activated neutrophils was digested with 500mU/ml micrococcal nuclease (Worthington 
Biochemical, Lakewood, NJ, USA). Micrococcal nuclease activity was quenched with 5mM 
EDTA following a 10-minute digestion at 37˚C. Chromatin released at each time point was 
quantified using the Picogreen double stranded DNA kit (Life Technologies, Carlsbad, CA, 
USA) according to the manufacturer’s protocol.  
Immunofluorescent Analysis of NETs  
Neutrophils were seeded onto 13mm round glass cover slips (0.15mm thick) and 
challenged with 1.0% e-liquid diluted in cell culture medium with or without 25nM PMA. 
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Cells were fixed with 4% paraformaldehyde (PFA; Sigma-Aldrich, St. Louis, MO, USA ) 
every hour during a 4-hour challenge and immunolabeling was conducted as described by 
Brinkmann et al. (34). Neutrophils were blocked (5% normal donkey serum (Jackson 
ImmunoResearch Laboratories, West Grove, PA, USA), 1% gelatin from cold water fish skin 
(Sigma-Aldrich, St. Louis, MO, USA), 1% bovine serum albumin (Sigma-Aldrich, St. Louis, 
MO, USA), and 0.05% Tween 20 (Sigma-Aldrich, St. Louis, MO, USA) in PBS 
(Gibco/Thermo Fisher Scientific, Waltham, MA, USA)) and incubated with a mouse anti-
human neutrophil elastase primary antibody (Dako, Carpinteria, CA, USA), which was 
detected with an Alexafluor 488 conjugated secondary antibody (Jackson ImmunoResearch 
Laboratories, West Grove, PA, USA). Negative controls were conducted using Isotype-
matched (IgG1κ) labeling of NETs at each time point. Chromatin was labeled with Hoechst 
33342 (Thermo Fisher Scientific, Waltham, MA, USA). Coverslips were mounted onto 
microscope slides with ProLong Gold Antifade Mountant (Thermo Fisher Scientific, 
Waltham, MA, USA) and the edges sealed with clear fingernail polish. Cells were imaged 
using a Nikon Digital Eclipse C-1 modular confocal microscope and Plan Apo VC 60x/1.40 
oil objective. 
Neutrophil and Alveolar Macrophage Phagocytosis 
Neutrophils isolated from venous blood were seeded at a density of 1x105 cells per 
well of a black, clear-bottom 96-well plate in RPMI-1640 media with 10mM HEPES buffer 
(Sigma Aldrich, St. Louis, MO, USA) and 0.5% FBS (Gibco/Thermo Fisher Scientific, 
Waltham, MA, USA). Cells were allowed to incubate at 37˚C and 5% CO2 for 30 minutes. 
Neutrophils were then challenged in triplicate with a final concentration of 1%, 0.5%, or 
0.25% e-liquid diluted in cell culture medium for 30 minutes. Opsonized pHrodo™ Red 
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Staphylococcus aureus BioParticles® (Thermo Fisher Scientific, Waltham, MA, USA) were 
prepared according to the manufacturer’s instructions and added to each well following e-
liquid challenge. Neutrophils and BioParticles were incubated at 37˚C and 5% CO2 for an 
additional 4 hours to assess e-liquid induced changes in phagocytic capacity. 
Cells obtained from BAL fluid were seeded at a density of 5x104 cells per well of a 
black, clear bottom 96-well plate (Corning Life Sciences, Tewksbury, MA, USA) in RPMI-
1640 medium with 10% FBS. Cells were allowed to incubate at 37˚C and 5% CO2 for 2 
hours. Non-adherent cells were then aspirated thereby enriching the alveolar macrophage 
population. Adherent alveolar macrophages were challenged in triplicate with cell culture 
medium containing 1%, 0.5%, or 0.25% flavored e-liquid for 1 hour. Following e-liquid 
challenge, opsonized pHrodo™ S. aureus BioParticles® were added to the cells and allowed 
to incubate as described above. 
To assess whether nicotine altered e-liquid-induced effects on neutrophil 
phagocytosis, nicotine (Sigma-Aldrich, St. Louis, MO, USA) was added to the “Kola”, “Hot 
Cinnamon Candies”, “Sini-cide”, and “PGVG vehicle” e-liquids at concentrations commonly 
stocked in vape shops (2.4%, 1.8%, 1.2%, and 0.6%). Nicotine- containing e-liquids were 
then diluted to 0.25% in cell culture medium, neutrophils were challenged as described 
above, and opsonized pHrodo™ Red S. aureus BioParticles® were added to assess 
phagocytosis. 
Phagocytosis of BioParticles® was quantified using a CLARIOstar fluorescent 
microplate reader (BMG Labtech, Offenburg, Germany) by assessing fluorescence emission 
at 585nm. Cell-free negative control wells were used to normalize for background 
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fluorescence resulting from e liquid challenge at 1%, 0.5%, or 0.25%. Data are presented as 
percent phagocytosis observed in the propylene glycol/vegetable glycerin (PG/VG) vehicle at 
each dilution tested. 
DTT Competition Assay 
Alveolar macrophages obtained from BAL fluid were seeded on black, clear-bottom 
96-well plates and allowed to incubate as described above. Non-adherent cells were removed 
and adherent alveolar macrophages were challenged with cell culture medium alone, 500µM 
cinnamaldehyde, 500µM dithiothreitol (DTT; Sigma-Aldrich, St. Louis, MO, USA), or a 
challenge, opsonized pHrodo™ S. aureus BioParticles® were added to the cells and 
incubated for an additional four hours. Phagocytosis of BioParticles® was quantified using 
the CLARIOstar fluorescent microplate reader as described above. 
Immunofluorescent Analysis of Macrophage Phagocytosis 
Alveolar macrophages were seeded onto 13mm round glass cover slips (0.15mm 
thick) at 2x105 cells per well of a cell culture-treated 24-well plate. Cells were allowed to 
incubate at 37˚C and 5% CO2 for 2 hours and were challenged with 1%, 0.5%, or 0.25% 
dilutions of flavored e-liquid for 1 hour as described above. Opsonized pHrodo™  S. aureus 
BioParticles® were added to each well according to the manufacturer’s protocol and cells 
were fixed with 4% PFA after 4 hours. Following 30-minute fixation at 4˚C, PFA was 
aspirated and cells were blocked for 1 hour with 5% normal donkey serum, 1% gelatin from 
cold water fish skin, 1% bovine serum albumin, and 0.05% Tween 20 in PBS (block buffer). 
AlexaFluor 488-conjugated phalloidin (Thermo Fisher Scientific, Waltham, MA, USA) and 
Hoechst 33342 were diluted in block buffer to the manufacturer’s recommended 
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concentrations and applied to the cells for 1 hour. Coverslips were washed with PBS, 
mounted onto microscope slides with ProLong Gold Antifade Mountant, and the edges 
sealed with clear fingernail polish. Cells were imaged using a Nikon Digital Eclipse C-1 
modular confocal microscope and Plan Apo VC 60x/1.40 oil objective. 
NK Cell Killing Assay 
1x105 NK cells were added to duplicate polypropylene flow cytometry tubes with 
0.25% e-liquids diluted in cell-culture medium for 1 hour. During e-liquid incubation, K-562 
human erythromyeloblastoid leukemia cells (ATCC, Manassas, VA, USA) were labeled with 
carboxyfluorescein succinimidyl ester (Cayman Chemical, Ann Arbor, MI, USA). Following 
e liquid challenge, 3.2x104 CFSE-labeled K-562 cells were added to each tube of NK cells 
and incubated for 4 hours at 37°C and 5% CO2. The entire cell suspension was then pelleted 
and stained with LIVE/DEAD® fixable dead cell stain kit (Thermo Fisher Scientific, 
Waltham, MA, USA), fixed with 0.5% PFA, and data were acquired on a BD™ LSRII Flow 
Cytometer as described in our previous studies (36).  
Enzyme-linked Immunosorbent Assay (ELISA) 
Supernatants were harvested from alveolar macrophages and neutrophils after 
challenge with diluted e-liquids. Specifically, cells collected from BAL were seeded in cell-
culture treated 96 well plates as described above. Media containing 1%, 0.5%, or 0.25% 
flavored e-liquid or PG/VG vehicle was added to each well and supernatants were collected 
after 24 hours. Neutrophils were seeded at a density of 1x105 cells per well of cell culture-
treated 96-well plates in RPMI-1640 media with 0.5% FBS and stimulated with 1%, 0.5%, or 
0.25% of each e-liquid flavor for 4 hours, followed by collection of supernatants. Medias 
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collected post-challenge were stored at -20˚C until analyzed. Interleukin 8 (IL-8) and 
interleukin 6 (IL-6) were quantified in cell culture supernatants via commercially available 
ELISA kits (BD Biosciences, San Jose, CA, USA). 
Vaped E-liquid Condensate 
Vaped e-liquid condensates (VEC) of “PG/VG (vehicle control)”, “Kola”, “Hot 
Cinnamon Candies” and “Sini-cide” were generated as described by Olmedo et al (57). 
Briefly, e-cigarette aerosol was produced by connecting a LAVABOX DNA 200 Box Mod 
(Volcano e-Cigs, Honolulu, HI, USA) and a SMOK TFV4 Mini Tank with a sub-ohm 
(0.37Ω) TF-CLP2 Clapton Coil (SMOKtech, Shenzhen, China) to a 16cm length of tubing 
(4.8mm internal diameter, Masterflex L/S 15, Vernon Hills, IL, USA). A peristaltic pump 
(drive number 07522-20 and head number 77200-62, Cole-Parmer, Vernon Hills, IL, USA) 
was used to pull aerosol from the e-cigarette device at a flow rate of one liter per minute. One 
puff of aerosol was generated every 30 seconds for 10 minutes (20 puffs total) using an 
output setting of 60 watts. Vaped aerosol was pumped through a series of alternating 250µl 
pipette tips and Tygon tubing (1.5mm internal diameter, S3 E-3603, Saint-Gobain 
Corporation, France) to allow the aerosol to cool and condense. VEC for each e-liquid was 
collected into a sterile 1.5ml microcentrifuge tubes for quantitation of cinnamaldehyde 
content. Alveolar macrophages and neutrophils were then seeded as described above and 
challenged with a 0.25% dilution of each VEC or unheated e-liquid to assess whether the 
vaping process altered e-liquid-induced effects on phagocytic function. 
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Mass Spectrometry of E-liquids 
Qualitative e-liquid analysis was performed on a Bruker Scion 456 gas 
chromatograph (GC)-triple quadrupole mass spectrometer (Bruker, Billerica, MA, USA) 
using an Agilent DB-5MS capillary column (30m, 0.25mm ID, 0.25µM film) (Agilent 
Technologies, Santa Clara, CA, USA). Samples were prepared by diluting 100µL of e- liquid 
in 1mL of methanol (optima grade) and vortexing for 30 seconds. Splitless injections (2µL) 
were performed using a Bruker CP-8400 autosampler. 
Cinnamaldehyde was quantified in e-liquid and VEC samples using the same GC-MS 
system and operating conditions. Cinnamaldehyde standard solutions were prepared to 
concentrations of 7.22mM, 3.61mM,1.44mM, 0.722mM, 0.361mM, and 0.181mM in 
methanol (Optima grade). A calibration curve was generated using standard addition methods 
by diluting the “Sini-cide”, “Hot Cinnamon Candies”, and “Kola” e-liquids to ratios of 1:500, 
1:100, and 1:10 respectively in the standard solutions. Dilution factors were selected to 
ensure that cinnamaldehyde concentrations fell within the linear range of the calibration 
curve. Analyses were performed in triplicate. Multiple reaction monitoring (MRM) was used 
for quantitation of the “Kola” e-liquid, as it provided the limit of detection needed for the 
lower cinnamaldehyde concentration. Two reactions were used: m/z 131 to m/z 77 and m/z 
131 to m/z 103. The m/z 77 product ion was used for quantitation with 90% of the scan time, 
and the m/z 103 product ion was used for qualification with 10% of the scan time to provide 
increased selectivity. Argon was used as the collision gas at a pressure of 1.5mTorr and the 
collision energy was 20eV. 
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The GC oven was programmed to hold the temperature at 50°C for 2 minutes, ramp 
to 300°C at a rate of 15°C/minute and hold at 300°C for 6.33 minutes for a total runtime of 
25 minutes. The transfer line and EI source were held at 250°C throughout the analysis. 
Compound identification and peak integration was done using AMDIS GC/MS Analysis 
software based on spectral matching with the NIST Mass Spectral Library (2011). 
Statistics 
Data were generated from cells isolated from a minimum of n=3 individuals, as noted 
in the figure legends. When appropriate, data are expressed as a percentage of PG/VG 
vehicle control. Macrophage and neutrophil data were analyzed using a two-way ANOVA 
with Fisher’s LSD posttest. NK cell-mediated cytotoxicity data were analyzed using a one-
way ANOVA with a Dunn’s multiple comparison test. All statistical tests were performed 
using GraphPad Prism Version 7. A p-value of <0.05 was considered to be significant. 
2.3  Results 
Effects of Flavored E-liquids on Alveolar Macrophages 
The effects of flavored e-liquids on alveolar macrophage phagocytosis were assessed 
by challenging cells with 1%, 0.5%, and 0.25% e-liquids diluted in cell culture medium, 
followed by incubation with Staphylococcus aureus BioParticles. The BioParticles used for 
this study emit a minimal fluorescent signal at physiologic pH (approximately 7.4); however, 
fluorescence intensity increases as particles are phagocytosed and subjected to an acidic pH 
in phagosomes. Exposure of alveolar macrophages to the highest dilution (1%) of PGVG 
vehicle alone produced a slight but significant reduction in BioParticle phagocytosis (Figure 
2.1A). Of the seven e-liquids tested, only “Kola” (1%) and “Sini-cide” (1%, 0.5%, and 
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0.25%) significantly suppressed phagocytosis as compared to the PG/VG vehicle control 
(Figure 2.1B). Fluorescent confocal microscopic analysis of macrophages challenged with 
0.25% “Sini-cide” revealed normal alveolar macrophage morphology but loss of phagocytic 
function and inability to engulf labeled BioParticles (Figure 2.1C). The suppression of 
macrophage phagocytosis induced by “Sini-cide” was validated by flow cytometry. Flow 
analysis confirmed that “Sini-cide” at all three dilutions used (1%, 0.5%, and 0.25%) 
significantly reduced phagocytic function (Figure 2.1D). The reduction in phagocytosis 
observed with the 1% “Sini-cide” challenge can be attributed to e-liquid-induced 
cytotoxicity; however, the 0.5% and 0.25% dilutions significantly suppressed phagocytosis 
without reducing macrophage viability (Figure 2.1E)
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Figure 2.1   Effects of flavored e-liquids on alveolar macrophage phagocytosis. Alveolar macrophages were challenged with 1, 
0.5, and 0.25% dilutions of propylene glycol/vegetable glycerin (PG/VG) vehicle (A) or electronic cigarette liquids (e-liquids, B) for 
1h before the addition of Staphylococcus aureus BioParticles. Phagocytosis was assessed 4h after the addition of Bioparticles (n=10 
experiments). C: fluorescent confocal microscopy of alveolar macrophages challenged with PG/VG vehicle (left) or “Sini-cide” e-
liquid (0.25%, right). White arrows, non-phagocytosed and extracellular BioParticles. D: e-liquid-induced suppression of phagocytosis 
was validated by flow cytometry (n=3). E: flow-based analysis of cell viability (n=3). Data are presented as means ± SE. Significance: 
**P<0.01 and ***P<0.001 compared with vehicle control.
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In addition to changes in phagocytic function, e-liquid-induced alterations in alveolar 
macrophage proinflammatory cytokine production were evaluated. Acute exposure to 1% 
“Kola” e-liquid significantly increased IL-6 secretion while 0.5% “Sini-cide” challenge 
significantly suppressed IL-6 secretion relative to the PG/VG vehicle control (Figure 2.2A). 
“Sini-cide” e-liquid significantly suppressed alveolar macrophage IL-8 secretion across all 
dilutions tested (Figure 2.2B). 
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Figure 2.2   Effects of flavored e-liquids on alveolar macrophage cytokine secretion. 
Alveolar macrophages were challenged with 1, 0.5, and 0.25% e-liquid dilutions for 24h and 
evaluated for changes in interleukin (IL)-6 (A) and IL-8 (B) protein secretion (n=5). Data are 
presented as means ± SE. Significance: *P<0.05 and ***P<0.001 compared with vehicle 
control. 
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Effects of Flavored E-liquids on Neutrophils  
Next, we determined the effects of flavored e-liquids on the phagocytic capacity of 
human primary neutrophils. Similar to the effect on alveolar macrophages, challenge with the 
1% dilution PG/VG vehicle alone significantly reduced neutrophil phagocytosis (Figure 
2.3A). Of the seven flavored e-liquids tested, “Hot Cinnamon Candies”, “Banana Pudding”, 
“Menthol Tobacco”, “Banana”, and “Sini-cide” reduced neutrophil phagocytosis across all 
dilutions in a dose-dependent manner (Figure 2.3B). While toxicity was observed at higher 
concentrations for “Kola” (1%) and “Sini-cide” (1%, 0.5%) flavors, none of the flavors 
showed significant toxicity at 0.25%, suggesting that suppression of phagocytosis was not 
due to e-liquid-induced cytotoxicity (LDH release assay; data not shown). Interestingly, 
“Sini-cide” challenge resulted in a dose-dependent change in neutrophil phagocytosis that 
was opposite of that observed in the other e-liquids. We observed that BioParticle 
fluorescence intensity (i.e. phagocytosis) increased as the percent “Sini-cide” challenge 
increased; however, this is likely due to cell lysis, which we only observed with the 0.5% and 
1.0% “Sini-cide” challenges. Furthermore, fluorescent confocal microscopic analysis of 
neutrophils challenged with 0.25% “Hot Cinnamon Candies” and “Sini-cide” revealed 
normal neutrophil morphology but an inability to engulf labeled BioParticles (Figure 2.3C). 
Next, we investigated whether neutrophils exposed to flavored e-liquids exhibited 
altered proinflammatory cytokine production. All flavored e-liquids, with the exception of 
“Solid Menthol” and “Sini-cide,” induced a significant increase in neutrophil IL-8 secretion 
(Figure 2.3D). Specifically, “Kola” (1%, 0.5%), “Hot Cinnamon Candies” (0.5%), “Banana 
Pudding” (1%, 0.5%, 0.25%), “Menthol Tobacco” (1%), and “Banana” (1%) significantly  
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increased IL-8 production relative to the PG/VG vehicle control. The “Sini-cide” e-liquid did 
not stimulate IL-8 secretion; however, this is likely due to the significant cytotoxicity 
observed with the 1% and 0.5% challenges. 
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Figure 2.3   Effects of flavored e-liquids on neutrophil phagocytosis. Neutrophils were 
challenged with 1, 0.5, and 0.25% dilutions of PG/VG vehicle (A) or e-liquids (B) for 30 min 
before addition of S. aureus BioParticles. Phagocytosis was assessed 4h after the addition of 
Bioparticles (n=5). C: fluorescent confocal microscopy of neutrophils challenged with 0.25% 
“Kola,” “Hot Cinnamon Candies,” and Sini-cide. D: neutrophils were challenged with 1, 0.5, 
and 0.25% e-liquid dilutions for 4h and evaluated for changes in IL-8 secretion (n=3). Data 
are presented as means ± SE. Significance: *P<0.05, **P<0.01, and ***P<0.001 compared 
with vehicle control. 
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In addition to phagocytosis, neutrophils exert their anti-bacterial function via the 
formation of neutrophil extracellular traps (NETs). To assess the impact of e-liquids on NET 
generation, primary human neutrophils were incubated with 1% e-liquids diluted in cell 
culture medium alone or in the presence of 25nM PMA, a PKC agonist and potent activator 
of NET formation. Challenge of neutrophils with a 1% dilution of PGVG with and without 
25nM PMA did not induce or alter NET formation as compared to NET formation generated 
with media alone and media with 25nM PMA (Figure 2.4A). Similar to PGVG, e-liquid 
challenges without the addition PMA did not stimulate normal NET formation; however, 1% 
“Sini-cide” induced chromatin release at all time points (Figure 2.4B). The pattern of 
chromatin extrusion observed with the “Sini-cide” challenge did not follow the oxidant-
driven temporal progression of NET formation (35, 37) or the rapid, oxidant-independent 
generation of NETs (38), suggesting e-liquid-induced cytotoxicity and cell lysis. To assess 
whether flavored e-liquids alter normal NET formation, neutrophils were challenged with 1% 
e-liquid dilutions containing 25nM PMA and NET extrusion was quantified over four hours. 
Stimulation of neutrophils with 1% “Kola” significantly enhanced chromatin release at 3 
hours, while challenge with 1% “Hot Cinnamon Candies” suppressed PMA-induced NET 
formation at 4 hours (Figure 2.4C). Exposure to 1% “Sini-cide” resulted in a similar pattern 
of chromatin release observed in the challenge without PMA. To visualize the time-
dependent effects of these e-liquids on NET formation, we fixed neutrophils at the various 
time points and examined cellular morphology and markers of NET formation, such as 
disintegration of nuclear membranes, nuclear material filling the cytoplasm and mixing with 
cellular granules, and complete loss of nuclear and granular integrity (39) using confocal 
microscopy. Figure 2.4D indicates that “Sini-cide” was cytotoxic resulting in chromatin 
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release by cell lysis within the first hour of exposure, confirming the non-specific release of 
DNA seen in Figures 2.4B and 2.4C. Interestingly, stimulation with “Kola” in the presence of 
PMA appeared to expedite the steps associated with NET formation, with complete loss of 
nuclear and granular integrity seen at 3 hours, rather than 4 hours. In addition, stimulation 
with “Hot Cinnamon Candies” appeared to block progression of NET formation. These data 
suggest that stimulation with “Kola” and “Hot Cinnamon Candies” have differential effects 
on NET formation. Furthermore, the visual illustration in Figure 2.4D largely reflects the 
quantitative assessment of chromatin release reported in Figures 2.4B and 2.4C.
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Figure 2.4   Effects of flavored e-liquids on neutrophil extracellular trap (NET) formation. Quantitation of nucleic acid released 
during challenge with a 1% dilution of PG/VG vehicle (A) or e-liquid challenges with 25nM phorbol 12-myristate,13-acetate (PMA, 
B) and without 25nM PMA (C) (n=3). D: confocal immunofluorescence microscopy of neutrophils challenged with 1% flavored e-
liquids, with and without 25nM PMA. Data are presented as means ± SE. Significance: *P<0.05 and *** P<0.001 compared with 
vehicle control
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Numerous studies have reported that nicotine elicits a variety of immune suppressive 
responses (13, 40, 41) and prolongs neutrophil survival (42-44). To investigate whether 
nicotine could alter the observed e-liquid-induced suppression of neutrophil phagocytosis, we 
added nicotine to the PGVG vehicle, “Kola”, “Hot Cinnamon Candies”, and “Sini-cide” e-
liquids at concentrations commonly found in commercially available e-liquids (0.6, 1.2, 1.8, 
and 2.4 mg/ml). Stimulation with a 0.25% dilution of e-liquids with and without nicotine did 
not significantly affect neutrophil phagocytosis beyond the effects observed with the 
different flavored e-liquids alone (Figure 2.5A). In addition, emerging evidence indicates that 
thermal decomposition of e-liquids during the vaping process can modify the chemical 
composition of the aerosol mixtures (45). To examine whether and how aerosolization of e-
liquids affects the suppressive effects on neutrophil phagocytosis, we prepared vaporized e-
liquid condensates (VEC), similar to previously published methods (46). Figure 2.5B shows 
that stimulation of neutrophils with PGVG vehicle, “Kola”, “Hot Cinnamon Candies” or 
“Sini-cide” VEC did not significantly alter neutrophil phagocytosis as compared to the 
unheated e-liquid challenges. These data suggest that vaping and aerosolization of these e-
liquids does not significantly modify the ability to suppress neutrophil phagocytosis. 
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Figure 2.5   Effects of nicotine and vaping on e-liquid-induced changes in neutrophil 
phagocytosis. Nicotine was added to the Kola, Hot Cinnamon Candies, Sini-cide, and 
PG/VG vehicle e-liquids at concentrations commonly stocked in vape shops (2.4, 1.8, 1.2, 
and 0.6%). A: nicotine-containing e liquids were diluted to 0.25% in cell culture medium, 
and neutrophils were challenged for 30 min before the addition of S. aureus Bioparticles. 
Phagocytosis was assessed 4h after the addition of Bioparticles (n=4). B: Kola, Hot 
Cinnamon Candies, Sini-cide, and “PG/VG” e-liquids were “vaped” to generate vaped e-
liquid condensates (VECs). Neutrophils were challenged with 0.25% dilutions of Kola, Hot 
Cinnamon Candies, Sini-cide, and PG/VG e-liquids or VECs for 30min before the addition 
of S. aureus Bioparticles. Phagocytosis was assessed 4h after the addition of Bioparticles 
(n=3). Data are presented as means ± SE. Significance: **P<0.01 and ***P<0.001 compared 
with vehicle control. 
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Effects of Flavored E-liquids on NK Cells 
To evaluate the impact of flavored e-liquids on normal NK cell function, we exposed 
NK cells to flavored e- liquids in cell-culture medium prior to incubation with fluorescently-
labeled K562 leukemia target cells. Based on the previous results in macrophages and 
neutrophils, we focused our analysis on the 0.25% e-liquid dilution. Following 4-hour 
incubation, the ability of the NK cells to eliminate target cells was determined using flow 
cytometry (Figure 2.6A). Killing of target cells was suppressed by cinnamon-flavored e-
liquids. Specifically, 0.25% “Hot Cinnamon Candies” and 0.25% “Sini-cide” reduced the 
killing efficiency of NK cells as compared to the PG/VG vehicle control (Figure 2.6A, 2.6B). 
Reductions in NK cell killing capacity were not due to a loss of NK cell viability (data not 
shown).  
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Figure 2.6   Effects of flavored e-liquids on natural killer (NK) cell-mediated 
cytotoxicity. NK cells were incubated for 1 h with 0.25% e-liquids and then combined with 
carboxyfluorescein succinimidyl ester (CFSE)-labeled K562 target cells for 4 h. A: flow 
cytometry analysis of CFSE bright target cells counter-labeled with a far-red live/dead 
indicator. B: quantitation of NK cell-mediated killing of K562 leukemia target cells (n=5). 
Data are presented as means ± SE. Significance: *P<0.05 compared with vehicle control. 
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Chemical Composition of Flavored E-liquids 
Gas chromatography-coupled mass spectrometry was used to determine the 
qualitative chemical composition of the 7 flavored e-liquids used for this study. Spiro[1,3-
dioxolane 2,2'(1'H)-naphthalene], 3',4'-dihydro-, vinyl trans-cinnamate, and cinnamaldehyde 
were present in the “Kola”, “Hot Cinnamon Candies”, and “Sini-cide” flavored e-liquids 
(Table 2.1). Quantitative mass spectrometry analysis for cinnamaldehyde content in these 
flavored e-liquids revealed that the “Kola,” “Hot Cinnamon Candies,” and “Sini-cide” 
contained 0.896mM ± 0.360mM, 39.328mM ± 3.414mM, and 1.131M ± 0.0199M, 
respectively (Table 2.2). Based on these measured concentrations of cinnamaldehyde in the 
neat e-liquids, we extrapolated the concentrations of cinnamaldehyde in the 1%, 0.5%, and 
0.25% dilutions of “Kola”, “Hot Cinnamon Candies”, and “Sini-cide” used to challenge cells. 
In addition, we determined whether aerosolization of these e-liquids modified the 
cinnamaldehyde content. As shown in Table 1, cinnamaldehyde was present in the VEC 
derived from “Kola”, “Hot Cinnamon Candies”, and “Sini-cide”, but at lower concentrations, 
likely eflecting wall-loss caused by the system generating the condensate.
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Table 2.1 Composition of flavored e-liquids used for this study
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Table 2.2   Quantitation of cinnamaldehyde in e-liquids and vaped e-liquid condensates. 
Values are means ± SD. †Cinnamaldehyde in e-liquid dilutions is extrapolated from neat e-
liquid measurements. 
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Effects of Cinnamaldehyde on Alveolar Macrophage, Neutrophil, and NK cell Function 
Mass spectrometry analysis revealed that cinnamaldehyde was a major flavoring 
component in “Sini-cide,” “Hot Cinnamon Candies,” and “Kola,” and each of these e-liquids 
impaired normal immune cell function in our study. To determine the specific contribution of 
cinnamaldehyde to the observed immunosuppressive effects, we challenged alveolar 
macrophages, neutrophils, and NK cells with various doses of cinnamaldehyde diluted in cell 
culture medium and assessed changes in functional endpoints. Alveolar macrophages were 
incubated with cinnamaldehyde for one hour prior to the addition of Staphylococcus aureus 
BioParticles. Changes in phagocytosis were assessed after four hours. A significant reduction 
in phagocytosis was observed with cinnamaldehyde concentrations at and greater than 
312.5µM, while cinnamaldehyde-induced cell death was only apparent at the 10mM 
concentration (Figure 2.7A). Similarly, neutrophils were challenged for 30 minutes with a 
broad range of cinnamaldehyde concentrations and phagocytosis of BioParticles was 
assessed. Neutrophil phagocytosis was significantly inhibited at cinnamaldehyde 
concentrations of 10µM and greater. Viability was significantly reduced with 5mM and 
10mM cinnamaldehyde exposures (Figure 2.7B). To assess the direct effects of 
cinnamaldehyde on NK cell killing of target leukemia cells, NK cells were challenged with a 
broad range of cinnamaldehyde concentrations for one hour prior to incubation with 
fluorescently-labeled K562 target cells. Flow cytometry analysis revealed that NK cell killing 
efficiency was significantly reduced with cinnamaldehyde challenges between 78µM and 
1mM. Exposure of target cells to cinnamaldehyde concentrations greater than 1.25mM 
caused significant cell death independent of NK cell activity. Cinnamaldehyde significantly 
reduced NK cell viability at concentrations of 625µM and greater (Figure 2.7C). 
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Figure 2.7   Effects of cinnamaldehyde on alveolar macrophage, neutrophil, and NK cell 
function. Alveolar macrophages (A) (n=3) and neutrophils (B) (n=3) were challenged with a 
broad range of cinnamaldehyde concentrations. Cinnamaldehyde-induced changes in 
Bioparticle phagocytosis and cell viability were evaluated by flow cytometry. C: NK cells 
(n=3) were challenged with a broad range of cinnamaldehyde concentrations, and changes in 
cell-mediated killing of K562 leukemia cells and NK cell viability were quantified using 
flow cytometry. Data are presented as means ± SE. Extrapolated e-liquid concentrations of 
cinnamaldehyde for each dilution tested (1, 0.5, and 0.25%) are indicated within each panel. 
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The inhibitory (IC50) and cytotoxic (LC50) concentrations for cinnamaldehyde on each 
endpoint in the respective cell type tested are reported in Table 2.3. 
 
Table 2.3   The inhibitory and cytotoxic potential of cinnamaldehyde on human 
primary alveolar macrophages, neutrophils, and NK cells. 
 
Cinnamaldehyde is a potent electrophile that likely reacts with free sulfhydryl groups 
on cysteine residues on proteins (47). However, it is unclear whether the sulfhydryl-
modifying activity of cinnamaldehyde contributes to the observed suppression of immune 
cell function. To investigate this potential mechanism, we conducted competition 
experiments using the small-molecule reducing agent dithiothreitol (DTT).  
Cinnamaldehyde- mediated suppression of alveolar macrophage phagocytosis was reversed 
by co-exposure with cinnamaldehyde and DTT (Figure 2.8), suggesting protein thiol 
modification as a potential mechanism for cinnamaldehyde-induced immune cell 
dysfunction. 
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Figure 2.8   Coexposure of alveolar macrophages with cinnamaldehyde and DTT 
reverses cinnamaldehyde-induced suppression of phagocytosis. Alveolar macrophages 
were challenged with cell culture medium, 500uM DTT, 500uM cinnamaldehyde, or 500uM 
DTT and 500uM cinnamaldehyde, and changes in BioParticle phagocytosis were evaluated 
(n=3). Data are presented as means ± SE.  
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2.4  Discussion 
Vaping e-cigarettes is frequently viewed as a safer alternative to cigarette smoking 
based on studies that have reported substantially lower levels of known toxicants and 
carcinogens commonly found in cigarette smoke (48-51). Recent publications have 
highlighted the potential risk for exposure to reactive chemicals (52-57) and toxicants (45, 
58, 59), such as flavoring agents, not present in traditional cigarette smoke. Furthermore, we 
recently demonstrated that vaping e-cigarettes is associated with decreased expression of 
immune genes in the nasal mucosa of human volunteers (60). However, the manner by which 
these genomic alterations may affect respiratory immune responses is not known. In the 
present study, we evaluated the effects of seven flavored e-liquids on respiratory innate 
immune cell function by exposing human alveolar macrophages, neutrophils, and NK cells to 
varying dilutions of e-liquid and VEC. In addition to identifying flavor-specific and dose-
dependent decreases in functional endpoints across all three human primary immune cell 
types, our data demonstrate that cinnamaldehyde-containing e-liquids had the most 
immunosuppressive effects across the different endpoints and cell types examined. Exposure 
of alveolar macrophages, neutrophils, and NK cells to a broad range of cinnamaldehyde 
spanning seven orders of magnitude established a dose- response relationship for 
cinnamaldehyde-induced suppression of human immune cell function, supporting a direct 
cause-and-effect relationship between exposure to cinnamaldehyde-containing e-liquids and 
suppression of respiratory immune cell function. Furthermore, addition of the thiol reducing 
agent DTT inhibited the effects cinnamaldehyde on alveolar macrophages, suggesting 
cinnamaldehyde-induced thiolation as a potential mechanism mediating the observed 
immune suppressive effects. 
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Cinnamon-flavored e-liquids are popular among e-cig users and are often identified 
as “Best Sellers” by online e-liquid retailers. However, some users have reported mouth, 
throat, and respiratory irritation after vaping some cinnamon e-liquids (61) and strong 
cinnamon-flavored e liquids have been reported to erode plastic tanks used on many second 
generation vaporizers 
(https://www.reddit.com/r/electronic_cigarette/comments/1bnuo7/why_do_some_eliquids_cr
ack_plastic_tanks/). Several recent studies have illustrated the potential for cinnamaldehyde 
to cause harm in the context of e- cigarette and e-liquid exposures. Behar et al. evaluated the 
effects of eight cinnamon-flavored refill fluids on human embryonic stem cells and human 
adult pulmonary fibroblasts and found that most of the e-liquids tested were cytotoxic (61). 
Furthermore, they specifically attributed the observed e-liquid-induced cytotoxicity to 
cinnamaldehyde and 2-methoxycinnamaldehyde. More recently, Lerner et al. showed that 
human lung fibroblasts exhibited cellular stress responses, morphological changes, increased 
IL-8 secretion, and ultimately cell death in response to challenge with a cinnamon flavored e 
liquid (62). Our data reveal that both cinnamon- flavored e-liquids and cinnamaldehyde 
suppress immune cell function in each cell type tested in a dose-dependent manner at 
concentrations below levels causing cytotoxicity (Table 2.2). Thus, our data establish a direct 
link between a specific flavoring chemical used in e-liquids and suppression of respiratory 
immune cell function. 
Innate immune cells of the respiratory system, which predominately consist of 
alveolar and airway macrophages, neutrophils in the perialveolar vasculature, and NK cells in 
the nasal passages and sinuses (63), play an essential role in eliminating inhaled pathogens 
and damaged host cells to prevent infection and injury. Toxicants that impair the innate 
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immune functions of these cell types, by either aberrant activation or suppression, would 
therefore disrupt respiratory immune system homeostasis and alter susceptibility to 
respiratory infections. Hwang et al. recently reported that e-cigarette vapor extract reduced 
both macrophage and neutrophil antimicrobial activity against Staphylococcus aureus (13). 
However, the effect was attributed to nicotine, propylene glycol, and glycerin rather than 
specific flavoring agents. We report here that acute exposure of human alveolar macrophages 
and neutrophils to various flavored e-liquids reduced phagocytosis of Staphylococcus aureus; 
however, the impaired clearance we observed was flavor-specific with phagocytosis being 
suppressed more broadly in neutrophils (Figures 2.1 and 2.3). Moreover, the addition of 
nicotine to our e-liquid challenges did not significantly alter the suppression of phagocytosis 
observed with exposure to nicotine-free e-liquids (Figure 2.5). While nicotine, at sufficient 
concentrations, may independently suppress innate immune cell activation and impair the 
clearance of Staphylococcus aureus, our data illustrate that chemical flavorings likely 
contribute to the suppression of key respiratory immune cell functions. Indeed, previous 
work by Kim et al. found that cinnamaldehyde alters immune responses in monocyte and 
macrophage cell lines by thiolation of target cysteine residues, supporting the notion that a 
more direct mode of action, such as protein modification, mediates the cinnamaldehyde-
induced suppression of macrophage immune function (27). To investigate whether the 
sulfhydryl-modifying activity of cinnamaldehyde mediates suppression of respiratory innate 
immune cell function, we conducted competition experiments using the small-molecule 
reducing agent dithiothreitol (DTT). The observed cinnamaldehyde-mediated suppression of 
alveolar macrophage phagocytosis was reversed by co-exposure with DTT, suggesting that 
the sulfhydryl-modifying activity of cinnamaldehyde correlates with cinnamaldehyde-
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induced reductions in phagocytic capacity (Figure 2.8). While these data strongly suggest 
that interactions between cinnamaldehyde and susceptible nucleophilic residues of proteins 
are driving cinnamaldehyde-mediated impairments of immune cell function, further work is 
needed to determine which proteins are adducted and which cellular pathways are affected. 
Neutrophils play an essential role in protecting the airways from bacterial infection by 
common inhaled pathogens including Streptococcus pneumoniae (64), Klebsiella 
pneumoniae (65), Legionella pneumophila (66), and Staphylococcus aureus (67). In healthy 
individuals, phagocytosis of bacterial pathogens stimulates the production of reactive oxygen 
species (ROS), which in turn facilitates the release of microbicide granule components into 
phagosomes. Tobacco smoke impairs respiratory burst activation and thereby compromises 
the anti-bacterial function of neutrophils (68). Furthermore, recent studies of neutrophil 
function (including cell migration, ROS generation, degranulation, phagocytosis and NET 
generation) in COPD patients indicate impaired responses that predispose towards reduced 
bacterial clearance and increased inflammation (69). Acrolein, an α,β-unsaturated aldehyde 
found in cigarette smoke, impairs neutrophil function by depleting glutathione levels and 
suppressing NADPH oxidase activity by the direct alkylation of cysteine residues in proteins 
involved in NADPH oxidase activation (68). While levels of acrolein in e-liquids and e-
cigarette aerosols are reported to be substantially lower than those present in cigarette smoke 
(49), α,β unsaturated aldehyde flavorings, such as cinnamaldehyde, may impair neutrophil 
function by a similar mechanism. Our results indicate that cinnamaldehyde-containing e-
liquids suppress neutrophil phagocytosis of Staphylococcus aureus in a dose-dependent 
manner (Figure 2.3A and 2.3B) and subsequent challenge with cinnamaldehyde alone 
recapitulated the effect (Figure 2.7B). Moreover, cinnamaldehyde-induced inhibition of 
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phagocytosis was observed at low micro molar concentrations (IC50 = 32.4µM ± 12.9µM), 
more than two orders of magnitude lower than those eliciting cytotoxicity (LC50 = 3.35mM ± 
0.84mM) (Table 2.3).  
Neutrophils also eliminate bacterial pathogens by expelling extracellular traps 
composed of chromatin and anti- microbial peptides originating from intracellular vesicles 
(35, 69, 70). NET formation is initiated by stimulation of surface receptors including Toll-
like receptors (TLRs), cytokine receptors, and fragment crystallizable (Fc) receptors resulting 
in activation of protein kinase C (PKC) and the NADPH oxidase complex (69, 71). While the 
exact role of NETs in respiratory disease remains unclear, accumulation of NETs has been 
implicated in the pathogenesis of numerous non-infectious diseases, inflammatory disorders, 
and autoimmune disorders, including cystic fibrosis, asthma, and COPD (72). Less is known 
about the consequences of impaired NET formation; however, the developmental syndrome 
of neonatal neutrophil dysfunction is characterized by compromised NET generation and 
increases susceptibility for neonatal septicemia and other infectious complications in human 
neonates (73). Our finding that 1% Kola (8.96µM cinnamaldehyde) significantly increased 
the rate of Phorbol 12-myristate 13-acetate (PMA)-induced NET formation, while 1% Hot 
Cinnamon Candies (393.28µM cinnamaldehyde) significantly decreased the rate of PMA-
induced NET formation, suggests that cinnamaldehyde may elicit a concentration-dependent, 
bimodal response (Figure 2.4). Aberrant NET activation, such as we observed during the 1% 
Kola e liquid exposure, may increase NET-mediated tissue damage and respiratory 
dysfunction. Alternatively, inhibition of NET formation, such as we observed with exposure 
to the 1% dilution of Hot Cinnamon Candies e-liquid, may allow for enhanced dissemination 
of bacterial pathogens in the lungs and increase the risk of respiratory infections. 
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NK cells are a subset of cytotoxic lymphocytes that serve as sentinels of the immune 
system by recognizing and killing virus-infected and tumor cells. Unlike other lymphocytes, 
NK cells do not require previous sensitization to recognize compromised cells; rather, they 
utilize activating and inhibiting receptors to interrogate host cells for molecular changes 
indicative of damage or infection (74). NK cells lyse host cells presenting abnormal surface 
antigens via exocytosis of cytotoxic perforin and granzymes. Studies indicate that smoking is 
associated with reduced numbers of circulating NK cells (75) and cigarette smoke reduces 
NK cell-mediated killing of cancer cells in vitro (76). Furthermore, our group reported that 
NK cells are a major immune cell type in human nasal passages and influenza-induced 
cytotoxic NK cell responses are suppressed in smokers (63). Here, we expanded on the 
current literature by evaluating the effects of flavored e-liquids and cinnamaldehyde 
flavoring on NK cell function. Our data indicate that exposure of NK cells to 0.25% dilutions 
of two cinnamon-flavored e liquids in our panel suppressed NK cell cytotoxic function, as 
measured by the ability to kill leukemia target cells (Figure 2.5). Exposure to 
cinnamaldehyde alone recapitulated this effect, inhibiting NK cell killing at low micromolar 
concentrations (IC50 = 20.5µM ± 5.4µM) (Figure 2.7 and Table 2.3). To our knowledge, we 
are the first to report that flavored e-liquids and cinnamaldehyde, a common flavoring agent, 
can suppress NK cell mediated killing of target cells, which could have implications for their 
ability to kill both tumorigenic and virus-infected host cells. 
Flavoring agents, which were banned from use in traditional cigarettes by the U.S. 
FDA in 2009, are broadly used in the manufacture of e-cigarettes and refill e-liquids (17) and 
contribute to the surging popularity of these products (77). A precedent for food-safe 
chemical flavorings causing inhalational injury was established in May 2000 when eight 
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workers at a microwave popcorn-processing facility developed bronchiolitis obliterans, an 
irreversible obstructive disease of the bronchioles, as a result of exposure to the aerosolized 
butter flavoring diacetyl (78). A recent study published by Allen et al. screened 51 unique, 
flavored e-liquids for the presence of diacetyl, acetoin, and 2-3 pentanedione (52) and 
revealed that 47 of 51 e-liquids contained at least one of the potentially hazardous butter-
flavoring chemicals. In addition to the butter flavorings, recent in vitro studies report that the 
cytotoxic effects of e-liquids were largely due to chemical flavorings (79, 80). Bahl el al. 
evaluated the cytotoxicity of 41 e-liquids on human pulmonary fibroblasts, human embryonic 
stem cells, and mouse neural stem cells. They report that cytotoxicity varied by product; 
however, cytotoxicity did not result from nicotine exposure but rather correlated with the 
number and concentration of chemicals used to flavor fluids (81). More recently, Gerloff et 
al. evaluated lung epithelial cell and fibroblast inflammatory responses following exposure to 
various e-cigarette flavoring chemicals. Their data indicate that ortho-vanillin, acetoin, and 
maltol stimulate proinflammatory cytokine (IL-8) secretion in lung epithelial cells and 
fibroblasts. Furthermore, the authors report that exposure of airway epithelial cells to 
diacetyl, coumarin, acetoin, maltol, and cinnamaldehyde resulted in a significant and 
persistent loss of epithelial barrier function (55). Taken together, previous reports and our 
data shown here demonstrate a clear dose-response relationship between levels of 
cinnamaldehyde occurring in commercially available e-liquids and suppressed function of 
human respiratory immune cells. These findings add to the concern that flavored e-liquids 
may contain potentially hazardous chemicals and illustrate the need to investigate the 
respiratory effects of common flavorings used in the manufacture of e-liquids. 
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CHAPTER 3. 
CINNAMALDEHYDE IN FLAVORED E-CIGARETTES SUPPRESSES CILIARY 
MOTILITY ON BRONCHIAL EPITHELIAL CELLS BY DYSREGULATION OF 
MITOCHONDRIAL RESPIRATION AND GLYCOLYTIC FUNCTION 
3.1  Introduction 
Mucociliary clearance is the primary physical airway defense that prevents inhaled 
pathogens and debris from injuring the airway epithelium and underlying tissues. Particles 
deposited on the epithelial surface during inspiration become trapped within airway mucus 
and motile airway cilia beat in coordinated metachronal waves to propel mucus-particle 
aggregates towards the larynx (1). Airway cilia are complex biochemical engines that are 
essential to effective mucus transport. Substances that interfere with normal cilia motility can 
impede mucociliary clearance and increase the residence time of inhaled pathogens, thereby 
enhancing susceptibility to respiratory infection. Reduced mucociliary clearance is a 
functional abnormality in smokers which often precedes or co-occurs with the development 
of chronic bronchitis and obstructive lung disease (2). Cigarette smoke alters mucus 
composition, airway surface hydration, cilia structure, intercellular cilia coordination, and 
reduces cilia beat frequency (CBF) (3-9). Many of the direct effects of cigarette smoke on 
cilia structure and function are believed to be due to highly reactive aldehydes produced 
when smoking. Hastie and colleagues exposed rabbit and porcine tracheal explants to 
formaldehyde, a known toxin in cigarette smoke, and observed a rapid but reversible 
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reduction in cilia motility (3). Further, they observed a dose-dependent reduction in ciliary 
axoneme ATPase activity that was also reversible. Acetaldehyde is reported to induce 
concentration- and time-dependent reductions in CBF and cilia-derived dynein ATPase 
activity in primary cultures and isolated axonemes of bovine airway epithelial cells (4). 
Acrolein is a known pulmonary hazard in cigarette smoke which alters mucus composition, 
irreversibly modifies glutathione, and induces ciliostasis at concentrations as low as 0.14ppm 
(0.14mg/L) (5-8). These and other aldehydes in cigarette smoke contribute to the increased 
occurrence of respiratory infections and pathogenesis of lung disease in smokers (9, 10).   
While smoking remains the number one cause of preventative death in the U.S., the 
prevalence of cigarette smoking among U.S. adults has steadily declined since 1965 (11). As 
the use of traditional tobacco products has fallen in recent years, the popularity of new and 
emerging tobacco products, such as e-cigarettes, has surged. There are currently thousands of 
flavored e-cigarette products on the market (12).  Over the last decade, e-cigarette devices 
have evolved from simple, disposable cig-a-likes to complex, highly-modifiable devices 
with advanced electronics. E-liquids are becoming increasingly customizable in terms of 
nicotine and propylene glycol/glycerine content, and there are countless flavor offerings 
available. These products are not only popular with current smokers attempting to quit but 
have rapidly gained popularity with adolescents and young adults who have never smoked 
(13-15). E-cigarettes have been heavily marketed as safer alternatives to traditional cigarettes 
and effective cessation aids to reduce smoking (16). This representation has led to the 
perception by many that e-cigarettes are harmless (17). Numerous scientific studies have 
reported that e-cigarettes produce substantially lower levels of known toxicants and 
carcinogens commonly found in cigarette smoke, including reactive aldehydes. However, 
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recent publications have highlighted the potential risk for exposure to toxicants (18), metals 
(19, 20), and reactive chemicals, such as flavoring agents (21), which are not present in 
traditional cigarette smoke.  
Most flavorings agents used in e-cigarettes are identified as “generally recognized as 
safe” (GRAS) by the U.S. Food and Drug Administration (FDA). However, this designation 
only pertains to oral exposures and not exposures by inhalation. Prolonged inhalation of 
some GRAS flavorings, including diacetyl, 2,3-pentanedione, and acetoin, is well 
documented to cause irreversible lung disease (22-24). The Flavor and Extract Manufacturers 
Association (FEMA) of the USA, a trade association of flavor ingredient manufacturers 
which evaluates the safety of food flavorings, has identified 1037 GRAS flavoring agents as 
potential respiratory hazards due to possible volatility and respiratory irritant properties, 
however most of these compounds still lack any toxicologic evaluation for inhalation 
exposures (17). Recent work by Sears and colleagues found that most current e-cigarette 
users perceive flavoring agents in e-cigarettes as safe to inhale, and the majority of college 
students they surveyed believed the FDA’s GRAS designation extended to safety of 
inhalation exposures (16). These findings are cause for concern as electrophilic flavoring 
agents, such as aldehydes and ketones, are commonly used to flavor e-cigarettes and there is 
currently no regulation governing the quantities used in these products. 
While the effects of aldehydes in cigarette smoke on airway cilia and mucociliary 
clearance are known, it is unclear whether reactive aldehyde flavorings in e-liquids will cause 
a similar response. Several recent studies have evaluated the concentrations of aldehyde 
flavoring agents in commercially available e-liquids. Behar and colleagues identified 
cinnamaldehyde in 20 of 39 e-liquids tested with concentrations ranging from 1.7×10−5M to 
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1.1M (25).  Recent work by Kosmider et al. quantified benzaldehyde in aerosol generated 
from 145 flavored e-liquids (26). One hundred eight of these e-liquids contained 
benzaldehyde, which ranged in concentrations from 5.129µg/30 puffs to 141.2µg/30 puffs. A 
study by Tierney and colleagues identified and measured flavorings in 30 e-liquids and found 
six unique aldehydes with concentrations that varied between e-liquids: vanillin (6.5x10−4M 
to 0.22M), ethyl vanillin (1.8x10−3M to 5.1x10−2M), benzaldehyde (5.7x10−3M to 0.20M), p-
tolualdehyde (0.023M), cinnamaldehyde (6.1x10−3M), and piperonal (2.0x10−3M to 
4.7x10−3M) (27). Our group recently evaluated a panel of seven e-liquids and identified 
numerous aldehyde flavorings, including vanillin, ethyl vanillin, benzaldehyde, 4-
anisaldehyde (4-methoxybenzaldehyde), cocoa hexenal (5-methyl-2-phenyl-2-hexenal), and 
cinnamaldehyde (28). The concentration of cinnamaldehyde in the e-liquids we tested ranged 
from 8.9×10−4M to 1.13M (28). Many of the aldehydes listed here have structural similarity 
to toxic aldehydes in cigarette smoke. We have previously shown that cinnamon e-liquids 
and cinnamaldehyde suppresses respiratory immune cell function at concentrations 
significantly lower than those resulting in cell death (28). However, whether cinnamon-
flavored e-liquids and/or cinnamaldehyde disrupt normal hBE cell function, such as airway 
cilia motility or bioenergetic pathways, is completely unknown. To address this knowledge 
gap, we exposed hBE cells to cinnamaldehyde-containing e-liquids, vaped e-liquid aerosol, 
and cinnamaldehyde alone, and quantified changes in cellular functions, including cilia 
motility, mitochondrial respiration, and glycolysis. 
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3.2  Materials and methods 
Primary hBE Cell Culture. 
Human lung tissue was procured under an Institutional Review Board-approved 
protocol, and hBE cell harvest and culture was performed using established procedures 
previously described in detail (29). Briefly, hBE cells were enzymatically dissociated with 
0.01% protease XIV (Sigma-Aldrich, St. Louis, MO, USA) and 0.001% DNase (Sigma-
Aldrich, St. Louis, MO, USA) in minimum essential medium (Sigma-Aldrich, St. Louis, MO, 
USA) from the trachea, main stem, and lobar bronchi of 6 non-smoker lung donors described 
in Table 1. Primary hBE cells were plated at a density of 2-6×106 per 100mm collagen-
coated (Advanced BioMatrix, San Diego, CA, USA) cell culture plate (Corning Life 
Sciences, Tewksbury, MA, USA) in BEGM medium (prepared in house). At 70-90% 
confluence, cells were passaged by trypsin (Sigma-Aldrich, St. Louis, MO, USA) 
dissociation, counted, and plated on human placental type IV collagen (Sigma-Aldrich, St. 
Louis, MO, USA)-coated 12mm Transwell permeable supports (Corning Life Sciences, 
Tewksbury, MA, USA) at a density of 3x105 cells per Transwell. Upon confluence, apical 
growth medium was removed and cultures were differentiated at an air-liquid interface (ALI) 
for greater than 40 days. Basolateral ALI growth medium (prepared in house) was replaced 
3-times per week and cultures were washed with PBS (Sigma-Aldrich, St. Louis, MO, USA) 
once each week to prevent accumulation of apical mucus and debris. Cell were cultured at 
37°C with 95% humidity and 5% carbon dioxide prior to all experiments.  
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Table 3.1   Demographic data for lung donors. 
 
Beas-2B Bronchial Epithelial Cell Culture 
Beas-2B cells were obtained from ATCC (Manassas, VA, USA) and cultured in 
serum-free keratinocyte growth medium (KGM; Lonza, Walkersville, MD, USA) under 
standard airway epithelial cell growth conditions (37°C, 95% humidity, and 5% carbon 
dioxide). All studies were performed using Beas-2B cells between passage 40 and passage 
60, with passage 1 defined as the thawed cells from the supplier. All experiments using Beas-
2B cells were repeated 4 times (N=4) with 3 technical replicates for each experimental 
condition. 
Flavored E-cigarette Liquids and Cinnamaldehyde 
Three cinnamaldehyde-containing, nicotine-free e-liquids (“Kola”, “Hot Cinnamon 
Candies”, and “Sinicide”) were purchased from a local vape shop (The Vapor Girl, Chapel 
Hill, NC, USA). E-liquids were stored in opaque glass bottles at room temperature and were 
diluted for use at the time of each experiment. All e-liquids used in this study were reported 
by the manufacturer to contain the humectants PG and VG at relative proportions of 55% and 
Table 1. Demographic data for lung donors 
 
Donor          Age,yr        Sex               Race               Smoking                     Cause of Death 
    1  57          F      Cau         NS         Intracranial hemorrhage 
    2             46          F      Cau         NS       Head trauma 
    3             14          M     Cau         NS       Head trauma 
    4             27          M     Blk/AA        NS           Head trauma 
    5             26          M     Hisp         NS       Head trauma 
    6             23          M     Cau         NS       Head trauma          
 
M, male; F, female; Cau, Caucasian; Blk/AA, Black/African American; Hisp, Hispanic; NS, 
nonsmoker. Non-cystic fibrosis (CF) lungs were obtained from organ donors whose lungs were 
unsuitable for transplant due to acute injury or lack of a matching recipient.  
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45%, respectively. A mixture of 55% PG (Thermo Fisher Scientific, Waltham, MA, USA) 
and 45% VG (Sigma-Aldrich, St. Louis, MO, USA) was used as a vehicle control for all e-
liquid and vape experiments. Food grade trans-cinnamaldehyde (≥98% pure) was purchased 
from Sigma Aldrich (St. Louis, MO, USA) and stored at room temperature in the opaque 
glass bottle provided by the manufacturer.  Cinnamaldehyde was diluted for use at the time 
of each experiment.  
CBF and Percent Active Area (%AA)  
Twenty-four hours prior to CBF analysis, 150µl of PBS was applied to the apical 
surface of well-differentiated (>40 day old) hBE cell cultures for 20 minutes to loosen mucus 
and debris. Apical PBS and basolateral medium were removed by vacuum aspiration and 
2.5ml of warm (37°C) ALI medium was added to the basolateral compartment. Twenty 
minutes prior to CBF analysis, the apical compartment of ALI cultures was briefly rinsed 
again with 150µl of PBS. For each CBF experiment, a well-differentiated hBE cell culture 
was placed on Nikon Diaphot inverted microscope equipped with a 20x phase contrast 
objective (Nikon, Melville, NY, USA) and CBF for a single 20x field of view was observed. 
Cilia motion was recorded with a high speed digital camera (Basler AG, Ahrensburg, 
Germany) and analyzed with software designed to quantify beat frequency and the percent of 
motion in the field of view (SAVA; Ammons Engineering, Mt. Morris, MI, USA)(30). 
Baseline whole-field CBF and %AA were evaluated at 30 second intervals for 5 minutes. 
Following baseline CBF and %AA assessment, cultures were challenged apically with 150µl 
of 1% (v/v) flavored e-liquid, 1% PG/VG vehicle, cinnamaldehyde (1mM, 5mM, 10mM, 
15mM), or ALI growth medium alone (media control). Whole-field CBF and %AA were 
quantified at 30 second intervals for 115 minutes following the apical addition of treatments. 
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Apical challenges were not removed for the duration of the experiment. All cilia beat 
measurements were conducted at room temperature (approximately 24°C). 
The threshold of detection for CBF was 2.5Hz and whole-field analysis data with less 
than 100 points of information collected were omitted from analysis. CBF and %AA data for 
each experiment were plotted as a function of time using GraphPad Prism version 7. Cell 
cultures from 4 donors (N=4) were used for CBF and %AA analysis. To determine whether 
any e-liquid or cinnamaldehyde treatment significantly altered CBF and %AA, the area under 
the curve (AUC) for each CBF and %AA plot was calculated and analyzed using a one-way 
ANOVA and Holm-Sidak multiple comparisons test. All statistical analyses were carried out 
using GraphPad Prism version 7. Differences with a P value ≤ 0.05 were considered 
significant. 
Vaped Aerosol Exposures 
Baseline whole-field CBF and %AA were evaluated in well-differentiated hBE cell 
cultures at 30 second intervals for 5 minutes as described above. Following baseline CBF and 
%AA assessment, cultures were placed into the center of a 3-liter acrylic exposure chamber 
and exposed to Sinicide or PG/VG aerosol, similar to previous studies conducted by Carson 
et al (31). E-cigarette aerosol was generated by connecting a LAVABOX DNA 200 Box 
Mod e-cigarette (Volcano e-Cigs, Honolulu, HI, USA) with a SMOK TFV4 Mini Tank and 
sub-ohm (0.37Ω) TF-CLP2 Clapton Coil (SMOKtech, Shenzhen, China) to the exposure 
chamber with a 10-cm length of tubing (4.8 mm ID; Masterflex L/S 15, Vernon Hills, IL, 
USA). Similar to previous studies, a vacuum pump connected to a flow meter was used to 
pull aerosol from the e-cigarette device at a flow rate of 3L/min (31). One 5-second puff of 
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aerosol was generated every 30 seconds for 5 minutes (10 puffs total) using an e-cigarette 
device setting of 70 watts. E-cigarette tank vents were fully opened to supply maximal 
airflow to the heating coil. Mouthpiece vents were completely closed to prevent dilution of 
aerosol. Thirty seconds after the final puff, the cell culture was removed from the exposure 
chamber and immediately placed on the microscope for CBF analysis. To assess particle 
deposition at the airway surface during vape exposures, 12mm glass coverslips were inserted 
into empty transwells and exposed to e-cigarette aerosols at the same time as hBE cultures. 
Immediately following vape exposures, glass coverslips were removed and weighed on a 
microbalance. Initial coverslip weights were subtracted from post-exposure weights do 
determine the mass of aerosol deposition. The mean deposition of aerosol was determined to 
be 828.7±78.5µg. Whole-field CBF and %AA were measured at 30-second intervals for 55 
minutes following the aerosol exposure. CBF and %AA data was plotted and AUC values for 
each experiment were calculated as described above. Cell cultures from 3 donors (N=3) were 
used for vape experiments. An unpaired t-test was used to determine whether there was a 
statistically significant difference between the effect of Sinicide and PG/VG. All statistical 
analyses were carried out using GraphPad Prism version 7. P value ≤ 0.05 was considered 
significant. 
Analysis of Mitochondrial Respiration and Glycolysis  
Live-cell metabolic assays were conducted using the Seahorse XFe24 Analyzer 
(Agilent Technologies, Santa Clara, CA, USA) and the Seahorse XF Cell Mito Stress Test kit 
(Agilent Technologies, Santa Clara, CA, USA). Beas-2B cells were plated at 3x104 cells per 
well in XF24 cell culture plates. Twenty-four hours after plating, Beas-2B growth medium 
was aspirated and replaced with keratinocyte basal medium without supplements or growth 
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factors (KBM; Lonza, Walkersville, MD, USA). Cells were analyzed 24 hours after plating 
in KBM medium. All cultures were >90% confluent at the time of analysis. XFe24 sensor 
cartridges were hydrated overnight with XF Calibrant at 37°C prior to analysis. XF Cell Mito 
Assay Media (XF Base Media with 10mM glucose, 1mM sodium pyruvate, and 2mM 
glutamine) was prepared fresh on the day of assay and adjusted to pH 7.4. KBM medium was 
aspirated from Beas-2B cells and replaced with warm (37°C) XF Cell Mito Assay Media. 
Cells were incubated at 37°C without CO2 for 1 hour prior to Seahorse analysis. Stock 
concentrations of oligomycin (Sigma-Aldrich, St. Louis, MO, USA), FCCP (Sigma-Aldrich, 
St. Louis, MO, USA), rotenone (Sigma-Aldrich, St. Louis, MO, USA), and Antimycin A 
(Sigma-Aldrich, St. Louis, MO, USA) were prepared in DMSO (Sigma-Aldrich, St. Louis, 
MO, USA) and stored at -20°C. Stock solutions were diluted to working concentrations in 
XF Cell Mito Assay Media with final DMSO concentrations less than 0.1%. Assay injections 
were ordered as follows: A) Vehicle or cinnamaldehyde (0.05-5.0mM adjusted to pH 7.4); B) 
1µM oligomycin; C) 1µM FCCP; D) 0.5µM rotenone and 0.5µM Antimycin A. Sequential 
mix-wait-measurement times were set at 3 minutes-2 minutes-3 minutes. Parameters for 
mitochondrial and glycolytic function were calculated as recommended by the instrument 
manufacturer (Agilent Technologies). Data were collected from four independent 
experiments (N=4). A one-way ANOVA and Dunnett’s multiple comparisons test were used 
to determine whether the effects of cinnamaldehyde were significantly different from the 
vehicle control. All statistical analyses were carried out using GraphPad Prism version 7. P 
value ≤ 0.05 was considered significant. 
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ATP, ADP, and AMP Quantification 
Nucleotide extraction from hBE cells 
Well-differentiated hBE cells cultures were briefly washed with PBS and 150µl of 
10mM cinnamaldehyde (diluted in ALI growth medium) was added to the apical surface. 
Cultures were incubated with cinnamaldehyde for 15 minutes, 120 minutes, or 24 hours, 
followed by a brief PBS wash of both the apical and basolateral surfaces to remove excess 
cinnamaldehyde. To assess intracellular nucleotide content, Transwell membranes were 
immediately excised with a #11 scalpel and placed, cells facing downward, into a 24-well 
plate containing ice-cold trichloroacetic acid (TCA; 5% in HPLC-grade water). Membranes 
were incubated on ice for 30 minutes to provide optimal nucleotide recovery. TCA solution 
was collected from each well and TCA was extracted from the solution with ethyl ether (10 
washes with 2ml). Residual ether remaining after aspiration of the final wash was removed 
by evaporation with nitrogen gas.  
Derivatization of Adenosine and Adenine Nucleotides 
Adenosine and Adenine nucleotides were derivatized using a modification of the 
protocol described by Lazarowski et al. (32). Briefly, 200µl aliquots of the TCA-extracted 
samples (diluted 1:10 in PBS) were added to microcentrifuge tubes containing 100µl 
derivatization buffer (62mM citric acid, 38mM Na2POH4; pH 4.0) followed by the addition 
of 10µl of 50% chloroacetaldehyde (v/v in HPLC grade water)( Sigma-Aldrich, St. Louis, 
MO, USA). Samples were heated at 80°C for 40 minutes, cooled to 4°C on ice, and analyzed 
by HPLC within 72 hours of derivatization. 
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HPLC Analysis 
Identification and quantification of ethenylated species were performed with an 
automated Waters HPLC apparatus equipped with a fluorescence detector (excitation, 
307nm; emission 410nm). Derivatized samples were transferred to 0.7-ml plastic vials (Sun-
SRi, Duluth, GA, USA) and kept at 4°C in the sample injector rack. A 100µl sample aliquot 
was injected into a Chromolith® reversed-phase column (RP-18e, 100-3mm; Merck KGaA, 
Darmstadt, Germany). The mobile phase (1.0ml/min, isocratic) was composed of 200mM 
NaH2PO4-H2O, 0.2M Na2HPO4-2H2O, and 5mM tetrabutyl NH4 Bromide (pH 6.1). Typical 
elution times (in minutes) of authentic etheno (ε) standards are as follows: εAMP, 2.09; 
εAdo, 2.61; εADP, 3.10; and εATP, 4.96). HPLC data was collected using Waters Empower 
Pro software build 1154. Individual nucleotide content was calculated as a percent of the 
total nucleotide counts. Data was collected from four independent experiments (N=4). A one-
way ANOVA and Dunnett’s multiple comparisons test was used to determine whether 
cinnamaldehyde-induced changes in nucleotide content at each time point was significantly 
different from untreated (0 minute) control. All statistical analyses were carried out using 
GraphPad Prism version 7. Differences with a P value ≤ 0.05 were considered significant.  
Chemical Inhibition of Glycolysis and Mitochondrial Respiration in hBE Cells for CBF 
and %AA Analyses 
The glycolytic function of well-differentiated hBE cells was inhibited by replacing 
growth medium with a modified Ringers solution consisting of 115mM NaCl, 20mM Hepes 
buffer, 5mM K2HPO4, 2mM MgSO4, 1mM CaCl2, 2mM glutamine, and 10mM 2-
deoxyglucose (33). hBE cell cultures were washed with PBS and baseline CBF and %AA 
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were determined by taking 10 random SAVA measurements (20x magnification) throughout 
each culture. Following baseline measurements, 500µl of the modified Ringers solution was 
added to the basolateral compartment and 150µl was added apically. CBF and %AA 
measurements were taken again at 15 minutes and 30 minutes after the addition of modified 
Ringers by randomly sampling 10 random fields. After the 30-minute measurements were 
recorded, the apical and basolateral modified Ringers solution was aspirated and replaced 
with 500µl of ALI growth medium in the basolateral compartment and 150µl of ALI medium 
apically.  CBF and %AA was assessed 15, 30, and 90 minutes after the addition of normal 
growth medium by sampling 10 random fields as described above.  
Inhibition of hBE cell mitochondrial respiration (but not glycolysis) was 
accomplished by replacing the 10mM 2-deoxyglucose in the modified Ringers solution with 
10mM glucose and supplementing the Ringers solution with 10µM Antimycin A, a potent 
mitochondrial complex III inhibitor.  hBE cell cultures were washed with PBS and CBF and 
%AA measurements were collected as described above.   
Inhibition of both glycolysis and mitochondrial respiration was achieved by using the 
modified Ringers solution (glucose free) with 10mM 2-deoxyglucose and 10µM Antimycin 
A. Measurements of CBF and %AA were collected as described above. CBF and %AA data 
for each experiment were plotted as a function of time using GraphPad Prism version 7. 
Well-differentiated hBE cell cultures from 4 donors (N=4) were used. Differences in CBF 
and %AA from baseline were determined by one-way ANOVA and Holm-Sidak multiple 
comparisons test. P value ≤ 0.05 was considered significant. 
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Cytotoxicity Assays 
hBE and Beas-2B cell viability was determined by measuring lactate dehydrogenase 
(LDH) release into the cell culture medium using a commercially available colorimetric 
(490/650 nm) assay kit following the manufacturer’s instructions (Thermo Fisher Scientific, 
Waltham, MA, USA). One hundred microliters of culture medium were used for analysis. 
The absorbance data for each sample was normalized to 100% cell death (maximal LDH 
release caused by lysis with 1.0% Triton X-100 in cell culture medium) and baseline LDH 
release (untreated cells) using the following formula: corrected viability = 100 – [[Abs(X) − 
Abs(Y)]/[Abs(MAX) − Abs(Y)]*100] where Abs(X) is the absorbance of the sample, Abs(Y) 
is the absorbance of media from the untreated control cells, and Abs(MAX) is the absorbance 
of media collected from cells exposed to 1.0% Triton X-100. Data for cinnamaldehyde 
toxicity in Beas-2B cells were collected from 4 independent experiments (N=4).  Data for 
cinnamaldehyde toxicity in well-differentiated hBE cells were conducted using cell cultures 
from 3 donors (N=3). Differences in viability following cinnamaldehyde exposures were 
evaluated by one-way ANOVA and Holm-Sidak multiple comparisons test. P value ≤ 0.05 
was considered significant. 
3.3  Results 
Temporal analysis of CBF and %AA during flavored e-liquid exposures 
We exposed well-differentiated hBE cells to PG/VG vehicle or e-liquids containing 
different concentrations of cinnamaldehyde. The effects of exposure on CBF and %AA were 
recorded over 120 minutes (Figure 3.1). Apical addition of the Kola and Hot Cinnamon 
Candies (HCC) e-liquids did not significantly alter CBF or %AA as compared to the PG/VG 
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vehicle (Figure. 3.1A-C). However, exposure to the Sinicide e-liquid rapidly reduced both 
CBF and %AA (Figure 3.1D). Interestingly, the complete ciliostasis was transient with %AA 
being fully recovered by 90 minutes.  CBF began to recover by 50 minutes but did not reach 
baseline levels by 120 minutes. Exposure of aerosolized Sinicide e-liquid inhibited CBF and 
%AA similar to what was observed with apical e-liquid exposures (Figure 3.1E). Both the 
Sinicide e-liquid and aerosolized Sinicide e-liquid exposures resulted in a significant 
reduction in CBF and %AA as compared to the PG/VG vehicle (Figure 3.2). 
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Figure 3.1   Effects of cinnamaldehyde-containing e-liquids on airway cilia motility. A-
D) Following 5-minute baseline measurements, well-differentiated primary hBE cells were 
exposed to 1% dilutions of e-liquids (v/v) in cell culture medium and cilia beat frequency 
(CBF; left panels) and percent of the 20x field of view in motion (%AA; right panels) were 
recorded for 120 minutes (N=4). E) 5-minute baseline measurements were recorded prior to 
exposing well-differentiated primary hBE cells to vaped Sinicide e-liquid aerosols for 5 
minutes. CBF and %AA were recorded for 50 minutes following exposures (N=3). Data 
presented as mean ± SEM. 
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Figure 3.2   Quantification of e-liquid-induced effects on cilia motility. Area under the 
curve (AUC) was calculated for both CBF and %AA data collected from A) e-liquid 
exposure experiments (N=4), and B) vaped Sinicide e-liquid experiments (N=3). Significant 
differences from the propylene glycol/vegetable glycerin (PG/VG) control were determined 
by one-way ANOVA and Holm-Sidak multiple comparisons test. Data presented as mean ± 
SEM. Significance represented as ** p<0.01, *** p<0.001 as compared to vehicle control. 
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Temporal analysis of CBF and %AA during flavored cinnamaldehyde exposures 
Previously published work from our group quantified cinnamaldehyde in the e-liquids 
used for this study: Kola, 0.896mM ± 0.360mM; ‘Hot Cinnamon Candies’, 39.32mM ± 
3.41mM; and Sinicide, 1,131mM ± 19.9mM (34). Our finding that exposure of hBE cells to a 
1% dilution of the Sinicide e-liquid (11.31mM cinnamaldehyde content based on 
quantification of neat Sinicide e-liquid) resulted in rapid, but transient, ciliostasis led us to 
investigate whether cinnamaldehyde alone, at concentrations approximate to those in the 1% 
Sinicide e-liquid, would produce a similar response. Apical exposures to 1mM, 5mM, 10mM 
and 15mM cinnamaldehyde produced dose-dependent reductions in both CBF and %AA 
(Figure 3.3) with 10mM and 15mM exposures significantly reducing CBF and %AA as 
compared to vehicle control (Figure 3.4). Similar to the effects of Sinicide on cilia motility, 
10mM and 15mM cinnamaldehyde caused a rapid reduction in cilia function that recovered 
over time. The time to recover was also dose-dependent with the higher exposure doses 
requiring more time for recovery. As observed with the Sinicide exposures, CBF recovery 
after 10mM and 15mM cinnamaldehyde exposures did not recover to the baseline frequency 
by 120 minutes. However, normal cilia beat was apparent 24 hours after exposure (data not 
shown).        
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Figure 3.3   Effects of cinnamaldehyde on airway cilia motility. Following 5-minute 
baseline measurements, well-differentiated primary hBE cells were exposed to either A) 
vehicle (cell culture medium) control, or B-E) 1mM, 5mM, 10mM, or 15mM 
cinnamaldehyde. Cilia beat frequency (CBF; left panels) and percent of the 20x field of view 
in motion (%AA; right panels) were recorded for 120 minutes (N=4). Data presented as mean 
± SEM. 
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Figure 3.4   Quantification of cinnamaldehyde-induced effects on cilia motility. Area 
under the curve (AUC) was calculated for both CBF and %AA data collected from each 
independent experiment (N=4). Significant differences from the vehicle (cell culture 
medium) control were determined by one-way ANOVA and Holm-Sidak multiple 
comparisons test. Data presented as mean ± SEM. Significance represented as **** 
p<0.0001. 
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Effects of cinnamaldehyde on bronchial epithelial cell mitochondrial respiration and 
glycolysis 
Motile cilia require sufficient ATP to maintain the energy requirements of ciliary 
proteins, including the molecular motors dynein and kinesin. Reductions in intracellular ATP 
levels can reduce motor protein ATPase activity leading to reduced cilia motility (35). To 
determine whether cinnamaldehyde alters ATP production in bronchial epithelial cells, we 
utilized the Seahorse XFe24 Analyzer and Seahorse XF Cell Mito Stress Test to assess 
bioenergetic function following exposure to various concentrations of cinnamaldehyde. The 
Seahorse XF Cell Mito Stress Test evaluates various parameters of mitochondrial and 
glycolytic function by injection of specific bioenergetic modulators. Cinnamaldehyde (or 
vehicle) was injected first for this assay to determine if exposure altered baseline 
mitochondrial respiration. Oligomycin, a potent ATP Synthase inhibitor, was injected after 
cinnamaldehyde (or vehicle) to measure changes in oxygen consumption (OCR) associated 
with mitochondrial ATP production and proton leakage across the mitochondrial membrane. 
In addition to reducing mitochondrial OCR, inhibition of ATP synthase forces the cell to rely 
on glycolysis for ATP production and allows for quantification the maximal glycolytic 
capacity by measuring changes in the extracellular acidification rate (ECAR). Following 
oligomycin, the protonophore FCCP is injected to collapse the proton gradient at the inner 
mitochondrial membrane.  Disruption of the proton gradient maximizes mitochondrial OCR 
allowing for quantification of maximal mitochondrial respiration and spare respiratory 
capacity. The final injection of rotenone and Antimycin A, inhibits mitochondrial Complex I 
and III respectively. These inhibitors prevent mitochondrial electron transport and 
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completely inhibit mitochondrial oxygen consumption allowing for quantification of the 
OCR linked to non-mitochondrial respiration processes.  
Exposure of Beas-2B cells to various concentrations of cinnamaldehyde resulted in a 
dose-dependent reduction in mitochondrial oxygen consumption (Figure 3.5A-B). Exposures 
of 0.25mM, 0.5mM, and 5.0mM cinnamaldehyde significantly reduced ATP production, 
reserve capacity, proton leak, and maximal respiration (Figures 3.5C-F, respectively). 
Interestingly, exposures of 0.25mM, 0.5mM, and 5.0mM cinnamaldehyde also significantly 
reduced the ECAR (Figure 3.6A-B) indicating an effect on glycolytic function. Stimulation 
of glycolysis by addition of oligomycin revealed that 0.5mM and 5.0mM exposures of 
cinnamaldehyde significantly reduced glycolytic capacity (Figure 3.6C). Taken together, 
these data indicate that cinnamaldehyde exposure causes a dose-dependent reduction in both 
mitochondrial respiration and glycolytic function (Figure 3.7). 
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Figure 3.5   Cinnamaldehyde induces a concentration-dependent reduction in bronchial 
epithelial cell mitochondrial respiration. A) Beas-2B cells were exposed to 0.05mM, 
0.25mM, 0.5mM, and 5.0mM concentrations of cinnamaldehyde and changes in 
mitochondrial oxygen consumption rate (OCR) were evaluated using a Seahorse bioanalyzer 
(N=4). Exposures of 0.25mM, 0.5mM, and 5mM cinnamaldehyde significantly suppressed 
B) basal OCR, C) ATP production, D) reserve capacity, E) proton leak, and F) maximal 
respiration, in a concentration-dependent manner. Data presented as mean ± SEM. 
Significance represented as **** p<0.0001. 
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Figure 3.6   Cinnamaldehyde reduces bronchial epithelial cell glycolytic function. A) 
Beas-2B cells were exposed to 0.05mM, 0.25mM, 0.5mM, and 5.0mM concentrations of 
cinnamaldehyde and the rate of extracellular acidification (ECAR) was measured using a 
Seahorse bioanalyzer (N=4). B) Exposures of 0.25mM, 0.5mM, and 5mM cinnamaldehyde 
significantly suppressed basal ECAR, while C) 0.5mM, and 5mM cinnamaldehyde 
significantly reduced Beas-2B cell glycolytic capacity. Data presented as mean ± SEM. 
Significance represented as ** p<0.01 and **** p<0.0001. 
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Figure 3.7   Cinnamaldehyde inhibits the basal energetic state of Beas-2B cells. A) 
Comparison of cinnamaldehyde-induced changes in mitochondrial OCR and glycolytic 
ECAR for 0.05mM, 0.25mM, 0.5mM, and 5mM exposures. Cinnamaldehyde causes an acute 
concentration-dependent reduction in both B) mitochondrial OCR and C) glycolytic ECAR. 
Data presented as mean ± SEM. Significance represented as * p<0.05 *** p<0.001 and **** 
p<0.0001. 
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Quantitation of intracellular ATP levels in well-differentiated hBE cells exposed to 
cinnamaldehyde 
Our observation that cinnamaldehyde rapidly impairs cellular bioenergetic pathways 
suggests that cells experience a concomitant reduction in intracellular ATP levels following 
exposure. To confirm cinnamaldehyde-induced reductions in intracellular ATP levels, well-
differentiated hBE cells were exposed to 10mM cinnamaldehyde for various times and 
adenosine nucleotide (ATP, ADP, and AMP) levels were quantified. Apical addition of 
10mM cinnamaldehyde significantly reduced hBE cell ATP levels after 15 minutes (Figure 
3.8A). 120-minute and 24-hour exposures did not significantly alter ATP levels as compared 
to the untreated controls, indicating that ATP levels are restored by the later time points 
although the cinnamaldehyde challenge is not removed. Notably, ADP and AMP levels were 
significantly elevated after 15-minute cinnamaldehyde exposure providing evidence that the 
reduction in ATP was due to hydrolysis by cellular activity and not exocytotic release or 
leakage at the cell membrane (Figure 3.8B-C).     
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Figure 3.8   Exposure of well-differentiated hBE cells to cinnamaldehyde causes a rapid 
but temporary reduction in intracellular ATP levels. Well-differentiated hBE cells were 
exposed to 10mM cinnamaldehyde for 15 minutes, 120 minutes, and 24 hours, and the effect 
on intracellular adenosine nucleotides was quantified by HPLC (N=4). Exposure caused A) a 
significant reduction in ATP levels after 15 minutes that correlated with increased levels of 
B) ADP and C) AMP. Data presented as mean ± SD. Significance represented as * p<0.05 
and ** p<0.01. 
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Inhibition of cellular bioenergetic activity and temporal analysis of hBE cell cilia 
motility 
Various aldehydes are reported to suppress airway cilia motility and impede 
mucociliary transport, including formaldehyde, acetaldehyde, acrolein, methacrolein, and 
crotonaldehyde (3, 4, 36-39). Many of these aldehydes have been identified as mitochondrial 
toxins and inhibitors of glycolytic activity (40-43). However, with the exception of some 
bacterial studies, there are very few reports which link toxin-induced impairments of 
bioenergetic pathways with altered cilia motility (33, 44). To better understand how targeted 
inhibition of mitochondrial respiration and glycolysis effects human airway cilia motility, we 
exposed well-differentiated hBE cells to the mitochondrial complex III inhibitor Antimycin 
A, the glycolytic pathway inhibitor 2-deoxy-D-glucose, and a combination of both to assess 
changes in CBF and %AA. hBE cells exposed to 2-deoxy-D-glucose experienced a 
significant increase in CBF but not %AA as compared to baseline levels (Figure 3.9A). 
Repletion of glucose at 30 minutes further increased CBF without affecting %AA. Exposures 
to Antimycin A caused a significant reduction in both CBF and %AA which was partially 
restored when the Antimycin a-containing medium was replaced with recovery medium 
(Figure 3.9B). Cells treated with glucose-free medium containing both 2-deoxy-D-glucose 
and Antimycin A experienced a significant and rapid reduction in CBF and %AA with 
complete ciliostasis occurring 30 minutes post exposure (Figure 3.9C). Replacing the 
inhibitors with recovery medium restored CBF to baseline levels by 60 minutes; however, 
%AA did not fully recover by 120 minutes.      
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Figure 3.9   Chemical inhibition of well-differentiated hBE cell glycolytic function and mitochondrial respiration significantly 
alters cilia motility. A) Inhibition of glycolytic function with 2-DG significantly increased CBF while B) inhibition of mitochondrial 
respiration with Antimycin A caused a significant reduction in CBF and %AA. C) Addition of both chemical inhibitors produced a 
greater reduction in CBF and %AA. However, Cilia motility was restored by removing inhibitors and supplementing cultures with 
fresh growth medium. (N=4). Data presented as mean ± SEM. Significance represented as * p<0.05, ** p<0.01, *** p<0.001, and 
**** p<0.00001. 
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3.4  Discussion 
In the present study, hBE cells were collected from healthy, non-smoker donors, 
differentiated to a mucociliary phenotype, and used to evaluate temporal changes in cilia 
motility subsequent to a single acute exposure to cinnamon-flavored e-liquid, vaped 
cinnamon e-liquid, or cinnamaldehyde flavoring. The data presented here demonstrate that 
cinnamaldehyde, at concentrations relevant to e-cigarette exposures, is capable of causing 
rapid ciliostasis that varies in time to recovery dependent upon the exposure does. Reductions 
in cilia motility correlated with a significant, but temporary reduction in intracellular ATP 
levels and cinnamaldehyde exposures of Beas-2B cells resulted in a dose-dependent 
reduction in mitochondrial respiration and glycolysis. While cinnamaldehyde suppressed 
bioenergetic activity, reduced ATP levels, and impaired cilia motility, exposures did not 
significantly reduce cell viability (Figure 3.10) or have long-lasting effects of cilia motility. 
Together, these data indicate that exposure to e-cigarette flavoring chemicals can have 
significant impact on essential airway epithelial cell physiology without causing overt 
cytotoxicity.  
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Figure 3.10   Effects of cinnamaldehyde on bronchial epithelial cell viability after acute 
exposures. A) Beas-2B cells (N=4) and B) well-differentiated hBE cells (N=3) were exposed 
to various concentrations of cinnamaldehyde and cytotoxicity was determined by 
quantification of LDH release after 120 minutes. Data presented as mean ± SEM.   
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Several studies have identified aldehydes at various concentrations in e-liquids and e-
cigarette aerosols (19, 45-49). Furthermore, recent work has shown that formaldehyde, 
acetaldehyde, and acrolein can be generated by the thermal degradation of propylene glycol 
and glycerin in e-cigarettes. While much of the current e-cigarette research has focused on 
identifying and quantifying known toxic aldehydes generated by e-cigarettes, fewer studies 
have investigated whether common aldehyde flavoring agents may also be toxic to 
respiratory tissues. Bahl and colleagues evaluated the effects of 29 e-liquids on human 
embryonic stem cells (hESCs), mouse neural stem cells (mNSEs), and human pulmonary 
fibroblasts (hPFs), and observed that a cinnamon-flavored e-liquid exhibited the most 
cytotoxicity across all cell types (50). Follow-up studies by Behar et al. attributed the 
cytotoxic effect to cinnamaldehyde and 2-methoxycinnamaldehyde (51). Moreover, sub-
cytotoxic cinnamaldehyde exposures resulted in depolymerization of microtubules, reduced 
proliferation, impaired cell migration, and increased DNA double strand breaks (25). Gerloff 
et al. recently reported that ortho-vanillin, but not cinnamaldehyde, stimulated IL-8 release 
by Beas-2B bronchial epithelial cells and HLF-1 human lung fibroblasts. Additionally, they 
observed that cinnamaldehyde impaired epithelial barrier function in 16-HBE human 
bronchial epithelial cells (52). We have previously shown that three cinnamaldehyde-
containing e-liquids impaired human neutrophil and alveolar macrophage phagocytosis, 
altered PMA-induced neutrophil extracellular trap (NET) formation, and suppressed the 
ability of natural killer (NK) cells to eliminate leukemia target cells (34). Exposures of these 
cells types to cinnamaldehyde alone recapitulated the effects of the cinnamon-e-liquids 
indicating that the altered immune cell function directly resulted from the bioactivity of this 
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aldehyde flavoring agent. These studies strongly indicate that inhalation of cinnamaldehyde 
will likely induce adverse health effects at several levels. 
The reactivity of aldehydes stems from their electrophilic carbonyl group which can 
form a chemical bond with electron-donating nucleophiles, such as amine groups on protein 
lysine residues (53). ⍺,β-unsaturated aldehydes, such as acrolein, are generally considered 
more reactive than saturated aldehydes as nucleophilic additions can occur at either the 
carbonyl group (1,2-addition) or β-carbon (1,4-addition). Nucleophilic addition at the β-
carbon (i.e., Michael addition) results in the formation of a stable, covalent addition. Weak 
bases, including alcohols, thiols, primary amines, and secondary amines can readily form 
Michael adducts with ⍺,β-unsaturated aldehydes (54, 55). By these mechanisms, reactive 
aldehydes can deplete the cellular glutathione pool, modify DNA, and form aldehyde-protein 
adducts (56, 57). These actions can produce a variety of cellular and biochemical responses 
including altered protein function, increased oxidative stress, inflammatory responses, 
apoptosis, and immunogenicity, which may be the underlying mechanisms of the various 
adverse effects described in the context of cinnamaldehyde exposures. 
Data shown here expand on our previous work by demonstrating that cinnamaldehyde 
dysregulates airway cilia motility, a critical component of effective mucociliary clearance 
and essential respiratory innate defense mechanism. Deficits in cilia motility which 
contribute to defective mucociliary clearance have been described in a number of inherited 
and acquired respiratory disorders. Primary ciliary dyskinesia (PCD), an autosomal recessive 
disorder of motile cilia, causes abnormalities in ciliary dynein structure and function which 
results in immotile cilia or impaired CBF (58). Cilia motility in PCD is dyskinetic, which 
results in a loss of the normal metachronal wave form and significantly impairs mucociliary 
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transport. This was clearly demonstrated in a study by Regnis et al. which found that PCD 
patients had prolonged retention of particles in their large airways at 24 hours as compared to 
healthy control subjects (59). The clinical respiratory manifestations of PCD are directly 
linked to the failure of mucociliary transport and include nasal congestion, chronic sinusitis, 
recurrent respiratory tract infections, and bronchiectasis (1). Similarly, patients with cystic 
fibrosis, an inherited disorder affecting the cystic fibrosis transmembrane conductance 
regulator (CFTR) gene, display abnormal mucociliary clearance which results in chronic 
infections, excessive inflammatory responses, bronchiectasis, and respiratory failure (60). 
The impaired mucociliary clearance in cystic fibrosis results from the abnormal biophysical 
properties of airway mucus rather than impaired airway cilia motility (61, 62). However, cilia 
from patients with cystic fibrosis do commonly exhibit structural anomalies similar to those 
in patients with chronic bronchitis (e.g., atypical arrangement of microtubule doublets, 
compound cilia, excess cytoplasmic matrix) (63). COPD, an acquired respiratory disease that 
most frequently occurs in chronic smokers, is characterized by persistent airflow limitation 
that is usually progressive and associated with an enhanced chronic inflammatory response in 
the airways and the lung to noxious particles or gases (64). Cigarette smoke significantly 
reduces cilia length and this phenomenon is more pronounced in COPD (65, 66). These 
structural defects impair mucociliary clearance and contribute to frequent respiratory 
infections, bacterial colonization of the lower respiratory tracts, chronic inflammation, 
oxidative stress, and severe tissue damage (64). The loss of ciliary motility and subsequently 
mucociliary transport is clearly associated with increased susceptibility to respiratory 
infections and negative health outcomes. Our finding that acute exposures to aerosolized 
cinnamon e-liquid and cinnamaldehyde induces rapid ciliostasis of airway epithelial cell CBF 
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is cause for concern as it demonstrates a potential risk for e-cigarette users inhaling 
cinnamaldehyde. While further studies are needed to address e-cigarette aerosol deposition in 
the lungs to ultimately understand exposure doses associated with vaping, these data add to 
the growing body of evidence that inhalational exposures of food-safe flavorings may have 
unintended and potentially harmful respiratory effects.  
Cinnamaldehyde is a potent antimicrobial agent and has been used extensively in the 
agriculture and food industries to prevent microbial growth in a broad range of foods and 
beverages (67). Studies by Gill and Holley which investigated the mechanisms of 
bactericidal action of cinnamaldehyde against L. monocytogenes and E. coli found that 
cinnamaldehyde rapidly reduced intracellular ATP levels and inhibited ATP synthesis (44). 
Follow-up studies confirmed that impaired ATP synthesis was mediated by cinnamaldehyde-
induced suppression of membrane bound ATPase activity (68, 69). These findings are similar 
to our observation that cinnamaldehyde reduces intracellular ATP concentrations in hBE 
cells. It is entirely unknown whether the ability of cinnamaldehyde to suppress bacterial ATP 
synthesis may alter the lung microbiome. Based on our data and the existing data on the 
antimicrobial functions of cinnamaldehyde, additional studies investigating acute, sub-
chronic, and chronic exposures on various ATP-dependent antimicrobial processes are 
warranted.    
ATP is the canonical energy carrier that powers cellular machinery, fuels metabolic 
reactions, and serves as a building block for nucleic acids. Depletion of ATP has widespread 
effects on many essential cellular systems. Molecular motor proteins, including dynein, 
kinesin, and myosin ATPases, function by hydrolyzing ATP. Hydrolysis of ATP converts 
chemical energy into mechanical motion by conferring a small conformational change on the 
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globular motor domain of the protein (70). Reductions in intracellular ATP levels beyond the 
minimal requirements for normal activity dysregulate motor protein functions, including 
ciliary motility and intracellular transport (33, 71). Additionally, the alveolar epithelium 
relies on basolateral Na+/K+-ATPases to actively transport Na+ out of epithelial cells and 
generate a transepithelial osmotic gradient which causes the movement of fluid out of the 
alveolar airspace (72). The active transport of Na+ and K+ across the cell membrane to 
maintaining an ionic gradient consumes approximately 40% of the ATP in mammalian cells 
(73). Studies on the respiratory effects of hypoxia have shown that hypoxia-induced ATP 
depletion inhibits Na+/K+-ATPase function by downregulation of active Na+ pumps at the 
membrane, which impairs fluid clearance from the alveolar space but conserves ATP levels 
(74). Furthermore, the net gain of intracellular solutes drives an isosmotic accumulation of 
intracellular water, resulting in cell swelling and dilation of the endoplasmic reticulum (75). 
These data suggest that cinnamaldehyde-induced reductions in ATP could have significant 
impact on the function of alveolar epithelial cells.  
In addition to being an essential energy source, ATP is also released by airway 
epithelial cells where it, and its metabolite adenosine, serve as secreted second messengers 
which regulate multiple cellular processes via autocrine/paracrine activation of purinergic 
receptors (76). These processes include stimulation of CFTR-dependent and CFTR-
independent (CaCC-mediated) chloride channel activity, regulation of Na+ absorption, 
regulation of mucin secretion, and regulation of CBF (76). More recently, ATP-mediated 
activation of purinergic receptors and subsequent activation of Duox1 has been shown to 
play an important role in airway epithelial cell migration and repair following injury (77). 
There are very little data on whether or how depletion of ATP alters purinergic receptor 
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activation and downstream cellular responses. It is plausible that ATP depletion would 
reduce receptor activation and dysregulate the downstream effects. Thus, cinnamaldehyde-
induced reductions of hBE cell intracellular ATP levels may affect ATP-mediated signaling 
dynamics and downstream cell functions.  
The sustained beating of airway cilia demands a tremendous amount of energy. A 
significant part of the ATP needed to fuel ciliary dynein ATPases is supplied by 
mitochondria massed at the base of each cilium (78). Inhibition of mitochondrial respiration 
disrupts ATP production, reduces the amount of available ATP for ciliary dynein, and in 
turn, impairs cilia motility (33). Reactive aldehydes present in cigarette smoke have been 
shown to impair mitochondrial function by various mechanisms. Formaldehyde has been 
reported to inhibit dinitrophenol-stimulated ATPase activity and reduce the rate of oxidative 
phosphorylation (40). Acetaldehyde inhibits oxidative phosphorylation and respiratory 
control through reactions with glutamate, P-hydroxybutyrate, and  ⍺-ketoglutarate (79). 
Acrolein is reported to cause a dose-dependent inhibition of NADH- and succinate-linked 
mitochondrial respiration, form protein carbonyls, and alter mitochondrial permeability (41). 
Aromatic aldehydes have also been reported to impair mitochondrial function. Anisaldehyde, 
benzaldehyde, p-tolualdehyde, which have all been identified in e-liquids and e-cigarette 
aerosols, were shown to inhibit pyruvate/malate- and succinate-mediated mitochondrial 
respiration in isolated rat liver mitochondria at concentrations ranging from 0.5mM to 
1.0mM (80). Exposures to 300µM benzaldehyde inhibited pyruvate/malate-mediated state 3 
mitochondrial respiration by 50% suggesting that no additional functional group or 
metabolism to another species was required for the inhibitory effects. Hence, many different 
aldehydes potentially inhaled by aerosolizing flavored e-liquids have known significant 
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effects on mitochondrial function. Similarly, cinnamaldehyde was also reported to impair 
mitochondria isolated from rat liver by uncoupling the electron transport chain and 
significantly inhibiting NAD(P)H oxidase (complex I) activity (81). To investigate whether 
cinnamaldehyde produced similar inhibition of mitochondrial function in airway epithelial 
cells, we exposed bronchial epithelial cells to various concentrations of cinnamaldehyde and 
evaluated changes in the rate of mitochondrial oxygen consumption. The reduction in 
bronchial epithelial cell mitochondrial respiration we observed supported the existing data 
describing cinnamaldehyde-induced suppression rat liver mitochondria function. In contrast 
to the previous report, we did not observe increases in basal oxygen consumption following 
the addition of cinnamaldehyde, indicating that cinnamaldehyde did not uncouple the 
electron transport chain. Interestingly, addition of cinnamaldehyde rapidly reduced the rate of 
extracellular acidification, which is an indicator of cellular glycolytic function. The 
suppression of both mitochondrial respiration and glycolysis supports our finding that 
cinnamaldehyde rapidly reduces intracellular ATP levels. It was beyond the scope of this 
study to identify specific molecular mechanisms by which cinnamaldehyde impaired 
bioenergetic processes. Acrolein, an electrophilic ⍺,β-unsaturated aldehyde, is reported to 
readily react with thiolate groups on redox-active cysteine residues to form covalent 
additions (82, 83). However, covalent bonds between acrolein and cysteine are somewhat 
unstable at physiologic pH and temperature, which results in a transition to Schiff base 
adducts with the ε-NH2 group of lysine and free N-terminal ⍺-NH2 groups (83). 
Cinnamaldehyde is also an ⍺,β-unsaturated aldehyde and would likely generate covalent and 
Schiff base additions to reactive cysteine residues, similar to acrolein. Hence, 
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cinnamaldehyde-induced modification of mitochondrial and glycolytic pathway proteins may 
be involved in the loss of bioenergetic functions and reduction of intracellular ATP.         
Taken together, the data presented here clearly demonstrate the capability of 
cinnamaldehyde to alter normal bronchial epithelial cell function by suppressing airway cilia 
motility, which is an essential respiratory mucosal defense mechanism. The cellular 
responses we observed following cinnamaldehyde exposure are similar to those described in 
previous studies using toxic aliphatic aldehydes found in cigarette smoke. This raises concern 
for inhalational exposures to aromatic aldehyde flavoring agents, such as cinnamaldehyde, in 
the context vaping. Based on our findings, we conclude that cinnamaldehyde, at sufficient 
exposure concentrations, disrupts bronchial epithelial cell mitochondrial respiration and 
glycolytic function, reduces intracellular ATP levels, and impairs cilia motility. Further work 
is necessary to determine how inhalation of cinnamaldehyde aerosols generated by e-
cigarettes recapitulates our in vitro findings in e-cigarette users in vivo, and whether 
exposures could lead to increased susceptibility to respiratory infections and enhanced risk of 
obstructive lung disease. Ultimately, understanding the biological effects of exposures to 
flavoring agents and concentrations at which these effects occur will be an essential 
component to evaluating the safety of e-cigarettes. 
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CHAPTER 4. 
COMMON E-CIGARETTE FLAVORING AGENTS ELICIT DOSE-DEPENDENT 
BIMODAL EFFECTS ON NRF2-PATHWAY ACTIVATION IN BRONCHIAL 
EPITHELIAL CELLS 
4.1  Introduction 
Cellular responses to environmental stresses are orchestrated by tightly-regulated 
protein networks which detect signals from the environment, transduce signals to gene 
expression machinery, and activate transcription factors to upregulate the necessary stress-
response genes. These responses must be precisely coordinated to effectively alleviate stress 
and maintain cell homeostasis (1-4). Among environmental stresses, oxidants and 
electrophiles are broadly recognized as etiologic factors for a host of human diseases 
including chronic inflammation, cancer, diabetics, rheumatoid arthritis, atherosclerosis, 
myocardial infarction, cardiovascular disease, respiratory disease, ischemic reperfusion 
injury, stroke, septic shock, aging and neurodegenerative diseases (5-7). To protect against 
oxidative and electrophilic stresses, vertebrates have evolved various defense mechanisms, 
which include the Nuclear factor erythroid-derived 2-like 2 (Nrf2)- Kelch-like ECH-
associated protein 1 (Keap1) antioxidant pathway (1, 8-10). Nrf2 is a basic leucine zipper 
protein transcription factor which regulates stress-dependent expression of numerous 
cytoprotective genes including NAD(P)H quinone oxidoreductase 1 (NQO1), glutathione s-
transferase (GST), heme-oxygenase 1 (HO-1), thioredoxin reductase 1 (TXNRD1), 
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sulfiredoxin 1 (SRXN1), glutamate-cysteine ligase, and multidrug resistance-associated 
proteins (MRPs) (11, 12). Transcription of these targets is mediated by Nrf2s interaction with 
a cis-acting antioxidant/electrophile responsive element (ARE/EpRE) located in the promoter 
of cytoprotective genes (13-15).  
In the absence of oxidative or electrophilic stress, homodimeric Keap1 sequesters 
Nrf2 into the cytoplasmic Cul3-containing E3 ubiquitin ligase complex where it undergoes 
polyubiquitin conjugation and subsequent degradation by the 26S proteasome (16). However, 
an alternate model in which Keap1 transiently engages in nucleocytoplasmic shuttling and 
targets Nrf2 for ubiquitylation in the nucleus has been proposed (15). The rapid proteasomal 
degradation of Nrf2 and its short half-life (approximately 20 minutes) limits Nrf2 activity 
and, thereby, regulates cellular redox homeostasis. In addition to sequestering Nrf2 and 
facilitating its degradation under homeostatic conditions, Keap1 acts as a molecular sensor 
for electrophilic chemicals. Each human Keap1 protein contains 27 cysteine residues (17). 
Importantly, 10 of these cysteines are adjacently located to positively-charged amino acids. 
The proximity of cysteine residues to positively-charged amino acids decreases the pKa of 
the cysteine sulfhydryl group and thus stabilizes the reactive thiolate anion (17). Both 
endogenous and exogenous electrophiles readily react with thiolate anions on Keap1 cysteine 
residues, resulting in a conformation change of Keap1, release and stabilization of Nrf2, and 
subsequent transcription of cytoprotective genes (17). However, if oxidant and electrophile 
exposures overwhelm the protective antioxidant responses of Nrf2 pathway activation, cell 
death and tissue damage can occur.  
Cigarette smoke is a toxic mixture of harmful substances, which causes damage to 
virtually every part of the body. In the lungs, cigarette smoke induces oxidative and 
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electrophilic stress, which contributes to the pathogenesis of cancer and chronic obstructive 
pulmonary disease (COPD) (18, 19). Cigarette smoke is a potent pro-oxidant, both by way of 
free radicals produced when combusting tobacco and also by way of generating intracellular 
oxidant species from smoke-induced disruption of normal cellular processes, such as 
mitochondrial respiration (20, 21). While the exact mechanisms underlying how components 
in cigarette smoke impair antioxidant defenses continue to be investigated, it is likely that 
chronic exposures to free radicals, reactive oxygen and nitrogen species, and aldehydes, 
which disrupt cellular redox homeostasis, play a central role in the pathogenesis and 
progression of cigarette-smoke-induced lung disease. Glutathione (GSH) is the most 
abundant non-protein thiol-containing antioxidant compound present in living organisms and 
plays an important role in protecting cells from oxidants and reactive electrophiles (22). α,β-
unsaturated carbonyls, such as acrolein, crotonaldehyde, and methyl vinyl ketone, are major 
toxicants in cigarette smoke and have been shown to irreversibly modify GSH (23). This 
modification, which is typically a covalent Michael addition to the thiol group of the 
cysteinyl moiety on GSH, depletes the intracellular pool of free GSH and thereby increases 
susceptibility to oxidant and electrophilic damage. Thus, depletion of GSH by cigarette 
smoke plays a significant role in the development and progression of oxidant-induced lung 
diseases including emphysema and COPD. 
In recent years, e-cigarettes have emerged as an alternative to traditional cigarettes. 
While the health effects of e-cigarette use remain unclear, studies of e-cigarettes aerosols 
have confirmed that their emissions are less complex than cigarette smoke and contain 
significantly lower levels of known toxicants, including free radicals, reactive oxygen 
species, and aldehydes (24, 25). A recent report from Public Health England concluded that 
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e-cigarettes are 95% less harmful than tobacco cigarettes, and when supported by a smoking 
cessation service, are effective at helping most people quit smoking (26). This view was 
supported by the Royal College of Physicians which stated that although harm from long-
term use of e-cigarettes cannot be excluded, it is likely to be substantially less than 
conventional cigarettes (27). However, e-cigarette aerosols remain poorly characterized 
complex mixtures of inert and reactive chemicals, and it is unclear how these products will 
affect respiratory health. Moreover, the lack of regulation in this industry creates 
considerable variability in the chemical composition of these products between 
manufacturers, precluding accurate estimations of e-cigarette safety.  
The use of food-grade flavoring agents in e-cigarettes represents a significant 
unknown in the context of oxidative lung damage. Many flavoring agents are reactive 
carbonyls and inherently bioactive at low concentrations (28). Analyses of e-cigarette refill 
liquids have identified reactive carbonyl flavoring agents at concentrations greater than 
1.0M, which may be cause for concern (29-32). Several studies have shown that flavored e-
cigarette aerosols contain reactive oxidants and induce oxidative and electrophilic stress 
responses in in vitro and animal in vivo models (33-37). There are conflicting data indicating 
that e-cigarettes, when used at lower temperatures, do not generate significant oxidants or 
induce cellular oxidative stress (38-40). Some common flavoring agents have been reported 
to have prooxidant effects on rat hepatocytes and generate reactive oxygen species in the 
presence of transition metals (41-43). Other common e-cigarette flavoring agents have been 
identified as nutraceuticals for their ability to activate Nrf2 antioxidant responses and 
upregulate cytoprotective gene expression (44, 45). However, it is unclear if flavoring agents, 
as components of e-cigarettes, will alter oxidative stress responses in respiratory tissues. In 
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order to better understand whether and how common e-cigarette flavoring agents affect 
oxidative stress response pathways in bronchial epithelial cells, we identified eight common 
e-cigarette flavoring agents in e-liquids which induced HEK293 cell cytotoxicity in high-
throughput screening assays, exposed bronchial epithelial cells containing an Nrf2/ARE 
luciferase promoter reporter with various concentrations of these flavoring chemicals, and 
quantified Nrf2 antioxidant pathway activation and cytotoxicity at each flavoring 
concentration. Furthermore, we investigated whether intracellular GSH levels modify 
flavoring-induced Nrf2 pathway activation. These data provide additional insights into the 
potential health effects of e-cigarette use.  
4.2  Materials and methods 
Selection of Flavoring Chemicals for Analysis  
Flavoring chemicals were selected for analysis using the University of North Carolina 
Center for Tobacco Regulatory Science and Lung Health database for e-liquid toxicity and 
chemical compositions (www.eliquidinfo.org). E-liquids were ranked according to their 
reported toxicity in HEK293T cells (lowest LC50 values to highest) and the chemical 
compositions of the 50 most cytotoxic e-liquids were compared. Isoamyl acetate, menthol, 
limonene, cinnamaldehyde, guaiacol, benzaldehyde, eugenol, and linalool were the most 
common flavoring agents in the 50 e-liquids we compared (Table 4.1). Because these 
flavoring agents were identified in multiple highly-cytotoxic e-liquids, they were selected for 
further investigation in this study.    
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Table 4.1   E-liquid flavoring agents used for this study. Comparison of the chemical 
constituents of e-liquids with the lowest LC50 (greatest toxicity) in HEK293T cells revealed 
common flavoring agents from various chemical classes. Data on e-liquid-induced 
cytotoxicity was obtained from University of North Carolina Center for Tobacco Regulatory 
Science and Lung Health database for e-liquid toxicity and chemical compositions 
(www.eliquidinfo.org).   
 
 
 
 
 
 
 
Structure 
 
Chemical  
Class 
Characterizing  
Flavor 
Times  
Identified 
 
Cinnamaldehyde 
 
 
aromatic aldehyde 
(⍺,β-unsaturated) 
 
cinnamon/spicy 
 
 
8/50 
 
 
 
Guaiacol 
 
 
monomethyl ether of 
catechol 
 
 
wood smoke 
 
 
8/50 
 
 
 
Eugenol 
 
 
allyl-chain 
substituted guaiacol  
 
 
clove 
 
 
3/50 
 
 
 
Benzaldehyde 
 
 
aromatic aldehyde 
 
 
cherry/almond 
 
 
4/50 
 
 
 
Limonene 
 
 
cyclic monoterpene 
 
 
citrus 
 
 
9/50 
 
 
 
 
Linaloool 
 
 
terpene alcohol 
 
 
floral 
 
 
3/50 
 
 
 
Menthol 
 
 
cyclic monoterpene 
alcohol 
 
 
 
minty/cool 
 
 
 
 
12/50 
 
 
 
 
 
Isoamyl Acetate  
 
 
 
carboxylic acid ester 
 
 
 
banana 
 
 
 
14/50 
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Beas-2B Bronchial Epithelial Cells 
Beas-2B bronchial epithelial cells were obtained from ATCC (Manassas, VA, USA) 
and cultured in serum-free keratinocyte growth medium (KGM; Lonza, Walkersville, MD, 
USA) under standard airway epithelial cell growth conditions (37°C, 95% humidity, and 5% 
carbon dioxide). All studies were performed using Beas-2B cells between passage 40 and 
passage 60, with passage 1 defined as the thawed cells from the supplier.  
Beas-2B ARE Promoter Luciferase Reporter Cells and Flavoring Exposures 
Beas-2B cells were transduced with a lentiviral vector containing tandem repeats of 
the human Nrf2 consensus DNA-binding site (ARE) linked to the firefly luciferase gene and 
a constitutively expressed green fluorescent protein (GFP) reporter (kind gift from Dr. Steve 
Simmons, National Health and Environmental Effects Research Laboratory, U.S. EPA, 
Durham, NC) at a multiplicity of infection (MOI) of 20. Stably transduced Beas-2B ARE-
luciferase reporter cells were plated in white 96-well plates (Corning Inc, Corning, NY, 
USA) at 6.0x104 cells per well in KGM and cultured overnight at 37°C prior to 
experimentation. For flavoring exposure experiments, growth medium was aspirated and 
cells were washed briefly with 1x PBS (Sigma-Aldrich, St. Louis, MO, USA). 
Cinnamaldehyde, guaiacol, eugenol, isoamyl acetate, limonene, linalool, menthol, and 
benzaldehyde (Sigma-Aldrich, St. Louis, MO, USA) were diluted in 37°C KGM to 10.0, 1.0, 
0.1, 0.01, 0.001, 0.0001, and 0.00001mM, and cells were incubated with 200µl of diluted 
flavorings or KGM alone for 24 hours (37°C, 95% humidity, and 5% carbon dioxide). 
Following exposures, cell culture medium was collected for cytotoxicity assays, cells were 
lysed with 1x Passive Lysis buffer (Promega, Madison, WI, USA), and cell lysates were 
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analyzed for GFP expression and luciferase activity on a BMG CLARIOstar microplate 
reader (BMG Labtech, Ortenberg, Germany). Luciferase activity was normalized to GFP 
expression and reported as percent Nrf2 activation observed in cells exposed to cell culture 
medium alone. Differences in luciferase activity following flavoring exposures were 
evaluated by one-way ANOVA and Holm-Sidak multiple comparisons test. Differences with 
a P value ≤ 0.05 were considered significant. 
Cytotoxicity Assays 
Beas-2B cell viability following 24-hour flavoring exposures was determined by 
measuring lactate dehydrogenase (LDH) release into the cell culture medium using a 
commercially available colorimetric (490/650 nm) assay kit following the manufacturer’s 
instructions (Thermo Fisher Scientific, Waltham, MA, USA). One hundred microliters of 
culture medium were used for analysis. The absorbance data for each sample was normalized 
to 100% cell death (maximal LDH release caused by lysis with 1.0% Triton X-100 in cell 
culture medium) and baseline LDH release (untreated cells) using the following formula: 
corrected viability = 100 – [[Abs(X) − Abs(Y)]/[Abs(MAX) − Abs(Y)]*100] where Abs(X) 
is the absorbance of the sample, Abs(Y) is the absorbance of media from the untreated 
control cells, and Abs(MAX) is the absorbance of media collected from cells exposed to 
1.0% Triton X-100. Data for cinnamaldehyde toxicity in Beas-2B cells were collected from 3 
independent experiments (N=3). Differences in viability following flavoring exposures were 
evaluated by one-way ANOVA and Holm-Sidak multiple comparisons test. Differences with 
a P value ≤ 0.05 were considered significant. 
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Buthionine-sulfoximine (BSO) Inhibition of Glutathione (GHS) Synthesis 
A 1M stock solution of BSO (Sigma-Aldrich, St. Louis, MO, USA) was prepared by 
dissolving BSO in sterile cell culture grade water (Thermo Fisher Scientific, Waltham, MA, 
USA) and vortexing for 2 minutes. BSO was further diluted to working concentrations of 1.0, 
0.5, 0.25, 0.125, 0.0625, 0.0313, 0.0158, 0.0078, or 0.0039mM in 37°C KGM. Beas-2B cells 
were incubated with BSO in KGM, cinnamaldehyde in KGM, or KGM alone for 24 hours 
and intracellular reduced GSH levels were quantified using a commercially available 
fluorescence-based kit following the manufacturer’s instructions (Abcam, Cambridge, United 
Kingdom).   
Inhibition of GSH Synthesis in Beas-2B ARE promotor luciferase reporter cells Prior to 
Cinnamaldehyde Exposures  
Beas-2B ARE-luciferase reporter cells were plated in white 96-well plates at 2.5x104 
cells per well in KGM and cultured overnight at 37°C prior to experimentation. Cells were 
briefly washes with 1x PBS and incubated with 10µM BSO for either 6 hours or 24 hours 
prior to the addition of cinnamaldehyde (10.0, 1.0, 0.1, 0.01, 0.001, 0.0001, and 
0.00001mM). After the addition of cinnamaldehyde, cells were incubated for an additional 
24 hours (37°C, 95% humidity, and 5% carbon dioxide). Following exposures, cell culture 
medium was collected for cytotoxicity (LDH) assays and cells were lysed for GFP 
expression and luciferase activity as described above. Luciferase activity was normalized to 
GFP expression and reported as percent Nrf2 activation observed in cells exposed to cell 
culture medium alone. Differences in luciferase activity following flavoring exposures were 
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evaluated by one-way ANOVA and Holm-Sidak multiple comparisons test. Differences with 
a P value ≤ 0.05 were considered significant. 
4.3  Results 
Nrf2 Pathway Activation by E-liquid Flavoring Agents  
Beas-2B cell Nrf2 pathway activation was flavor-specific and concentration 
dependent (Figure 4.1). Cinnamaldehyde (0.01mM), guaiacol (0.01, 0.1, 1.0mM), and 
eugenol (0.01, 0.1mM) significantly increased Nrf2 pathway activation. However, this effect 
was bimodal as greater concentrations of cinnamaldehyde (0.1, 1.0, 10.0mM), guaiacol 
(10.0mM), and eugenol (10.0mM) significantly suppressed Nrf2 pathway activation as 
compared to their media only controls. The highest concentration of linalool (10.0mM) and 
menthol (10.0mM) also significantly suppressed Nrf2 pathway activation although lower 
concentrations had no significant effect. Benzaldehyde, limonene, and isoamyl acetate had no 
effect on Nrf2 pathway activation at any of the concentrations investigated.  
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Figure 4.1   Nrf2 antioxidant pathway activation is flavor-specific and concentration-
dependent. Cinnamaldehyde (0.01mM), guaiacol (0.01mM, 0.1mM, and 1.0mM), and 
eugenol (0.01mM and 0.1mM) significantly increased Nrf2 pathway activation as compared 
to the media control (N=3). High concentrations of cinnamaldehyde (0.1mM, 1.0mM, and 
10.0mM), guaiacol (10.0mM), eugenol (10.0mM), linalool (10.0mM), and menthol 
(10.0mM) significantly suppressed Nrf2 pathway activation as comparted to the media only 
controls. Data presented as mean ± SEM. Significance represented as * p<0.05, ** p<0.01, 
*** p<0.001, and **** p<0.0001. 
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Effects of Flavoring Agents on Cell Viability 
The effect of flavorings on Beas-2B cell viability was also flavor-specific and 
concentration dependent (Figure 4.2). Cinnamaldehyde (10mM), eugenol (10.0mM), 
limonene (10.0mM), linalool (10.0mM), and menthol (10.0mM) significantly reduced cell 
viability to 78.9%, 62.3%, 75.7%, 71.7%, and 61.5%, respectively. Guaiacol, benzaldehyde, 
and isoamyl acetate did not significantly affect cell viability at any of the concentrations 
tested.  
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Figure 4.2   Cytotoxicity is flavor-specific and concentration-dependent. The highest 
concentrations of cinnamaldehyde (10mM), eugenol (10.0mM), limonene (10.0mM), linalool 
(10.0mM), and menthol (10.0mM) induced significant cytotoxicity, as determined by LDH 
released following 24-hour exposures (N=3). Data presented as mean ± SEM. Significance 
represented as **** p<0.0001. 
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Effect of BSO and Cinnamaldehyde on Intracellular GSH Levels 
Twenty-four-hour exposure of Beas-2B cells to BSO significantly reduced 
intracellular GSH levels in a concentration-dependent manner (Figure 4.3A). Reductions in 
GSH ranged from 41.8% (3.9µM BSO) to 20.6% (1mM BSO) of control levels. Reduced 
GSH levels did not significantly activate Nrf2 pathway activation (Figure 4.3B) or decrease 
Beas-2B cell viability (Figure 4.3C) at any of the concentrations tested. Previous studies 
investigating mechanisms of cinnamaldehyde toxicity in rat isolated hepatocytes report an 
immediate reaction between cinnamaldehyde and GSH which resulted in depleted 
intracellular GSH levels (46, 47). To determine if non-cytotoxic concentrations of 
cinnamaldehyde altered GSH levels in bronchial epithelial cells, we exposed Beas-2B cells to 
cinnamaldehyde for 24 hours and then quantified GSH. Cinnamaldehyde depleted GSH in 
Beas-2B cells over a concentration range of 0.5mM to 0.016mM (Figure 4.4). All 
cinnamaldehyde exposures eliciting a significant reduction decreased GSH by approximately 
25% from GSH levels observed in media controls.  
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Figure 4.3   Buthionine-sulfoximine (BSO) depletion of glutathione (GSH) does not 
activate Nrf2 responses or cause cell death. A) BSO is a potent inhibitor of GSH synthesis 
in Beas-2B cells as indicated by a significant reduction in intracellular GSH levels at all 
concentrations tested (0.004mM to 1.0mM). B) Depletion of GSH did not significantly affect 
Nrf2 signaling or C) reduce cell viability, as determined by LDH release (N=3). Data 
presented as mean ± SEM. Significance represented as **** p<0.0001. 
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Figure 4.4   Cinnamaldehyde reduces Beas-2B cell GSH levels. Beas-2B cells were 
exposed to various concentrations of cinnamaldehyde (0.004mM to 1.0mM) for 24 hours and 
intracellular GSH levels were quantified (N=3). Cinnamaldehyde concentrations from 
0.016mM to 0.5mM significantly reduces intracellular levels of GSH (N=3). Data presented 
as mean ± SEM. Significance represented as * p<0.05. 
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Effect GSH depletion on Cinnamaldehyde-induced Nrf2 Pathway Activation 
To investigate the role GSH plays in Nrf2 pathway activation by cinnamaldehyde, 
Beas-2B cells were pretreated with 10mM BSO for 6 hours or 24 hours to deplete GSH 
levels prior to cinnamaldehyde exposures. BSO depletion of GSH significantly enhanced 
cinnamaldehyde-induced Nrf2 pathway activation for 0.01mM, 0.001mM, 0.0001mM, and 
0.00001mM exposures (Figure 4.5). However, BSO depletion of GSH did not alter the 
concentration-dependent bimodal effect on Nrf2 pathway activation as 0.1mM, 1.0mM, and 
10.0mM cinnamaldehyde suppressed Nrf2 pathway activity as observed with 
cinnamaldehyde alone.   
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Figure 4.5   BSO depletion of Beas-2B cell GSH increases sensitivity to cinnamaldehyde-
induced activation of the Nrf2 pathway. Beas-2B cells were pretreated with 10µM BSO for 
either 6 hours or 24 hours before the addition of cinnamaldehyde. Depletion of GSH 
significantly enhanced cinnamaldehyde-induced activation of Nrf2 pathway activation with 
0.00001mM, 0.0001mM, 0.001mM, and 0.01mM exposures (N=3). Data presented as mean 
± SEM. Significance represented as * p<0.05, *** p<0.001, and **** p<0.0001. 
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4.4  Discussion 
Here, we investigated whether common food-safe flavoring agents in e-cigarette refill 
liquids had the capacity to modulate normal Nrf2 antioxidant pathway activity in bronchial 
epithelial cells and whether exposures to cinnamaldehyde, a reactive α,β-unsaturated 
aldehyde flavoring agent, altered bronchial epithelial cell GSH levels. Our data indicate that 
cinnamaldehyde, guaiacol, and eugenol have concentration-dependent effects on Nrf2 
pathway activation with lower concentrations significantly increasing ARE-luciferase 
activity and the highest concentrations significantly suppressing luciferase activity as 
compared to the media only controls. The observation that 0.01mM cinnamaldehyde 
augments Nrf2 pathway activation supports findings from previous studies. Chew and 
colleagues observed increased Nrf2/ARE-luciferase reporter activity in colon carcinoma 
HCT 116 cells exposed to 0.01mM cinnamaldehyde, which decreased with exposures to 
higher concentrations (48). Wang et al. report that 0.01mM cinnamaldehyde induced human 
umbilical vein endothelial cell (HUVEC) Nrf2 expression, promoted Nrf2 nuclear 
translocation‚ and increased HO-1, NQO1, catalase, and glutathione peroxidase 1 (GPX1) 
expression under high glucose conditions (49). Kim et al. exposed human dental pulp cells 
(hDPCs) to 0.02mM cinnamaldehyde and observed increased Nrf2 nuclear translocation and 
upregulation of HO-1 protein expression, which correlated with reduced levels of 
intracellular reactive oxygen species and protected the hDPCs from H2O2-induced oxidative 
stress (50). Similarly, Hiroshi et al. exposed human keratinocytes to 0.025mM 
cinnamaldehyde and observed a significant induction of Nfr2 activation and HO-1 
expression, which correlated with a reduction in benzo[a]pyrene-induced oxidative stress 
(51). Interestingly, the authors noted that cinnamaldehyde potently suppressed AHR nuclear 
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translocation following benzo[a]pyrene exposure. Altogether, these findings suggest that low 
micro-molar concentrations of cinnamaldehyde activate the Nrf2 pathway and upregulate 
cytoprotective gene expression in a variety of cell types without negatively impacting cell 
viability.  
Other studies have reported that higher concentrations of cinnamaldehyde enhance 
oxidative stress. Raveendran and colleagues orally exposed rats to 73.5 mg/kg 
cinnamaldehyde for 30 days and observed reduced GSH and ascorbic acid levels, as well as 
reduced catalase and glucose-6-phosphate dehydrogenase activity in rat livers (41). 
Additionally, the authors observed elevated levels of thiobarbituric acid reactive substances, 
indicating oxidative damage. Ka et al. report that exposure of human promyelocytic leukemia 
HL-60 cells to 0.04mM cinnamaldehyde rapidly decreased intracellular GSH and 
significantly induced reactive oxygen species-mediated mitochondrial permeability transition 
and release of cytochrome c, resulting in increased cell death (52). Our findings and the 
existing literature support the idea of a potential bimodal response pattern for 
cinnamaldehyde, where exposure concentrations at or below 0.01mM may initiate 
cytoprotective gene expression and enhance cellular responses to environmental stresses. 
However, cinnamaldehyde-induced inhibition of Nrf2 pathway activation at high 
concentrations would likely have the opposite effect and enhance oxidative and electrophilic 
damage, which could exacerbate the progression of respiratory diseases such as emphysema 
and COPD.  
Our observation that guaiacol significantly enhanced Nrf2 pathway activation 
contradicts a previous study by Senger and colleagues which found that chemicals with 
structural similarity to catechol, including guaiacol (0.03mM), did not significantly activate 
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the Nrf2 pathway or induce expression of Nrf2 target genes in human dermal microvascular 
endothelial cells after 24-hour exposure (53). One possible explanation for this discrepancy 
could be inherent differences in the endogenous peroxide/peroxidase content of Beas-2B 
bronchial epithelial and dermal microvascular endothelial cells. Numerous studies have 
shown that guaiacol can be oxidized by peroxidases in the presence of H2O2 resulting in the 
formation of various reactive quinones (54, 55). Indeed, a colorimetric assay of peroxidase 
activity using guaiacol is a common analytical method for quantifying enzymatic activity 
based on the change in absorbance at 470nm (56). Quinones are oxidative, electrophilic 
Michael acceptors known to activate Nrf2 antioxidant response through their interactions 
with reactive cysteine residues on Keap1 (57, 58). Thus, it is plausible that the addition of 
guaiacol in our study resulted in the generation of quinone species, which subsequently 
induced Nrf2 pathway activation.  
Eugenol (4-allyl-2-methoxyphenol) is an allyl-chain substituted guaiacol, which is the 
characteristic odor and flavor of clove. Eugenol is widely used as a flavoring additive in 
various foods and beverages, and has been investigated as a pharmacological agent (59). 
Studies have indicated that eugenol has both antioxidant and prooxidant properties, which are 
dependent on exposure concentrations. At low micro-molar concentrations, eugenol is 
reported react with 2,2-diphenyl-1-picrylhydrazyl (DPPH) and shows high DPPH free 
radical-scavenging activity (60-62). The reported IC50 values for DPPH scavenging by 
eugenol range from 98µM to 138µM (62, 63). Additionally, eugenol has ferric ion (Fe3+) 
reducing ability and electron donor properties for neutralizing free radicals by forming stable 
products (62). While there is substantial literature on the radical-scavenging activity of 
eugenol, there is a paucity of data on whether eugenol effects Nrf2 pathway activation. Han 
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and colleagues observed that MCF 7 breast cancer cells exposed to low micro-molar 
concentrations of eugenol (5, 10, or 20µM) had concentration-dependent inhibition of 
cytochrome p450 1A1 and 1B1 (CYP1A1 and CYP1B1) activity and reduced AHR nuclear 
translocation (64). Furthermore, 18-hour treatment with eugenol significantly induced ARE-
luciferase activity, Nrf2 nuclear translocation, and NQO1 expression, indicating that, similar 
to cinnamaldehyde, eugenol suppresses AHR nuclear translocation and activates the Nrf2 
antioxidant pathway. Our findings that eugenol induces ARE-luciferase activity in bronchial 
epithelial cells is in agreement with the data reported by Han. However, the exact mechanism 
by which eugenol activates Nrf2 remains unclear. Similar to guaiacol, eugenol may undergo 
oxidation by cellular enzymes to form quinone methides. These electrophilic Michael 
acceptors may react with thiolate anions on Keap1, thereby releasing Nrf2 and stimulating 
antioxidant responses.  
 
 
Figure 4.6   Chemical structures of Nrf2 pathway activators. A) Known activators of the 
Nrf2 antioxidant pathway. B) Common e-cigarette flavoring agents shown here to activate 
the Nrf2 pathway.  
Curcumin 
Eugenol Guaiacol
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Susceptibility of the lung to oxidative and electrophilic injury, such as that originating 
from cigarette smoke exposure, depends largely on induction of cytoprotective gene 
expression (18, 65). Animal studies have shown that disruption of the Nrf2 gene and 
subsequent reductions in Nrf2-dependent gene expression in mice lead to earlier-onset and 
more severe cigarette smoke-induced emphysema than observed in wild-type littermate 
controls (66). The emphysema in these Nrf2-deficient mice was associated with more 
pronounced bronchoalveolar inflammation, enhanced markers of oxidative stress, and greater 
endothelial cell and type II pneumocyte death as compared to Nrf2-sufficient animals. 
Alveolar macrophage expression of antioxidant and antiprotease genes was also significantly 
attenuated in Nrf2-deficient mice, which contributed to the severity of lung injury and 
elastase-provoked emphysema (67). Transplantation of wild-type bone marrow into Nrf2-
deficient mice significantly reduced elastase-induced lung injury and delayed the onset of 
emphysema clearly demonstrating the importance of Nrf2 in protecting against cigarette 
smoke-related respiratory insults. Further demonstrating this point, we have shown that 
consumption of broccoli sprout homogenates containing the Nrf2 activating agent 
sulforaphane (SFN) enhanced NQO1 expression in nasal lavage cells and significantly 
reduced virus quantity and virus-induced markers of inflammation in healthy smokers (68). 
Moreover, our data indicate that SFN-induced Nrf2 pathway activation significantly reduces 
susceptibility to influenza infections by inhibiting viral entry (69). Furthermore, rodent 
studies demonstrate that SFN-induced Nrf2 pathway activation augments endogenous 
antioxidant defense responses and improves airway epithelial barrier integrity in HIV-
infected animals (70). Taken together, these data demonstrate that Nrf2 status plays an 
important role in health and disease. 
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Cinnamaldehyde is known to covalently modify cellular proteins. Indeed, allergic 
reactions to cinnamaldehyde have been related to its Michael reactivity and the ability to 
form stable adducts with proteins (71). However, little is known regarding the effects of 
cinnamaldehyde on cellular GSH levels. Gowder and colleagues exposed rats to 
cinnamaldehyde by oral gavage for 10, 30, and 90 days, and observed dose-dependent 
reductions in ascorbic acid, alpha-tocopherol, and GSH in rat kidney tissues (72). Liao et al. 
exposed a human endothelial cell line to 100µM cinnamaldehyde and observed a rapid 
reduction in GSH levels followed by a significant increase in GSH levels after 9-hour 
exposures. This increase was attributed to the induction of Nrf2-mediated glutamylcysteine 
synthetase gene expression, which suggests a potential temporal component to 
cinnamaldehyde-induced changes in GSH levels (73).  To our knowledge, there are no 
studies evaluating the effects of cinnamaldehyde on GSH levels in human respiratory tissues. 
To address this knowledge gap, we exposed Beas-2B cells to various concentrations of 
cinnamaldehyde for 24 hours and quantified changes in intracellular GSH content. 
Cinnamaldehyde (0.016, 0.31, 0.63, 0.125, 0.25, and 0.5mM) reduced GSH levels in Beas-
2B cells by approximately 25%. While cinnamaldehyde did significantly reduce GSH levels, 
we did not observe a concentration-dependent effect, which has been reported with aldehyde 
exposures in rodent studies. Meacher and Menzel exposed adult rat lung type II alveolar cells 
to various low-molecular-weight aldehydes and observed concentration-dependent reductions 
in GSH (74). However, this study exposed cells to aldehydes for 20 minutes prior to GSH 
analysis. Based on the data reported by Liao et al., GSH levels may rapidly decrease and 
recover following aldehyde exposures (73). Twenty-four-hour exposures in our study may 
reflect this recovery phase. The data presented here also demonstrate the role for GSH in 
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buffering the Nrf2 antioxidant pathway against activation by electrophiles. Inhibition of GSH 
synthesis with BSO augmented cinnamaldehyde-induced activation of the Nrf2 pathway, 
significantly increasing activation at the 0.00001mM cinnamaldehyde exposure and 
increasing the maximal response (0.01mM cinnamaldehyde) by approximately 50%. These 
observations indicate that dysregulation of antioxidant/electrophile defenses, such as 
depletion of glutathione, enhances the biological activity of cinnamaldehyde and potentially 
other electrophilic flavoring agents.  
There is a growing body of evidence suggesting that many flavoring compounds have 
nutraceutical value and that ailments stemming from dysregulation of cellular redox 
homeostasis may be alleviated by the bioactivity of these substances (75-78). Much of the 
existing literature attributes the potential health benefits of nutraceuticals to the induction of 
antioxidant genes and upregulation of phase II detoxifying enzymes as a means for 
eliminating environmental stresses (79, 80). While the vast majority of these studies have 
been done in the context of oral exposures, the emergence of e-cigarettes and the ubiquitous 
use of flavoring agents with these devices creates a necessity for understanding the biological 
effects of inhalational exposures. We have previous shown that cinnamon-flavored e-liquids 
and cinnamaldehyde inhibited neutrophil, alveolar macrophage, and NK cell innate immune 
functions in a concentration-dependent manner (29). Moreover, inhibition of immune 
functions occurred well below cytotoxic concentrations of cinnamaldehyde. More recently, 
we reported that vaped cinnamon e-liquid aerosol and cinnamaldehyde caused temporary 
stasis of human bronchial epithelial cell motile cilia by transient suppression of 
mitochondrial respiration and glycolysis (Chapter 3). The data we report here demonstrate 
that cinnamaldehyde, guaiacol, and eugenol, common e-cigarette flavoring agents, have a 
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dose-dependent bimodal effect on Nrf2-pathway activation in bronchial epithelial cells. The 
bimodal response we observed may present cause for concern as sufficiently high 
concentrations of these compounds may impair antioxidant responses in vapers and promote 
oxidative and electrophilic lung damage; pathologic changes commonly observed in 
smoking-related lung diseases. On the other hand, our data suggest that low concentrations of 
these flavoring agents stimulate Nrf2 pathway activation, which may have potential 
therapeutic benefits. However, e-cigarette aerosols have also been shown to contain reactive 
electrophiles (acrolein, formaldehyde, crotonaldehyde, etc.) metals, and reactive oxygen 
species, which may disrupt cellular defenses such as free GSH and exacerbate oxidative and 
electrophilic damage (33, 34, 81, 82). Thus, further work is necessary to determine, in the 
context of complex e-cigarette aerosols and repeated vaping exposures, how flavoring agents 
will affect lung health. 
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CHAPTER 5. 
PERSPECTIVES, FUTURE DIRECTIONS, AND CONCLUDING REMARKS 
5.1  Perspectives 
5.1.1  Flavorings drive youth initiation on e-cigarettes 
The e-cigarette industry has seen tremendous growth over the last decade. E-cigarette 
sales in the U.S. more than doubled between 2012 and 2013, from $273.6 million to $636.2 
million, respectively (1). In 2014, U.S. e-cigarette sales reached approximately $2.5 billion 
and estimates for 2016 sales are approximately $3.3 billion (2). The rapid expansion of the e-
cigarette industry reflects the rise in popularity of these products among teens and 
adolescents (3). The 2015 National Youth Tobacco Survey reported that 27.1% of middle 
and high school students had tried e-cigarettes, and 4.3% of middle school students and 
11.3% of high school students reported using e-cigarettes within the past 30 days (4). Similar 
findings have been reported by the Monitoring the Future (MTF) and Youth Risk Behavioral 
Surveillance (YRBS) cross-sectional surveys (5, 6). While e-cigarette use in this 
demographic is strikingly high, it remains unclear what, precisely, youth are vaping. 
Substantial proportions of youth report using non-nicotine electronic cigarettes. The MTF 
survey found that nearly two-thirds of ever e-cigarette users reported vaping “just flavoring” 
at last use (5). A recent study by Harrell and colleagues found that at initiation, the majority 
of Texas school-going youth (98%), Texas young adult college students (95%), and young
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 adults (71.2%) nationwide said their first e-cigarettes were flavored to taste like something 
other than tobacco, compared to 44.1% of older adults nationwide (7). Furthermore, the 
authors report that fruit and candy flavors predominated for all groups; and, for youth, flavors 
were an especially salient reason to use e-cigarettes. The indication that many youths are 
using e-cigarettes specifically to inhale flavorings is concerning because 1) many flavoring 
agents are reactive compounds which have structural similarities to known respiratory 
irritants and toxicants, 2) there is a dearth of information on the health effects of inhaling 
reactive food flavoring agents, and 3) there is currently no regulation on the breadth or 
quantity of flavoring agents used in these products. 
 5.1.2  The perception of e-cigarette flavoring agents as harmless  
The vast majority of flavoring agents used in the manufacture of e-cigarette liquids 
have been designated as “generally recognized as safe” (GRAS) by the United States Food 
and Drug Administration (U.S. FDA). With the emergence of e-cigarettes, the applicability 
of the GRAS designation has often been misconstrued. In 1958, the U.S. FDA established the 
Food Additives Amendment to the 1938 Food, Drugs, and Cosmetic Act, which stated that 
any substance intentionally added to food is a food additive and is subject to pre-market 
approval by U.S. FDA, unless the use of the substance is generally recognized as safe (8). 
Substances would be exempt from pre-market evaluation as a food additive if there was 
consensus among a panel of scientific experts (which may be from the food industry) that the 
substance was generally recognized as safe under the conditions of its intended use. This 
provision allowed common substances, such as table salt, to be used in food preparation 
without being required to undergo extensive and costly pre-market evaluation. The caveat to 
this designation is that it is only applicable to substances added to foods and intended for oral 
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consumption. This entirely precludes the notion of GRAS substances in e-cigarettes, as 
inhalation does not fall within the intended use of food additives. Nonetheless, early e-
cigarette products were sometimes marketed with the U.S. FDA GRAS logo printed on the 
bottle or displayed on websites. This misrepresentation/misunderstanding may have 
contributed to a perception that inhalation of e-cigarette flavorings is harmless (9). The idea 
that inhalational and oral exposures of the same substance may have inherently different 
biological effects reflects a fundamental principle of toxicology; the route of exposure for a 
xenobiotic can influence toxicological responses. 
5.1.3  The route of exposure makes the poison 
Reactive aldehydes are natural constituents of foods and are commonly used as 
flavoring or aroma additives to improve the attractiveness of dietary products (10). The most 
common aldehydes in food are furfural (present in apples, cherries, carrots, potatoes and 
coffee, which has the highest concentration of 2.34mM [0.025%]), anisaldehyde (present in 
apricots, cranberries, alcoholic beverages, and anise, which has the highest concentration of 
183.6mM [2.5%]), vanillin (present in fruits, asparagus, spices, and vanilla, which has the 
highest concentration of 152.5mM [2.32%]), trans-2-hexenal (the aroma of bananas, which 
contain 0.8mM [0.0076%]), and cinnamaldehyde (approximately 90% of cinnamon oil) (11). 
Cinnamaldehyde is often added to candies and chewing gum at concentrations of 
approximately 5.0mM [0.07%] and 37.1mM [0.49%], respectively (11). The alimentary canal 
has evolved substantial defense mechanisms to neutralize, process, and eliminate reactive 
chemicals, such as dietary aldehydes. This detoxification begins with saliva in the oral cavity. 
Human saliva contains significant quantities of enzymes, including peroxidase, catalase, 
super oxide dismutase, glutathione peroxidase, alcohol dehydrogenase, and aldehyde 
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dehydrogenase (12-14). Additionally, there is an abundance of antioxidants, including GSH 
and its precursors cysteine, cysteinylglycine and homocysteine, uric acid, and vitamins E and 
C (14, 15). Aldehyde dehydrogenase 3A1 (ALDH3A1), the predominate aldehyde 
dehydrogenase in saliva which converts aldehydes to less reactive carboxylic acids, is highly 
active towards aromatic and long aliphatic aldehydes, including cinnamaldehyde, 
benzaldehyde, anisaldehyde, vanillin, and 4-hydroxy-2-nonenal (11, 13). ALDH3A1 is 
considered an essential defense mechanism against food aldehydes as individuals with 
insufficient ALDH3A1 activity are predisposed to cancers of the oral cavity (11). Aldehydes 
that persist beyond the oral cavity can be rapidly oxidized by ALDH1A1 isoforms expressed 
in esophageal, stomach, and intestinal epithelial cells (11). The combination of aldehyde 
dehydrogenase enzymes and electrophile sinks, such as glutathione, actively protects the 
alimentary canal from oxidative and electrophilic damage. However, despite these robust 
defenses, high concentrations of and prolonged exposures to some common food aldehydes 
are associated with cancers of the gastrointestinal tract (10).  
As discussed in Chapter 1, the lungs have evolved effective defense mechanisms, 
including a protective airway surface liquid milieu, mucociliary clearance, epithelial tight 
junctions, and resident leukocyte populations, to protect the body against common 
environmental toxicants. However, it is unclear how well these defenses will withstand new 
and emerging insults, such as those produced when vaping. The inhalation of reactive 
aldehyde flavoring agents presents a significant concern based on the known detrimental 
effects of environmental aldehydes on the respiratory system. This concern is compounded 
by data reporting that flavoring agents in e-liquids, including cinnamaldehyde, exceed 
concentrations used in foods and beverages (11, 16, 17).  
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5.1.4  The known respiratory effects of flavoring agents 
Perhaps the most well-known example of a food-safe flavoring causing severe 
inhalation toxicity is diacetyl-induced lung disease. In May, 2000, eight persons who had 
formerly worked at a microwave popcorn production facility were reported to the Missouri 
Department of Health to have bronchiolitis obliterans, an irreversible obstructive lung disease 
(18). The etiologic agent in all eight cases was determined to be the GRAS butter-flavoring 
agent diacetyl (2,3-butanedione). Follow-up studies in rats and mice confirmed the inhalation 
toxicity of diacetyl with sub-chronic exposures causing necrotizing rhinitis, necrotizing 
laryngitis, and bronchitis, emphysema and hyperemia, and death (19). Electron transfer and 
the subsequent generation of reactive oxygen species (ROS) has been proposed as a 
mechanism of diacetyl-mediated respiratory toxicity (20).  
Eugenol and cinnamaldehyde have both been identified as potent skin sensitizers in 
humans, and there are data linking these sensitizers to asthma. A 2015 case report describes a 
34-year-old professional cleaner who developed cough, dyspnea, and maculopapular 
erythema after inhalation and dermal exposures to an industrial cleaning agent containing 
eugenol (21). Bronchial challenge with eugenol significantly reduced pulmonary function 
and induced cough and dyspnea. Based on these responses, the patient was subsequently 
diagnosed with eugenol-induced occupational asthma. A study investigating the health 
effects of cinnamon dust exposures in 40 Sri Lankan cinnamon workers found that 20 
workers (50%) experienced skin irritation, 15 workers (37.5%) had increased cough, and 9 
workers (22.5%) were asthmatic (22). The number of asthmatics in this study was reported to 
be disproportionately higher than other Sri Lankan industries with comparable working 
conditions and dust exposures. However, more evidence is needed to directly link 
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inhalational exposures of cinnamaldehyde and the development or exacerbation of asthma. 
There are also reports of mint flavoring agents causing or exacerbating respiratory 
conditions. Several case studies describe wheezing, bronchospasm, dyspnea, or asthma 
exacerbation in individuals following exposures to mint-containing products, including 
toothpaste, chewing gum, and candies (23-25). These reports indicate that inhalation 
exposure to common food-flavorings can affect biological functions in the lungs. 
5.1.5  Cinnamon e-liquids and cinnamaldehyde suppress respiratory defenses 
The focus of this dissertation work was to investigate whether flavored e-liquids and 
specific flavoring agents alter innate immune functions of the respiratory system as a means 
to assess the potential health effects of e-cigarette use. Our data indicate that 
cinnamaldehyde-containing e-liquids suppress neutrophil and alveolar macrophage 
phagocytosis of S.aureus bioparticles, neutrophil extracellular trap formation, natural killer 
(NK) cell targeted cell killing of leukemia cells (Chapter 2), and human bronchial epithelial 
(hBE) cell cilia motility (Chapter 3). Furthermore, the e-liquid-induced effects on neutrophil 
and macrophage phagocytosis, NK cell killing, and cilia motility were recapitulated 
following exposure to cinnamaldehyde alone suggesting that the e-liquid-induced 
suppression was driven by cinnamaldehyde. All of the observed effects were 
dose/concentration dependent and dose-responses varied between cell types. Neutrophils and 
NK cells were the most susceptible to the effects of e-liquid and cinnamaldehyde exposures, 
with IC50 values for phagocytosis and targeted cell killing of 0.0324mM and 0.0205mM, 
respectively. The IC50 for alveolar macrophage phagocytosis was 0.243mM. Exposure of 
hBE cells to 10mM and 15mM cinnamaldehyde significantly suppressed cilia motility. Taken 
together, these data indicate that the components of the respiratory innate defense system 
 
 197 
have varying degrees of susceptibility to acute exposures of cinnamaldehyde. These data are 
meaningful because they suggest that different exposure doses of cinnamaldehyde may elicit 
different health outcomes. If e-cigarette users receive inhalation exposures to 
cinnamaldehyde of 20-30µM, neutrophil phagocytosis and NK cell killing functions may be 
suppressed. This could potentially increase susceptibility to respiratory infections, enhance 
dissemination of pathogens in the lungs, and promote inflammation. Compromised 
neutrophil anti-bacterial activity has been proposed as a major cause of increased 
susceptibility to respiratory infections in smokers (26). However, other innate defense 
mechanisms, such as macrophage phagocytosis and cilia motility, would likely maintain 
normal defense functions during exposures to 20-30µM cinnamaldehyde and may effectively 
compensate for neutrophil and NK cell dysfunction. E-cigarette users receiving 
cinnamaldehyde exposures at 300µM may lose the phagocytic functions of neutrophils and 
alveolar macrophages, which would likely pose a greater risk for respiratory infections and 
inflammation. Additionally, our data indicate that cinnamaldehyde exposures greater than 
0.1mM significantly suppress Nrf2 pathway activation and reduced GSH levels in hBE cells. 
The loss of these antioxidant responses could exacerbate oxidative damage resulting from 
normal cellular processes or infections and significantly enhance inflammation in the lungs. 
Exposures sufficient to impair cilia motility (≥10mM cinnamaldehyde) would likely have 
severe effects on respiratory health as impaired mucociliary clearance in smokers is 
associated with increased occurrence of respiratory infections and obstructive lung diseases 
(27, 28). Moreover, we observed that 10mM cinnamaldehyde was highly cytotoxic to 
immune cells. Exposures at this concentration could lead to an abundance of necrotic 
immune cells releasing toxic enzymes into the airways. Cigarette smoke-induced neutrophil 
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necrosis- mediated release of proteolytic enzymes, particularly elastase and matrix 
metalloproteinase, cause significant damage to host tissue and are believed to be key 
mediators of destructive lung diseases (29). Our in vitro data suggests that e-cigarette users 
inhaling sufficiently high concentrations of cinnamaldehyde may have compromised innate 
defense responses, which could promote respiratory infections and increase oxidative stress 
in the lungs.  
 
 
Figure 5.1   Summary of the cinnamaldehyde-induced effects reported in Chapters 2, 3, 
and 4.  
 
5.1.6  Potential concerns for cinnamaldehyde exposures and cancer 
Much of the existing literature on cinnamaldehyde has focused on its potential use as 
a chemotherapeutic agent. For example, cinnamaldehyde has been reported to induce in vitro 
and in vivo melanoma cell death through the inhibition of NF-κB and AP-1 (30). 
Additionally, human cervical cancer cells (SiHa) treated with cinnamaldehyde exhibited 
reduced proliferation and migration, down regulation of Her-2 expression, and increased 
apoptosis which was mediated by elevations in intracellular calcium levels (31). Imai and 
 
 199 
colleagues observed that mice fed a diet containing 5000 ppm [37.8mM] cinnamaldehyde 
daily for 26 weeks had significantly lower rates of 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (NNK)-induced lung tumors as compared to mice without cinnamaldehyde (32). 
More recently, polyphenolic compounds constructed on a cinnamaldehyde scaffold were 
shown to cause cell cycle arrest at the G2/M phase and induce apoptosis in cisplatin-resistant 
A2780/Cis human ovarian cancer cells (33). All of these, as well as other studies, suggest 
that cinnamaldehyde may have potential as a chemotherapeutic agent or work synergistically 
with other chemotherapeutic agents. However, our observation that cinnamaldehyde, at low 
micro molar concentrations, impairs NK cell function raises concern that e-cigarette users 
may have impaired surveillance and elimination of tumorigenic cells. NK cell activity is 
impaired in smokers and NK cell cytotoxic and secretory functions are commonly disrupted 
in lung cancer patients (34-36). Additionally, our observation that low micro molar 
concentrations of cinnamaldehyde increase hBE cell Nrf2 pathway activation may have 
implications for cancer. While Nrf2 pathway activation is a mechanism to restore cellular 
redox homeostasis, aberrant activation of Nrf2 is a common feature of non-small cell lung 
cancers (37). The Cancer Genome Atlas (TCGA) indicates that approximately 1/3 of 
squamous cell lung cancers display Keap1/Nrf2/Cullin3 pathway alterations (38). Hu et al. 
examined Nrf2 sequences of 103 patients with non-small cell lung cancer and found that the 
Nrf2 mutation rate in ever-smokers was significantly higher than that in never-smokers (39). 
In accordance with Hu, Sasaki et al. sequenced Nrf2 in 262 surgically resected lung tumors 
and confirmed that Nrf2 activating mutations were significantly more common in smokers 
and squamous lung cancers (40). Other studies have shown that biallelic inactivation of 
Keap1 is a common event in non-small cell lung cancers (41). It has been suggested that 
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aberrant Nrf2 activation in lung cancer leads to increased expression of drug efflux pumps, 
thereby providing a mechanism for resistance to platinum-based chemotherapy agents (41, 
42). In support of this idea, a recent study showed that siRNA-mediated inhibition of Nrf2 
augmented carboplatin-induced tumor growth inhibition in a non-small cell lung cancer 
xenograft mouse model (42). Taken together, the inhibition of NK cell functions and 
enhanced Nrf2 pathway activation achieved with low micro molar concentrations of 
cinnamaldehyde, may be physiologic changes that promote the development or progression 
of lung cancer in e-cigarette users. This may be particularly important for long-term smokers 
with dysplastic changes or early stage cancer who transition to e-cigarettes, as impaired NK 
cell functions and enhanced Nrf2 pathway activation may accelerate tumor growth. 
Additional sub-chronic and chronic cinnamaldehyde inhalation studies in animals would be 
useful to assess whether 1) the in vitro findings of cinnamaldehyde-induced NK cell 
dysfunction and Nrf2 pathway activation occur in vivo, 2) whether low dose exposures 
increase the rates of non-small cell lung cancers, and 3) whether cinnamaldehyde exposure 
accelerates cancer progression resulting from exposures to other carcinogens, such as those 
in cigarette smoke. 
5.1.7  Cinnamaldehyde-induced suppression of bioenergetic functions   
One of the most interesting findings we report here is that cinnamaldehyde elicits 
dose-dependent reductions in hBE cell mitochondrial respiration and glycolytic activity, as 
determined by reductions in the cellular oxygen consumption rate (OCR) and extracellular 
acidification rate (ECAR). We validated this observation by exposing hBE cells to 10mM 
cinnamaldehyde and quantifying ATP levels 15 minutes, 120 minutes, and 24 hours after 
exposure. The addition of 10mM cinnamaldehyde caused a significant reduction in ATP 
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levels 15 minutes post exposure. However, ATP levels recovered by 120 minutes and 
reached baseline levels by 24 hours. These data demonstrate that cinnamaldehyde-induced 
dysfunction of bioenergetic pathways in hBE cells significantly reduces ATP, but only 
temporarily. In the context hBE cell defense functions, we show that this reduction in ATP 
causes transient ciliostasis, which may disrupt mucociliary clearance and increase the risk of 
infections in respiratory tissues. However, cinnamaldehyde-induced disruption of 
bioenergetic functions may have broad implications involving other cellular processes and 
various cell types. Countless cellular processes are dependent upon the hydrolysis of ATP. 
ATPase enzymes convert ATP to ADP and phosphate, releasing energy which is used to 
facilitate chemical reactions which otherwise would not occur. Transmembrane ATPases 
facilitate the transport of solutes into and out of the cell. Molecular motor proteins, including 
cytoskeletal motors (myosins, kinesins, dyneins), nucleic acid motors (helicases and 
topoisomerases), polymerization motors (actin ATPase), and rotary motors (FoF1-ATP 
synthase), utilize ATP hydrolysis to facilitate molecular movement. Reduction in ATP below 
threshold activation levels would disrupt the function of these proteins and disrupt normal 
cellular activity. 
Phosgene (carbonyl chloride, COCl2) is a toxic gas which forms acyl linkages with 
amino, hydroxyl and sulfhydryl groups on proteins (43). Phosgene-protein modifications lead 
to inhibition of enzymes involved in energy metabolism, reduced cellular ATP levels, loss of 
alveolar epithelial barrier integrity, and significant pulmonary edema (43). The pulmonary 
edema associated with phosgene exposure is believed to result from insufficient ATP to 
power Na+/K+-ATPases (which typically account for approximately 40% of cellular ATP 
consumption) (44, 45). Additionally, phosgene exposure dysregulates actin polymerization 
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and disrupts epithelial tight junctions, which may result from insufficient ATP (46, 47). The 
acute effects on tight junction integrity have been quantified by rapid reductions in 
transepithelial electrical resistance (TEER) (48). Based on this information, it is plausible 
that cinnamaldehyde-induced reductions in hBE cell ATP levels may have similar effects on 
Na+/K+-ATPase functions and reduce epithelial barrier integrity in the airways of e-cigarette 
users. Indeed, we have preliminary data that indicate a rapid reduction in well-differentiated 
hBE cell TEER and disruption of tight junction (zonula occludens-1; ZO-1) protein 
expression following acute exposure to cinnamaldehyde (data not shown). Additional 
investigation of cinnamaldehyde effects on Na+/K+-ATPase activity would also be useful.   
In Chapter 2, we report that cinnamaldehyde impairs respiratory immune cell 
phagocytosis and reduces NK cell killing of transformed cells. However, potential 
mechanisms underlying this dysregulation were not identified. Based on the observation of 
cinnamaldehyde-induced dysregulation of bioenergetic functions, it is possible that 
reductions in intracellular ATP played a role in the altered immune cell functions. Recent 
studies have shown that stimulation of neutrophil formyl peptide receptors (FPRs) increases 
mitochondrial membrane potential and triggers a rapid burst of ATP to be released from 
neutrophils (49, 50). ATP-mediated autocrine activation of purinergic receptors on neutrophil 
membranes boosts Ca2+ signaling, amplifies mitochondrial ATP production, and initiates 
functional neutrophil responses (49). Disruption of this process by depletion of ATP or 
impaired mitochondrial function could prevent neutrophil activation and phagocytosis of 
pathogens.  Macrophages are also reported to utilize ATP-purinergic receptor signaling for 
subsequent activation and ablation of ATP may cause a similar inhibition of function (51). 
Additionally, hypoxia-induced depletion of ATP in alveolar macrophages significantly 
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reduced phagocytosis of glutaraldehyde-fixed red blood cells, demonstrating a clear link 
between available ATP and phagocytic capacity (52). NK cells require the ATP-dependent 
molecular motor myosin II for lytic granule fusion with the cell membrane and subsequent 
killing of target cells (53). Reduced intracellular ATP levels could impair myosin activity and 
limit NK cell killing ability. Furthermore, ATP depletion has been reported to cause 
cytoskeletal derangements (54). Neutrophils, alveolar macrophages, and NK cells require 
tightly-controlled regulation of cytoskeletal rearrangement to effectively carry out their 
immune functions.  Further work is needed to determine if cinnamaldehyde exposures reduce 
intracellular ATP levels in immune cells similar to the levels observed in hBE cells. 
5.2  Future directions 
While the work presented here adds to the general knowledge of how a common 
aldehyde flavoring agent, in the context of e-cigarette use, may affect respiratory innate 
defense responses, it has also highlighted significant knowledge gaps and potential avenues 
for future research.  Some of these future directions will be discussed the following section.     
5.2.1  E-cigarette aerosol deposition in the lung 
We, and others, have shown that some chemical constituents of e-cigarettes have 
significant in vitro and in vivo toxicities. However, it is still unclear whether e-cigarette users 
will reach exposure doses resulting in toxicity. Dosimetry models can be used to predict 
doses of inhaled material; however, these models require several parameters including 
particle size distribution. Aerosols generated by e-cigarettes are concentrated, chemically 
complex, and temporally dynamic as they contain semi-volatile compounds which change in 
particle size with dilution (55). These characteristics have led to considerable variability in 
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reports of particle size distribution (55-60). Moreover, many of the studies investigating e-
cigarette particle size distribution have used disposable first-generation “cig-a-likes”, which 
does not reflect the devices typically used by adolescent and young adult e-cigarette users. 
Moving forward, it will be essential to understand the aerosol characteristics of third-
generation e-cigarette devices and how different vaping temperatures affect particle size 
distribution. This information, when incorporated with real-world puff topography and use 
frequency, will be extremely useful for establishing dose exposures for chemical constituents 
in e-cigarettes and accurately integrating our in vitro findings into risk assessments for e-
cigarette use.  
5.2.2  Cinnamaldehyde and mucociliary clearance in healthy e-cigarette users 
The data presented in Chapter 3 clearly indicate that cinnamon-flavored e-liquids, 
cinnamon e-liquid aerosols, and cinnamaldehyde alone have the capacity to rapidly induce 
hBE cell ciliostasis. This observation is striking and may have serious health implications if 
response translates to impaired mucociliary clearance in e-cigarette users. In vivo mucociliary 
clearance rates can be quantified in humans assuming that a labeled and inhaled marker 
deposited on the airway surface is cleared from the lung at the same rate as the airway 
secretions in which it is immersed. The most common technique for measuring mucociliary 
clearance in vivo is to use inhaled, radiolabeled Technetium-99m sulfur colloid (Tc99m-SC) 
particles that, upon deposition in the airways, can be tracked by gamma camera (gamma 
scintigraphy) to determine their rate of egress (61). Immediately following controlled 
inhalation of Tc99m-SC particles, an initial deposition scan is recorded followed by imaging 
with gamma camera at regular intervals to monitor the egress of Tc99m-SC particles from 
the lung. The temporal analysis of particle egress allows for the calculation of particle 
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retention as a percent or fraction of the initial deposition. Using this approach, healthy e-
cigarette users could vape cinnamaldehyde-containing e-liquids prior to inhalation of Tc99m-
SC particles, and the effects of cinnamaldehyde on mucociliary clearance could be 
quantified. This translational approach would allow a direct comparison between our in vitro 
data and real-word exposures in healthy e-cigarette users.     
5.2.3  Spontaneous recovery of cilia motility and the role of ALDH   
An interesting phenomenon described in Chapter 3 is the spontaneous recovery of 
cilia motility without the removal of cinnamaldehyde. We are investigating underlying 
mechanisms of this recovery; however, it is currently unclear what, precisely, is driving this 
response. Previous work on the dermatologic and toxicologic assessment of cinnamaldehyde 
indicates that cinnamaldehyde is rapidly metabolized to cinnamic acid (62). Studies in 
rodents show that cinnamic acid undergoes β-oxidation to form benzoic acid, which then 
undergoes glucuronidation reactions to form glycine or glucuronic acid conjugates, which are 
eliminated in the urine (62). Very little has been reported about the enzymatic oxidation of 
cinnamaldehyde. Wang and colleagues report that cytosolic aldehyde dehydrogenase 1 
(ALDH1) and mitochondrial aldehyde dehydrogenase 2 (ALDH2) purified from human liver 
effectively detoxify cinnamaldehyde in vitro (63). More recent work from Solobodowska 
identified ALDH1A1 and ALDH3A1 as effective enzymes for eliminating cinnamaldehyde; 
however, ALDH1A1 was significantly more effective (a KM value 35 times lower than 
ALDH3A1). While we did not quantify the conversion of cinnamaldehyde to cinnamic acid 
or other metabolites, it is plausible that the recovery of mitochondrial function and cilia 
motility rely on the metabolism of cinnamaldehyde. Additionally, our finding reported in 
Chapter 4 indicate that cinnamaldehyde reacts with GSH and other studies have suggested 
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that other cysteine-rich proteins may act as “electrophile sinks” (64). Hence, the rapid 
metabolism or sequestration of cinnamaldehyde could be among the underlying mechanisms 
of the rapid reversal of the ciliary stasis and decreases in ATP synthesis. 
Based on these data, future studies investigating the mechanisms of cinnamaldehyde 
metabolism in hBE cells and the role of ALDH enzymes would be useful. Furthermore, if 
future studies indicate that ALDH enzymes play an important role in hBE cell metabolism 
and the protection/restoration of ciliary function, it would be extremely useful to investigate 
whether populations with frequently-occurring ALDH inactivation mutations (e.g., Asians 
and Native Americans) have enhanced susceptibility to the effects of cinnamaldehyde and 
other aldehyde e-cigarette flavoring agents (65, 66).    
5.2.4  The inclusion of aldehyde flavorings in e-cigarette carbonyl quantification 
Many investigators have attempted to make head-to-head comparisons of the 
quantities of toxic aldehydes in cigarette smoke versus aerosols generated when vaping. In a 
2014 study by Goniewics and colleagues, aerosols generated from 12 “cig-a-like” type e-
cigarettes were evaluated for the presence of toxic compounds found in cigarette smoke (67). 
Formaldehyde, acetaldehyde, acrolein, and o-methylbenzaldehyde were present in the e-
cigarette aerosol. However, concentrations of these carbonyls ranged between 9 and 450 
times lower than the concentrations in an equivalent volume of cigarette smoke. Similarly, 
work by Uchiyama et al. reported the carbonyl content of aerosols generated from 13 
Japanese “cig-a-like” type e-cigarettes (68). Formaldehyde, acetaldehyde, acrolein, propanal, 
glyoxal, and methylglyoxal were generated by 9 of the e-cigarettes tested at concentrations of 
140, 120, 40, 46, 23, and 21µg/10 puffs, respectively. In a recent letter to the New England 
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Journal of Medicine, Jensen and colleagues reported that a 2nd generation “tank-style” e-
cigarette with a 5.0V output setting produced 380±90µg of formaldehyde in 10 puffs; 
concentrations much higher than previous studies and exceeding formaldehyde levels of 
traditional cigarettes (69).  However, this study was criticized for using power levels that 
likely resulted in “dry-puff” conditions, which confound the finding. More recently, a study 
by Sleiman et al. reported extremely high aldehyde emissions from a 2nd generation e-
cigarette device equipped with a dual-coil atomizer (70). The authors quantified 
formaldehyde, acetaldehyde, and acrolein at 48200µg, 19080µg, and 10060µg per gram of 
vaped e-liquid, respectively. These levels far exceed carbonyl levels found in cigarette 
smoke. The average formaldehyde content of a single cigarette under intense smoking 
conditions is reported to be 74µg (71). Based on this value, the concentration of 
formaldehyde measured in one gram of vaped e-liquid in the Sleiman study would equate to 
that of approximately 650 cigarettes. Interestingly, a recent replication study of Sleiman’s 
work by Farsalinos and colleagues reported significantly lower quantities of formaldehyde, 
acetaldehyde, and acrolein using the same e-liquid and device used by Sleiman. Farsalinos 
quantified formaldehyde, acetaldehyde, and acrolein at 4259.6µg, 2156.2µg, and 623.6µg per 
gram of vaped e-liquid, respectively. The reductions in carbonyl content suggest that the 
prior measurements by Sleiman may have been due to “dry-puff” conditions. While the 
concentrations reported by Farsalinos are significantly lower than those reported by Sleiman, 
4259.6µg of formaldehyde in 1 gram of vaped e-liquid equates to the amount of 
formaldehyde generated by approximately 57 cigarettes; an exposure concentration that is 
still cause for concern. 
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While the studies described here make efforts to compare and contrast the reactive 
aldehydes in traditional cigarettes and e-cigarettes, the contribution of flavoring agents to the 
total aldehyde is not considered. The Sinicide e-liquid in our studies contained approximately 
1.14M cinnamaldehyde (Chapter 2). Based on this concentration, vaping 1ml of this e-liquid 
(5 to 20 5-second puffs depending on the device settings) would expose the user to 150.66mg 
of cinnamaldehyde. A study by Fujioka et al. found that the total carbonyl content recovered 
from regular size cigarettes ranged from 1.92mg per cigarette to 3.14mg per cigarette (72). 
This would indicate that the cinnamaldehyde content alone in 1ml of Sinicide e-liquid is 
78.5% to 48.0% of the total content of a typical cigarette. Depending on the other carbonyls 
present in Sinicide aerosols (i.e. other flavorings, thermal degradation products of PG and 
VG, etc.), the total carbonyl content of 1ml of this e-liquid could be comparable to or greatly 
exceed the carbonyl content of a traditional cigarette. Based on our studies, cinnamaldehyde 
can directly affect cellular functions, suppress antioxidant responses, and deplete GSH levels. 
These data provide a clear indication that cinnamaldehyde (and likely other carbonyl 
flavoring agents) should be included in future studies assessing the carbonyl content of e-
cigarette aerosols and e-liquids.   
5.2.5  Quantifying cinnamaldehyde-protein adducts in cells and e-cigarette users 
The data here indicate that cinnamaldehyde has concentration-dependent effects on 
various cell types and critical cell processes. However, we did not investigate specific 
molecular drivers of these responses. The predominant mechanism by which ⍺,β-unsaturated 
aldehydes disrupt cellular functions is via protein modification. Nucleophilic additions can 
occur at either the carbonyl group (1,2-addition) or β-carbon (1,4-addition). Addition at the 
β-carbon (i.e., Michael addition) results in the formation of a stable, covalent modification. 
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Weak bases, including alcohols, thiols, primary amines, and secondary amines can readily 
form Michael adducts with ⍺,β-unsaturated aldehydes (73, 74). Nucleophilic addition at the 
carbonyl group (Schiff base formation) are less stable than Michael additions and believed to 
occur less frequently during aldehyde-protein interactions (75). A logical next step for our 
work is to investigate cinnamaldehyde-protein adducts in order to identify underlying 
molecular drivers of cellular dysregulation. To this end, hBE cells or respiratory immune 
cells could be exposed to cinnamaldehyde and cell lysates collected for adduct proteomic 
analysis by high-performance liquid chromatography (HPLC)-tandem mass spectrometry 
(MS/MS). This would provide an effective approach for, 1) identifying adducted proteins, 
and 2) determining which amino acid is adducted (i.e. whether the adduction is a Michael 
addition or a Schiff base). To expand this work further, nasal-scape biopsies of the inferior 
nasal turbinate epithelium could be collected from non-smokers and healthy e-cigarette users 
and analyzed for aldehyde-protein adducts using this HPLC-MS/MS approach.  
5.3  Concluding remarks 
In summary, the data presented in this dissertation significantly add to our knowledge 
of how common food-safe flavoring agents, in the context of e-cigarette use, can affect 
respiratory innate defense responses. Specifically, we demonstrate that the α,β-unsaturated 
aldehyde flavoring agent cinnamaldehyde, at sufficient exposure doses, can impair 
respiratory innate immune cell functions, suppress airway cilia motility by dysregulation of 
mitochondrial respiration and glycolytic function, and modify airway epithelial cell redox 
homeostasis by depletion of glutathione (GSH) and dose-dependent modulation of Nrf2 
antioxidant pathway activation. These findings are cause for concern as electrophilic 
flavoring agents, such as cinnamaldehyde, are commonly used to flavor e-cigarettes and there 
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is currently no regulation governing the quantities used in these products. E-cigarettes may 
have the potential to reduce cigarette consumption and improve smoking-related morbidity 
and mortality rates. However, as we stated in Chapter 1, the net effect of e-cigarettes on 
public health, whether harm or benefit, depends on: 1) their effect on youth transition to 
tobacco smoking, 2) their effect on adult smoking cessation, and 3) their intrinsic toxicity. 
Our work, as well as the work of others, clearly indicates that flavoring additives, at 
concentrations observed in e-liquids, can significantly disrupt normal cell physiology in ways 
that may have implications for the development and exacerbation of respiratory disease. As 
the high concentrations of flavorings in e-liquids likely contribute to the intrinsic toxicity of 
e-cigarettes, the quantities of flavoring agents used in these products should be regulated. To 
this end, the information provided here may be particularly useful in the development of 
health-protective policies aimed at reducing or eliminating harmful and potentially harmful 
chemicals from e-cigarettes. 
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